data_1t0g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t0g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 118.959 -0.543 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.565 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.457 ' ND2' HG23 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 HG23 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.438 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.717 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.409 ' O ' HD21 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CG ' HD21 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 91' ' ' ASN . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.642 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.527 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.642 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.493 -1.225 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.411 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 46.6 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 24' ' ' ASP 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD22 ' CG ' ' A' ' 93' ' ' TRP . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HB3' HD21 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.59 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.59 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.541 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.598 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.572 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.572 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.419 ' HB3' HG11 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 33' ' ' ILE . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 87' ' ' ILE . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.638 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.526 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.494 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.654 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 28.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 44' ' ' LYS . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' HD12 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.48 ' OG ' HD22 ' A' ' 79' ' ' LEU . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.48 HD22 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.537 HD23 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' N ' ' HD3' ' A' ' 85' ' ' LYS . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.554 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.476 ' HB3' HD21 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.483 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.241 0.651 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.694 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.694 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.434 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.416 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.584 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.509 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.535 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 83' ' ' THR . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.525 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.488 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.604 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.631 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? . . . . . 0 C--O 1.246 0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.62 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.62 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 34.5 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.474 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.458 HG13 ' CA ' ' A' ' 22' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 75' ' ' VAL . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' HG11 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' HA3' ' OD1' ' A' ' 21' ' ' ASN . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.508 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.621 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.561 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD21 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 122.265 1.031 . . . . 0.0 113.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' N ' ' HA2' ' A' ' 105' ' ' GLY . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.615 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' GLN . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 17' ' ' LEU . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.501 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 59' ' ' LYS . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 87' ' ' ILE . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LYS . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.55 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD23 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' ' N ' ' A' ' 10' ' ' GLU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.681 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.681 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 38.9 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' HG23 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.449 HG23 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 44' ' ' LYS . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 33' ' ' ILE . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' O ' HG11 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.681 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.502 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' HD21 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 71' ' ' ASN . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.681 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.489 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.595 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 26' ' ' SER . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.401 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 56' ' ' PHE . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.477 ' O ' HG21 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.496 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD23 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' MET . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' N ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD23 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.523 HG13 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' THR . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.443 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.443 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.472 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.407 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.435 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB3' HD23 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.619 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.556 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.422 HG21 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.625 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.458 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.534 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 13' ' ' THR . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' O ' ' HA3' ' A' ' 105' ' ' GLY 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.659 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.659 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.409 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.571 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD21 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB2' HD21 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.645 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 81' ' ' GLY . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 80' ' ' GLU . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.665 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.645 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD21 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.402 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.608 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.558 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.476 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.558 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.53 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.466 ' OD1' HG23 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.466 HG23 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.503 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.633 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.475 ' CB ' HD21 ' A' ' 79' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 78' ' ' SER . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 81' ' ' GLY . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.551 ' HB3' HD23 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 92.6 m-20 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.523 ' HD1' ' O ' ' A' ' 89' ' ' THR . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.418 HG12 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.604 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.604 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD11 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 56' ' ' PHE . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' C ' HD11 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.622 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' O ' HG21 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.409 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HB3' HD23 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 87' ' ' ILE . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.508 ' CG ' HD23 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB2' HH11 ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.609 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.609 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.7 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.697 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.446 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.402 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.438 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 55' ' ' MET . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.61 ' O ' HG21 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.512 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.551 ' CG ' HD21 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.492 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.413 -2.279 0 CA-C-O 121.778 0.799 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.693 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.693 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 19' ' ' GLN . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.568 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.559 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.5 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.539 ' C ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' C ' ' A' ' 69' ' ' SER . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.49 ' C ' HD21 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.569 ' CG ' HD21 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.545 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.702 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.702 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 30.0 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 19' ' ' GLN . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CD1' ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 33' ' ' ILE . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.527 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.601 HD21 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.509 ' CG ' HD22 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.612 ' O ' HG21 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD22 ' CG ' ' A' ' 67' ' ' LYS . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.601 ' CG ' HD21 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HG2' HG23 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.556 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.723 ' N ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' A' ' 23' ' ' THR . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.517 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 HG21 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' HA ' HG11 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 HD22 ' CG ' ' A' ' 93' ' ' TRP . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HB3' HD21 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 HD23 HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.464 HD21 HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.647 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.498 HG22 ' OD2' ' A' ' 60' ' ' ASP . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.723 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.723 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' OD1' HG21 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 HG21 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.656 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.5 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.474 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.648 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.649 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.558 ' O ' HG21 ' A' ' 75' ' ' VAL . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD11 HD23 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.596 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.549 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.549 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.402 ' O ' HD11 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HB3' ' O ' ' A' ' 78' ' ' SER . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HB3' HD23 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.424 HD11 HG23 ' A' ' 87' ' ' ILE . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.455 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.402 ' CD2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.508 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.448 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 12' ' ' PHE . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.496 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE2' HG12 ' A' ' 108' ' ' VAL . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.642 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.642 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 37.5 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.475 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' HG22 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' N ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' SER . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 79' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 81' ' ' GLY . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 80' ' ' GLU . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.609 ' CG ' HD23 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.33 -151.18 7.27 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.47 122.99 34.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 117.36 0.58 . . . . 0.0 109.993 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -68.66 97.0 0.76 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.906 0.86 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.61 70.69 1.02 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.59 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.2 p80 -152.65 93.68 1.8 Allowed 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 121.963 0.887 . . . . 0.0 109.857 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -138.76 16.67 2.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 122.392 1.091 . . . . 0.0 108.821 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -155.62 -44.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -125.99 -169.25 1.98 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.648 174.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.542 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.565 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.457 ' ND2' HG23 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 HG23 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.527 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.438 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.717 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.409 ' O ' HD21 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CG ' HD21 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 91' ' ' ASN . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.642 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.527 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.642 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.3 -86.96 0.12 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 62.79 82.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 0.0 110.797 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -106.04 94.86 5.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -79.68 110.65 15.21 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.538 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -81.46 155.52 25.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -139.6 90.76 2.43 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 111.41 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -173.56 -78.71 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER 165.48 155.72 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.626 1.971 . . . . 0.0 106.541 169.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.411 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 46.6 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.4 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 24' ' ' ASP 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.51 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD22 ' CG ' ' A' ' 93' ' ' TRP . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.54 HD21 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HB3' HD21 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.59 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.59 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.541 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.598 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.307 0.099 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.72 109.3 2.57 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -79.32 81.95 5.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.434 0.635 . . . . 0.0 110.453 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -89.85 -23.43 21.68 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -91.55 93.98 9.22 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -107.76 104.44 13.94 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.69 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -96.59 96.22 8.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.724 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 64.21 -74.45 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.62 1.168 . . . . 0.0 113.022 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -133.0 134.04 43.93 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.572 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.572 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.419 ' HB3' HG11 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 33' ' ' ILE . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' HD21 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' C ' HD13 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.592 HD13 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 87' ' ' ILE . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.638 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.526 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.526 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.494 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.34 109.05 2.31 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -91.43 143.54 26.51 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -88.91 24.94 1.92 Allowed 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.746 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -133.19 93.3 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.343 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.6 p-80 -159.87 179.8 8.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -126.45 -86.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -105.12 -37.11 7.04 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -87.84 158.52 18.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.654 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 28.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.421 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.417 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CD1' ' HG3' ' A' ' 44' ' ' LYS . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' HD12 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.48 ' OG ' HD22 ' A' ' 79' ' ' LEU . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.48 HD22 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.537 HD23 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' N ' ' HD3' ' A' ' 85' ' ' LYS . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.554 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.476 ' HB3' HD21 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.483 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.0 57.88 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.611 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 56.8 m-70 -116.22 85.74 2.35 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 31.8 t-80 -68.26 -50.76 51.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.87 112.31 24.23 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.624 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -108.63 -169.02 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -117.64 68.18 0.76 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.362 0.601 . . . . 0.0 109.818 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 176.66 -49.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.673 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.52 172.1 18.93 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.231 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.6 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.694 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.694 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.434 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.416 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.572 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.584 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.509 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.535 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 83' ' ' THR . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.525 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.604 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.631 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.22 -170.75 33.32 Favored Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' HB3' ' H ' ' A' ' 4' ' ' HIS . 27.3 m170 60.8 -156.81 0.34 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.334 0.567 . . . . 0.0 110.813 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.43 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 55.7 t-80 76.84 -67.05 0.23 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.47 1.108 . . . . 0.0 112.348 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -141.18 104.76 4.69 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.945 0.403 . . . . 0.0 111.259 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -138.98 92.23 2.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.13 -46.93 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.533 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -89.11 160.44 17.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? -79.59 157.86 27.23 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.62 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.62 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 34.5 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.474 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.458 HG13 ' CA ' ' A' ' 22' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 75' ' ' VAL . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' O ' HG11 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' HA3' ' OD1' ' A' ' 21' ' ' ASN . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.508 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.621 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.561 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD21 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--O 1.244 0.768 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.59 114.26 0.9 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.73 154.28 22.15 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 3.7 p80 -70.52 139.3 51.56 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 117.867 -1.533 . . . . 0.0 107.958 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -71.45 -41.71 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -170.59 -168.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -75.22 71.76 2.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 119.593 1.088 . . . . 0.0 111.754 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 164.6 108.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 126.815 2.046 . . . . 0.0 107.38 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.7 mt 68.45 113.25 0.04 OUTLIER 'General case' 0 C--O 1.25 1.091 0 C-N-CA 124.744 1.217 . . . . 0.0 113.485 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 4' ' ' HIS . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.615 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' GLN . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 17' ' ' LEU . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.501 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.508 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 59' ' ' LYS . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 87' ' ' ILE . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LYS . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.55 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD23 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' ' N ' ' A' ' 10' ' ' GLU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.687 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.24 126.05 7.93 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -152.84 24.54 0.57 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.142 0.471 . . . . 0.0 111.826 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 67.96 117.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.865 1.266 . . . . 0.0 113.552 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.58 79.83 2.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.035 0.445 . . . . 0.0 111.1 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -144.32 90.6 2.11 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 m80 68.54 -0.76 2.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -88.9 154.83 19.93 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp -66.56 157.65 31.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.681 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.681 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 38.9 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' OD1' HG23 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 HG23 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 44' ' ' LYS . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 33' ' ' ILE . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' O ' HG11 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.681 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.502 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.496 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HB3' HD21 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 71' ' ' ASN . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.681 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.532 ' HB3' HD21 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.595 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HB3' ' OH ' ' A' ' 20' ' ' TYR . 1.4 mpt? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.66 105.64 0.27 Allowed Glycine 0 C--O 1.213 -1.187 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 -78.99 0.48 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.428 -0.454 . . . . 0.0 109.924 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -159.62 113.55 2.28 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.308 1.043 . . . . 0.0 109.421 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -128.81 95.21 4.03 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.701 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -71.91 76.76 0.9 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -144.21 100.28 3.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.385 -2.079 . . . . 0.0 105.385 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 64.38 -159.25 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt -75.96 166.37 23.59 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.833 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.479 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 1' ' ' MET . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 26' ' ' SER . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.401 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 56' ' ' PHE . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.56 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.477 ' O ' HG21 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.496 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD23 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 55' ' ' MET . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' N ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD23 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.523 HG13 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' THR . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.581 0.229 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.01 137.29 13.68 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.914 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -163.74 133.53 4.14 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -89.08 158.66 17.89 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.236 0.541 . . . . 0.0 111.854 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -138.38 -1.24 1.92 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -155.77 179.89 8.77 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 126.551 1.94 . . . . 0.0 107.15 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.63 82.98 0.67 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -140.85 -63.92 0.46 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.324 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -141.43 90.14 2.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.443 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.443 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.472 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.407 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.435 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB3' HD23 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.619 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.534 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.556 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' HB3' HD21 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 79' ' ' LEU . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.422 HG21 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.625 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.625 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.458 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.534 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 13' ' ' THR . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.217 -0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.41 -149.2 51.61 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.979 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -89.1 -62.61 1.44 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -141.79 -26.5 0.67 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.12 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 p80 49.03 -169.71 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.812 1.645 . . . . 0.0 112.984 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 10' ' ' GLU . 26.5 t60 68.88 17.63 8.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 111.144 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -89.97 154.42 19.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.022 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 76.42 -64.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.949 1.299 . . . . 0.0 108.608 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -174.14 179.47 1.88 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 6' ' ' HIS 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.659 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.659 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.409 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.465 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.571 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD21 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB2' HD21 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.645 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 81' ' ' GLY . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 80' ' ' GLU . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.665 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.665 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.645 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD21 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.402 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.608 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.558 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.476 HG13 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.558 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.05 -146.66 49.12 Favored Glycine 0 N--CA 1.445 -0.747 0 O-C-N 123.639 0.587 . . . . 0.0 112.653 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 70.26 -66.46 0.28 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.442 1.097 . . . . 0.0 112.722 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -56.18 113.0 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -157.52 142.85 17.09 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.5 m-70 -123.11 124.72 43.72 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.824 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -148.7 95.25 2.4 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 160.83 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.61 1.564 . . . . 0.0 107.449 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp 73.95 140.71 0.06 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 127.296 2.238 . . . . 0.0 114.141 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.466 ' OD1' HG23 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.466 HG23 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.503 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.633 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.475 ' CB ' HD21 ' A' ' 79' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 78' ' ' SER . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.55 ' HG2' ' H ' ' A' ' 81' ' ' GLY . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.55 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.551 ' HB3' HD23 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.523 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 92.6 m-20 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.523 ' HD1' ' O ' ' A' ' 89' ' ' THR . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.418 HG12 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 6' ' ' HIS . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 152.25 27.06 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.432 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.5 -18.21 49.26 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.252 12.4 m-70 72.0 94.54 0.08 Allowed 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -94.86 92.34 6.88 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.57 ' CB ' ' HB2' ' A' ' 10' ' ' GLU 0.302 7.7 p80 -87.2 115.69 24.78 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 -170.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -73.53 126.19 29.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.326 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 72.96 -70.01 0.17 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.763 1.225 . . . . 0.0 110.107 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.32 -177.66 3.74 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' HB2' ' CB ' ' A' ' 6' ' ' HIS . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.604 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.604 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD11 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 56' ' ' PHE . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' C ' HD11 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.622 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.508 HD23 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' O ' HG21 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.409 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' HB3' HD23 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 87' ' ' ILE . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.508 ' CG ' HD23 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.08 76.76 0.83 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.545 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.98 94.2 6.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 t60 62.03 101.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -93.02 173.52 7.7 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.3 95.55 0.94 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.76 0.79 . . . . 0.0 113.087 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -133.67 75.88 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 m80 73.61 -52.45 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.217 1.407 . . . . 0.0 109.53 -169.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt -138.92 -178.59 5.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' HB2' HH11 ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.609 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.609 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.7 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.697 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.446 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.402 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.438 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 55' ' ' MET . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.61 ' O ' HG21 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' HB3' HD21 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.551 ' CG ' HD21 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.512 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.492 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.74 173.0 55.08 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -129.21 -46.92 1.21 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -141.48 105.01 4.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -70.3 135.51 48.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 66.49 60.63 0.59 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.14 1.376 . . . . 0.0 112.42 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -145.24 147.79 32.78 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -81.12 -53.29 6.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.6 109.21 13.77 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.408 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.693 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.693 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 19' ' ' GLN . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.568 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 29' ' ' ILE . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.5 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.539 ' C ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' C ' ' A' ' 69' ' ' SER . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.49 ' C ' HD21 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.49 HD21 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.569 ' CG ' HD21 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.545 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.63 -127.56 9.26 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 69.82 -177.24 0.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.742 0.817 . . . . 0.0 112.534 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 73.51 -1.08 3.16 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -86.53 131.0 34.29 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.828 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -123.14 173.34 7.94 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -82.99 -26.6 31.12 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -70.5 -64.42 0.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.06 146.21 26.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.451 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.702 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.702 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 30.0 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 19' ' ' GLN . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CD1' ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 33' ' ' ILE . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA3' ' CD1' ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.527 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.601 HD21 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.509 ' CG ' HD22 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.612 ' O ' HG21 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD22 ' CG ' ' A' ' 67' ' ' LYS . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.601 ' CG ' HD21 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HG2' HG23 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.556 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.41 157.68 9.73 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.811 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -126.18 164.28 21.3 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -144.98 81.07 1.63 Allowed 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 123.909 0.884 . . . . 0.0 109.367 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -112.61 96.91 6.24 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -78.89 168.31 19.89 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 m80 69.91 10.24 7.4 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.601 1.161 . . . . 0.0 111.625 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -143.59 170.81 15.13 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.35 135.52 35.68 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.472 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.723 ' N ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.533 ' OD1' HG22 ' A' ' 23' ' ' THR . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.517 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 HG21 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.496 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' HA ' HG11 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 HD22 ' CG ' ' A' ' 93' ' ' TRP . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.574 ' HB3' HD21 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 HD23 HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.464 HD21 HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.647 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.498 HG22 ' OD2' ' A' ' 60' ' ' ASP . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.647 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 36.62 11.93 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.553 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -75.32 142.03 43.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -80.02 135.27 36.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -73.82 99.52 3.21 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.524 0.678 . . . . 0.0 111.452 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -138.75 104.42 5.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -94.19 97.49 10.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -166.11 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.45 131.95 36.82 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.723 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.723 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' OD1' HG21 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 HG21 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.656 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.5 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.474 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.648 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.649 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.558 ' O ' HG21 ' A' ' 75' ' ' VAL . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD11 HD23 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.596 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.517 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.549 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.01 39.56 2.71 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.074 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -84.65 88.53 7.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 117.718 0.759 . . . . 0.0 109.104 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.251 0.5 OUTLIER -152.65 63.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -150.97 81.76 1.33 Allowed 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.931 1.292 . . . . 0.0 110.93 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -128.45 -31.92 2.23 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 52.6 t-80 -173.91 148.43 1.41 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 58.9 t-80 75.29 152.79 0.14 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 123.844 0.715 . . . . 0.0 111.103 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.73 153.56 23.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.556 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.402 ' O ' HD11 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.566 ' HB3' ' O ' ' A' ' 78' ' ' SER . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' LYS . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HB3' HD23 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.424 HD11 HG23 ' A' ' 87' ' ' ILE . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.455 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.402 ' CD2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.508 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.448 ' O ' ' HD1' ' A' ' 97' ' ' PHE . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 12' ' ' PHE . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.616 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 66.5 mtt . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 120.927 0.394 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.86 11.17 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -89.46 66.57 7.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.956 0.884 . . . . 0.0 111.898 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -155.76 126.89 7.08 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.307 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -110.81 153.96 24.65 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.931 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.458 ' HB2' ' HG2' ' A' ' 10' ' ' GLU . 57.0 m80 -84.48 92.24 8.03 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -76.53 89.66 3.29 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.194 0.521 . . . . 0.0 111.543 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 172.25 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -177.74 147.52 0.49 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 172.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.496 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.442 ' OE2' HG12 ' A' ' 108' ' ' VAL . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.642 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.642 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 37.5 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.616 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' CD ' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.475 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' HG22 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HB3' ' N ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 78' ' ' SER . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 79' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 81' ' ' GLY . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 80' ' ' GLU . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.609 ' CG ' HD23 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 118.959 -0.543 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 108' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.576 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 56' ' ' PHE . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 32' ' ' ALA . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.448 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.521 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.714 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 34' ' ' LYS . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.4 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CG ' HD22 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.684 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.684 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.493 -1.225 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.416 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 48.3 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.416 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.627 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.416 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.627 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.581 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HB3' HD22 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.556 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.606 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.556 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.481 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.643 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.436 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG13 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.42 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HD2' HG11 ' A' ' 75' ' ' VAL . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' LEU . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 75' ' ' VAL . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.601 ' C ' HD12 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 87' ' ' ILE . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 83' ' ' THR . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.466 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.656 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.401 HG21 HH21 ' A' ' 36' ' ' ARG . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.537 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.537 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.497 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.497 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 27.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 ' HA3' ' A' ' 48' ' ' GLY . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 62' ' ' SER . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.45 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' H ' ' A' ' 34' ' ' LYS . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB3' HD22 ' A' ' 82' ' ' LEU . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.488 ' HB3' HD22 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.45 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.521 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.241 0.651 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.519 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.558 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.558 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.683 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.509 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.539 HD22 ' HG2' ' A' ' 73' ' ' GLU . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' HB3' HD22 ' A' ' 82' ' ' LEU . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.517 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.487 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 4.2 m-20 -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.555 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.655 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? . . . . . 0 C--O 1.246 0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.47 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 33.7 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' HA3' ' A' ' 48' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 79' ' ' LEU . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' SER . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.575 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CG ' HD22 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 105' ' ' GLY . 68.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 122.265 1.031 . . . . 0.0 113.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' N ' ' HA2' ' A' ' 105' ' ' GLY . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.618 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 29' ' ' ILE . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 86' ' ' GLU . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CG ' HD22 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.476 ' H ' HD22 ' A' ' 9' ' ' LEU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.532 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.532 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 40.7 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.689 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.405 ' CD1' HD13 ' A' ' 79' ' ' LEU . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.549 ' HG2' HG21 ' A' ' 33' ' ' ILE . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.621 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' HG22 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.526 HG22 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 44' ' ' LYS . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 40' ' ' VAL . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG21 ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB3' HG11 ' A' ' 103' ' ' VAL . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 32' ' ' ALA . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 31' ' ' VAL . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' HG22 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 59' ' ' LYS . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.593 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 7.7 m-20 -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD22 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.506 ' HG2' HG21 ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.679 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' PHE . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 ' HA2' ' A' ' 105' ' ' GLY . 1.3 tm? . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.489 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' HD22 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.573 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.599 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 62' ' ' SER . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' HA3' ' A' ' 105' ' ' GLY 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.509 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 48' ' ' GLY . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 32' ' ' ALA . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 29' ' ' ILE . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 55' ' ' MET . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HB2' HD22 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.682 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.0 m-20 -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CG ' HD22 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.566 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.599 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.1 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' HA2' ' A' ' 58' ' ' GLY . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.582 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.476 HG22 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.582 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.436 ' HB3' HG13 ' A' ' 37' ' ' VAL . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 30' ' ' TYR . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' HD12 ' A' ' 65' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 75' ' ' VAL . 35.0 p-10 -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.522 ' HA ' HD12 ' A' ' 82' ' ' LEU . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.673 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 79' ' ' LEU . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 11.2 m120 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' HB3' HD22 ' A' ' 65' ' ' LEU . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.437 HG11 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.46 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 40' ' ' VAL . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 94' ' ' GLU . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 45' ' ' SER . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' C ' HD12 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.665 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 82' ' ' LEU . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.5 p30 -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HG2' HG23 ' A' ' 83' ' ' THR . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CG ' HD22 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.47 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.5 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 52.0 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 94' ' ' GLU . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD22 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.498 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.413 -2.279 0 CA-C-O 121.778 0.799 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.55 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.55 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.2 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.577 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.55 ' HB3' HG13 ' A' ' 37' ' ' VAL . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.552 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 64' ' ' ALA . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.471 ' C ' HD23 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.523 HG23 ' HG2' ' A' ' 85' ' ' LYS . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.605 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CG ' HD22 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 108' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.553 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 28.6 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.674 HG21 ' HG2' ' A' ' 94' ' ' GLU . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' CG ' HG12 ' A' ' 75' ' ' VAL . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' CG ' HD21 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 86' ' ' GLU . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' HB3' HD22 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.602 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.674 ' HG2' HG21 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.53 HG12 ' HA2' ' A' ' 35' ' ' GLY . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.611 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.589 HG22 HG23 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.614 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.509 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 21' ' ' ASN . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.646 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.677 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' HA2' ' A' ' 35' ' ' GLY . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.677 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.729 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 30' ' ' TYR . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.513 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HG3' HG12 ' A' ' 75' ' ' VAL . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' HD22 ' A' ' 79' ' ' LEU . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.667 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.594 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 97' ' ' PHE . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.572 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.523 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.563 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.563 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 30' ' ' TYR . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.407 ' HG2' HG21 ' A' ' 89' ' ' THR . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.717 ' HB3' HD22 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.526 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 65' ' ' LEU . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.495 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 39.2 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 41' ' ' THR . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.641 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 28' ' ' PRO . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 82' ' ' LEU . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.623 HD22 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 55' ' ' MET . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 90' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HB3' HD22 ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.623 ' CG ' HD22 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' CD1' HG12 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.641 HG12 ' HA2' ' A' ' 35' ' ' GLY . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.33 -151.18 7.27 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.47 122.99 34.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 117.36 0.58 . . . . 0.0 109.993 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -68.66 97.0 0.76 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.906 0.86 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.61 70.69 1.02 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.2 p80 -152.65 93.68 1.8 Allowed 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 121.963 0.887 . . . . 0.0 109.857 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -138.76 16.67 2.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 122.392 1.091 . . . . 0.0 108.821 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -155.62 -44.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -125.99 -169.25 1.98 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.648 174.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 6' ' ' HIS . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 108' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.576 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 56' ' ' PHE . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 32' ' ' ALA . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.448 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.521 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.714 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 34' ' ' LYS . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.4 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CG ' HD22 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.684 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.684 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.3 -86.96 0.12 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 62.79 82.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 0.0 110.797 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -106.04 94.86 5.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -79.68 110.65 15.21 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.538 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -81.46 155.52 25.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -139.6 90.76 2.43 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 111.41 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -173.56 -78.71 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER 165.48 155.72 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.626 1.971 . . . . 0.0 106.541 169.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 48.3 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.416 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.627 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.416 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.627 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.581 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HB3' HD22 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.556 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.606 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.556 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.481 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.643 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.307 0.099 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.72 109.3 2.57 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -79.32 81.95 5.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.434 0.635 . . . . 0.0 110.453 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -89.85 -23.43 21.68 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -91.55 93.98 9.22 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -107.76 104.44 13.94 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.69 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -96.59 96.22 8.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.724 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 64.21 -74.45 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.62 1.168 . . . . 0.0 113.022 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -133.0 134.04 43.93 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.436 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG13 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.42 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HD2' HG11 ' A' ' 75' ' ' VAL . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' LEU . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 75' ' ' VAL . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.601 ' C ' HD12 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 87' ' ' ILE . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 83' ' ' THR . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.466 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.656 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.401 HG21 HH21 ' A' ' 36' ' ' ARG . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.537 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.537 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.34 109.05 2.31 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -91.43 143.54 26.51 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -88.91 24.94 1.92 Allowed 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.746 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -133.19 93.3 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.343 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.6 p-80 -159.87 179.8 8.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -126.45 -86.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -105.12 -37.11 7.04 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -87.84 158.52 18.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.497 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 27.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 ' HA3' ' A' ' 48' ' ' GLY . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 62' ' ' SER . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.45 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' H ' ' A' ' 34' ' ' LYS . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB3' HD22 ' A' ' 82' ' ' LEU . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.488 ' HB3' HD22 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.45 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.521 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.0 57.88 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.611 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.606 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 56.8 m-70 -116.22 85.74 2.35 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 31.8 t-80 -68.26 -50.76 51.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.87 112.31 24.23 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.624 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -108.63 -169.02 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -117.64 68.18 0.76 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.362 0.601 . . . . 0.0 109.818 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 176.66 -49.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.673 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.52 172.1 18.93 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.231 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.519 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.708 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.708 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.683 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.509 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.539 HD22 ' HG2' ' A' ' 73' ' ' GLU . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' HB3' HD22 ' A' ' 82' ' ' LEU . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.517 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.487 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 4.2 m-20 -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.555 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.655 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.22 -170.75 33.32 Favored Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.418 ' HB3' ' H ' ' A' ' 4' ' ' HIS . 27.3 m170 60.8 -156.81 0.34 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.334 0.567 . . . . 0.0 110.813 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.418 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 55.7 t-80 76.84 -67.05 0.23 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.47 1.108 . . . . 0.0 112.348 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -141.18 104.76 4.69 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.945 0.403 . . . . 0.0 111.259 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -138.98 92.23 2.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.13 -46.93 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.533 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -89.11 160.44 17.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? -79.59 157.86 27.23 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.47 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 33.7 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' HA3' ' A' ' 48' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 79' ' ' LEU . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' SER . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.575 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CG ' HD22 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--O 1.244 0.768 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.59 114.26 0.9 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.73 154.28 22.15 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 3.7 p80 -70.52 139.3 51.56 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 117.867 -1.533 . . . . 0.0 107.958 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -71.45 -41.71 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -170.59 -168.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 91.6 m-70 -75.22 71.76 2.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 119.593 1.088 . . . . 0.0 111.754 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 7' ' ' HIS . 44.7 t-80 164.6 108.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 126.815 2.046 . . . . 0.0 107.38 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 105' ' ' GLY . 68.7 mt 68.45 113.25 0.04 OUTLIER 'General case' 0 C--O 1.25 1.091 0 C-N-CA 124.744 1.217 . . . . 0.0 113.485 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 4' ' ' HIS . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.618 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 29' ' ' ILE . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 86' ' ' GLU . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CG ' HD22 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.476 ' H ' HD22 ' A' ' 9' ' ' LEU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.687 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.24 126.05 7.93 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -152.84 24.54 0.57 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.142 0.471 . . . . 0.0 111.826 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 67.96 117.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.865 1.266 . . . . 0.0 113.552 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.58 79.83 2.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.035 0.445 . . . . 0.0 111.1 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -144.32 90.6 2.11 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 m80 68.54 -0.76 2.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -88.9 154.83 19.93 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp -66.56 157.65 31.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.532 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.532 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 40.7 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.689 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.405 ' CD1' HD13 ' A' ' 79' ' ' LEU . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.549 ' HG2' HG21 ' A' ' 33' ' ' ILE . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.621 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HB3' ' OH ' ' A' ' 20' ' ' TYR . 1.4 mpt? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.66 105.64 0.27 Allowed Glycine 0 C--O 1.213 -1.187 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 -78.99 0.48 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.428 -0.454 . . . . 0.0 109.924 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -159.62 113.55 2.28 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.308 1.043 . . . . 0.0 109.421 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -128.81 95.21 4.03 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.701 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -71.91 76.76 0.9 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -144.21 100.28 3.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.385 -2.079 . . . . 0.0 105.385 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 64.38 -159.25 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt -75.96 166.37 23.59 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.833 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 1' ' ' MET . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' HG22 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.526 HG22 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 44' ' ' LYS . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 40' ' ' VAL . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG21 ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB3' HG11 ' A' ' 103' ' ' VAL . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 32' ' ' ALA . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 31' ' ' VAL . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' HG22 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 59' ' ' LYS . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 7.7 m-20 -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD22 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.506 ' HG2' HG21 ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.679 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' PHE . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.581 0.229 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.01 137.29 13.68 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.914 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -163.74 133.53 4.14 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -89.08 158.66 17.89 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.236 0.541 . . . . 0.0 111.854 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -138.38 -1.24 1.92 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -155.77 179.89 8.77 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 126.551 1.94 . . . . 0.0 107.15 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.63 82.98 0.67 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -140.85 -63.92 0.46 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.324 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 ' HA2' ' A' ' 105' ' ' GLY . 1.3 tm? -141.43 90.14 2.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.489 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' HD22 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.573 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.599 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 62' ' ' SER . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.217 -0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.41 -149.2 51.61 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.979 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -89.1 -62.61 1.44 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -141.79 -26.5 0.67 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.12 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 p80 49.03 -169.71 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.812 1.645 . . . . 0.0 112.984 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 10' ' ' GLU . 26.5 t60 68.88 17.63 8.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 111.144 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -89.97 154.42 19.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.022 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 76.42 -64.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.949 1.299 . . . . 0.0 108.608 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -174.14 179.47 1.88 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 6' ' ' HIS 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.509 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 48' ' ' GLY . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 32' ' ' ALA . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 29' ' ' ILE . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 55' ' ' MET . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HB2' HD22 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.682 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.0 m-20 -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CG ' HD22 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.566 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.599 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.05 -146.66 49.12 Favored Glycine 0 N--CA 1.445 -0.747 0 O-C-N 123.639 0.587 . . . . 0.0 112.653 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 70.26 -66.46 0.28 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.442 1.097 . . . . 0.0 112.722 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -56.18 113.0 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -157.52 142.85 17.09 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.5 m-70 -123.11 124.72 43.72 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.824 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -148.7 95.25 2.4 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 160.83 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.61 1.564 . . . . 0.0 107.449 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp 73.95 140.71 0.06 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 127.296 2.238 . . . . 0.0 114.141 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.404 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.1 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' HA2' ' A' ' 58' ' ' GLY . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.582 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.476 HG22 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.582 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.436 ' HB3' HG13 ' A' ' 37' ' ' VAL . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 30' ' ' TYR . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' HD12 ' A' ' 65' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 75' ' ' VAL . 35.0 p-10 -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' HA ' HD12 ' A' ' 82' ' ' LEU . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.673 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 79' ' ' LEU . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 11.2 m120 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' HB3' HD22 ' A' ' 65' ' ' LEU . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.437 HG11 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 6' ' ' HIS . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 152.25 27.06 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.432 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.5 -18.21 49.26 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.252 12.4 m-70 72.0 94.54 0.08 Allowed 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -94.86 92.34 6.88 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.584 ' CB ' ' HB2' ' A' ' 10' ' ' GLU 0.302 7.7 p80 -87.2 115.69 24.78 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 -170.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -73.53 126.19 29.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.326 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.7 m80 72.96 -70.01 0.17 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.763 1.225 . . . . 0.0 110.107 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.32 -177.66 3.74 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 6' ' ' HIS . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 40' ' ' VAL . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 94' ' ' GLU . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 45' ' ' SER . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' C ' HD12 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.665 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 82' ' ' LEU . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.5 p30 -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HG2' HG23 ' A' ' 83' ' ' THR . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CG ' HD22 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.08 76.76 0.83 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.545 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.98 94.2 6.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 t60 62.03 101.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -93.02 173.52 7.7 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.3 95.55 0.94 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.76 0.79 . . . . 0.0 113.087 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -133.67 75.88 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 m80 73.61 -52.45 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.217 1.407 . . . . 0.0 109.53 -169.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt -138.92 -178.59 5.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.47 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.5 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 52.0 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 94' ' ' GLU . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD22 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.498 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.74 173.0 55.08 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -129.21 -46.92 1.21 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -141.48 105.01 4.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -70.3 135.51 48.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 66.49 60.63 0.59 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.14 1.376 . . . . 0.0 112.42 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -145.24 147.79 32.78 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -81.12 -53.29 6.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.6 109.21 13.77 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.408 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.55 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.55 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 1.2 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.577 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.55 ' HB3' HG13 ' A' ' 37' ' ' VAL . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.552 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 64' ' ' ALA . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.471 ' C ' HD23 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.523 HG23 ' HG2' ' A' ' 85' ' ' LYS . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.605 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CG ' HD22 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.63 -127.56 9.26 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 69.82 -177.24 0.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.742 0.817 . . . . 0.0 112.534 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 73.51 -1.08 3.16 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -86.53 131.0 34.29 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.828 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -123.14 173.34 7.94 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -82.99 -26.6 31.12 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -70.5 -64.42 0.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.06 146.21 26.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 108' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.553 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.553 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 28.6 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.674 HG21 ' HG2' ' A' ' 94' ' ' GLU . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' CG ' HG12 ' A' ' 75' ' ' VAL . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' CG ' HD21 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 86' ' ' GLU . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' HB3' HD22 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.602 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.674 ' HG2' HG21 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.53 HG12 ' HA2' ' A' ' 35' ' ' GLY . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.611 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.41 157.68 9.73 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.811 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -126.18 164.28 21.3 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -144.98 81.07 1.63 Allowed 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 123.909 0.884 . . . . 0.0 109.367 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -112.61 96.91 6.24 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -78.89 168.31 19.89 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 m80 69.91 10.24 7.4 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.601 1.161 . . . . 0.0 111.625 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -143.59 170.81 15.13 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -81.35 135.52 35.68 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.472 177.431 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.589 HG22 HG23 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.509 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 21' ' ' ASN . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.646 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.677 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' HA2' ' A' ' 35' ' ' GLY . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.677 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 36.62 11.93 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.553 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -75.32 142.03 43.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -80.02 135.27 36.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -73.82 99.52 3.21 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.524 0.678 . . . . 0.0 111.452 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -138.75 104.42 5.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -94.19 97.49 10.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -166.11 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.45 131.95 36.82 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.729 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 30' ' ' TYR . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.513 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HG3' HG12 ' A' ' 75' ' ' VAL . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' HD22 ' A' ' 79' ' ' LEU . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.667 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.594 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 97' ' ' PHE . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.572 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.01 39.56 2.71 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.074 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -84.65 88.53 7.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 117.718 0.759 . . . . 0.0 109.104 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.251 0.5 OUTLIER -152.65 63.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -150.97 81.76 1.33 Allowed 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.931 1.292 . . . . 0.0 110.93 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -128.45 -31.92 2.23 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 52.6 t-80 -173.91 148.43 1.41 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 58.9 t-80 75.29 152.79 0.14 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 123.844 0.715 . . . . 0.0 111.103 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.73 153.56 23.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.523 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.563 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.563 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 30' ' ' TYR . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.407 ' HG2' HG21 ' A' ' 89' ' ' THR . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.717 ' HB3' HD22 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.526 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 65' ' ' LEU . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 66.5 mtt . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 120.927 0.394 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.86 11.17 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -89.46 66.57 7.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.956 0.884 . . . . 0.0 111.898 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -155.76 126.89 7.08 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.307 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -110.81 153.96 24.65 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.931 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 10' ' ' GLU . 57.0 m80 -84.48 92.24 8.03 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -76.53 89.66 3.29 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.194 0.521 . . . . 0.0 111.543 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 172.25 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -177.74 147.52 0.49 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 172.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.495 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 39.2 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 41' ' ' THR . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.641 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 28' ' ' PRO . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 82' ' ' LEU . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.623 HD22 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 55' ' ' MET . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 90' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HB3' HD22 ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.623 ' CG ' HD22 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' CD1' HG12 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.641 HG12 ' HA2' ' A' ' 35' ' ' GLY . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 118.959 -0.543 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 108' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.54 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.54 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.576 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 56' ' ' PHE . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.521 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 32' ' ' ALA . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.448 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.521 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.714 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 34' ' ' LYS . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.4 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CG ' HD22 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.684 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.684 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.493 -1.225 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.416 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 46.6 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.416 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.414 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.627 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.416 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.627 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.581 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HB3' HD22 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.556 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.606 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.556 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.481 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.643 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.586 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.586 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG13 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.42 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HD2' HG11 ' A' ' 75' ' ' VAL . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' LEU . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 75' ' ' VAL . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.601 ' C ' HD12 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 87' ' ' ILE . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 83' ' ' THR . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.466 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.656 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.401 HG21 HH21 ' A' ' 36' ' ' ARG . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.537 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.537 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.656 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.656 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 28.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 ' HA3' ' A' ' 48' ' ' GLY . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 62' ' ' SER . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.45 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' H ' ' A' ' 34' ' ' LYS . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB3' HD22 ' A' ' 82' ' ' LEU . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.488 ' HB3' HD22 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.45 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.521 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.241 0.651 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.519 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.708 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.708 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.683 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.509 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.539 HD22 ' HG2' ' A' ' 73' ' ' GLU . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' HB3' HD22 ' A' ' 82' ' ' LEU . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.517 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.487 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.555 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.655 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? . . . . . 0 C--O 1.246 0.919 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.613 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.613 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 34.5 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' HA3' ' A' ' 48' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 79' ' ' LEU . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' SER . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.575 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CG ' HD22 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 105' ' ' GLY . 68.7 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 122.265 1.031 . . . . 0.0 113.485 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.416 ' N ' ' HA2' ' A' ' 105' ' ' GLY . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.618 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 29' ' ' ILE . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 86' ' ' GLU . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CG ' HD22 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.476 ' H ' HD22 ' A' ' 9' ' ' LEU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.682 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.682 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 38.9 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.689 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.405 ' CD1' HD13 ' A' ' 79' ' ' LEU . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.549 ' HG2' HG21 ' A' ' 33' ' ' ILE . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.621 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.527 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.527 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' HG22 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.526 HG22 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 44' ' ' LYS . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 40' ' ' VAL . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG21 ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.679 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB3' HG11 ' A' ' 103' ' ' VAL . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 32' ' ' ALA . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 31' ' ' VAL . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' HG22 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 59' ' ' LYS . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.593 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD22 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.506 ' HG2' HG21 ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.679 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' PHE . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 ' HA2' ' A' ' 105' ' ' GLY . 1.3 tm? . . . . . 0 CA--C 1.498 -1.045 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.459 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.489 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.446 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' HD22 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.573 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.599 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 62' ' ' SER . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' HA3' ' A' ' 105' ' ' GLY 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.655 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.655 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 48' ' ' GLY . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 32' ' ' ALA . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 29' ' ' ILE . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 55' ' ' MET . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HB2' HD22 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.682 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CG ' HD22 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.566 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.599 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp . . . . . 0 CA--C 1.501 -0.92 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.554 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' HA2' ' A' ' 58' ' ' GLY . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.582 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.476 HG22 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.582 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.436 ' HB3' HG13 ' A' ' 37' ' ' VAL . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 30' ' ' TYR . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' HD12 ' A' ' 65' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.522 ' HA ' HD12 ' A' ' 82' ' ' LEU . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.673 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 79' ' ' LEU . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 92.6 m-20 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.545 ' HB3' HD22 ' A' ' 65' ' ' LEU . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.437 HG11 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.503 -0.862 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.615 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 40' ' ' VAL . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 94' ' ' GLU . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 45' ' ' SER . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' C ' HD12 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.665 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 82' ' ' LEU . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HG2' HG23 ' A' ' 83' ' ' THR . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CG ' HD22 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.617 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.617 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' A' ' 16' ' ' GLN . 49.7 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 94' ' ' GLU . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD22 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.498 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.413 -2.279 0 CA-C-O 121.778 0.799 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.7 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.7 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.577 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.55 ' HB3' HG13 ' A' ' 37' ' ' VAL . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.552 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 64' ' ' ALA . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.471 ' C ' HD23 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.523 HG23 ' HG2' ' A' ' 85' ' ' LYS . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.605 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CG ' HD22 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 108' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.703 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.703 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 30.0 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.674 HG21 ' HG2' ' A' ' 94' ' ' GLU . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' CG ' HG12 ' A' ' 75' ' ' VAL . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' CG ' HD21 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 86' ' ' GLU . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' HB3' HD22 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.602 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.674 ' HG2' HG21 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.53 HG12 ' HA2' ' A' ' 35' ' ' GLY . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.611 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.789 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.589 HG22 HG23 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.614 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.509 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 21' ' ' ASN . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.646 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.557 HD23 HD22 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.557 HD22 HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.677 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' HA2' ' A' ' 35' ' ' GLY . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.677 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.729 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 30' ' ' TYR . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.513 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HG3' HG12 ' A' ' 75' ' ' VAL . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' HD22 ' A' ' 79' ' ' LEU . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.667 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.594 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 97' ' ' PHE . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.572 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--O 1.246 0.899 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.523 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.563 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.563 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 30' ' ' TYR . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.407 ' HG2' HG21 ' A' ' 89' ' ' THR . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HA ' HD22 ' A' ' 88' ' ' ASN . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.717 ' HB3' HD22 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 85' ' ' LYS . 50.8 m-80 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.526 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 65' ' ' LEU . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.66 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.645 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.645 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 37.5 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HD2' ' A' ' 27' ' ' LYS . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 41' ' ' THR . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.629 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.641 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 28' ' ' PRO . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 82' ' ' LEU . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.623 HD22 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 55' ' ' MET . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 90' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HB3' HD22 ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.623 ' CG ' HD22 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' CD1' HG12 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.641 HG12 ' HA2' ' A' ' 35' ' ' GLY . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.33 -151.18 7.27 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.47 122.99 34.93 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 117.36 0.58 . . . . 0.0 109.993 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -68.66 97.0 0.76 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.906 0.86 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.61 70.69 1.02 Allowed 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.2 p80 -152.65 93.68 1.8 Allowed 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 121.963 0.887 . . . . 0.0 109.857 175.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -138.76 16.67 2.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 122.392 1.091 . . . . 0.0 108.821 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -155.62 -44.48 0.08 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.8 OUTLIER -125.99 -169.25 1.98 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.648 174.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 6' ' ' HIS . 8.7 mm-40 -117.45 166.19 12.63 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -171.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 26.4 tt0 -125.06 121.95 35.8 Favored 'General case' 0 N--CA 1.385 -3.695 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.71 169.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.5 ' O ' HG22 ' A' ' 108' ' ' VAL . 67.3 m-85 -114.62 142.23 46.73 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.928 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.54 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.0 m -100.4 143.31 30.73 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.08 66.62 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.65 -30.76 70.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.517 0.675 . . . . 0.0 111.186 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.54 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.53 -35.46 58.28 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.295 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 tp -66.94 -29.35 69.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.092 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.3 t -60.9 -11.62 8.49 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.09 0.956 . . . . 0.0 110.917 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.576 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 59.7 mt-30 -96.14 -16.67 21.37 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.289 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -91.23 33.48 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.319 1.048 . . . . 0.0 109.917 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 23' ' ' THR . 31.2 p-10 -77.51 -11.56 59.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.173 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 93.76 -19.0 55.43 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.47 0.948 . . . . 0.0 115.47 172.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 21' ' ' ASN . 11.2 t -85.69 -10.73 55.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 118.114 0.957 . . . . 0.0 111.126 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.1 85.03 7.19 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.497 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 60.44 21.19 10.84 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 121.909 0.862 . . . . 0.0 111.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 45.6 t 64.04 71.95 0.47 Allowed 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.718 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 65.6 mttm -76.98 164.22 60.51 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 23.7 Cg_exo -65.08 133.07 34.1 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.349 1.366 . . . . 0.0 109.513 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.2 mp -93.57 136.06 26.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 85.2 m-85 -138.66 141.62 39.03 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 56' ' ' PHE . 7.0 p -123.37 130.83 74.01 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -108.93 141.93 40.3 Favored 'General case' 0 N--CA 1.407 -2.59 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.276 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -139.06 113.21 7.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.521 ' H ' ' HB3' ' A' ' 62' ' ' SER . 7.9 tmtt? 66.44 25.21 10.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 122.202 1.001 . . . . 0.0 108.461 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 93.91 -0.41 67.04 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.68 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -100.18 112.93 25.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 32' ' ' ALA . 96.9 t -91.99 117.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 120.989 0.423 . . . . 0.0 110.976 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 86.1 m-85 -104.76 143.58 32.92 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -87.1 133.23 33.64 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 m -127.14 30.51 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.0 p -69.44 -22.73 63.64 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.045 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.9 p -69.95 -22.92 63.13 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.504 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -121.77 37.34 2.95 Favored Glycine 0 N--CA 1.436 -1.332 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.563 ' HE3' ' OG ' ' A' ' 26' ' ' SER . 63.9 tttm -57.78 -40.42 79.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m -62.23 -24.65 67.36 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -90.99 -38.12 13.04 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.476 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 62.1 m-85 -96.68 -66.75 0.88 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -112.85 58.78 0.4 Allowed Glycine 0 CA--C 1.5 -0.89 0 C-N-CA 119.307 -1.425 . . . . 0.0 113.886 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.448 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 28.7 m -150.4 20.59 0.84 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.5 44.62 7.81 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.99 179.89 38.37 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.233 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.02 -14.28 59.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.626 0.25 . . . . 0.0 111.197 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -103.66 28.4 6.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -60.3 -25.31 65.66 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.216 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.8 mmt -76.17 -17.64 59.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.886 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.3 m-85 -87.78 -38.09 16.04 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.847 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.69 111.3 0.78 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.381 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 71.97 31.96 63.92 Favored Glycine 0 C--O 1.217 -0.931 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.238 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 75' ' ' VAL . 26.3 tptt -146.61 149.03 32.73 Favored 'General case' 0 N--CA 1.386 -3.648 0 O-C-N 122.271 -0.546 . . . . 0.0 109.659 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.7 t70 -86.01 116.44 24.23 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 165.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -104.6 21.33 17.0 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -172.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.521 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 28.5 p -53.88 -57.95 9.06 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -173.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.714 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 61.6 ttt180 -54.13 -40.33 67.29 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.93 -34.02 68.72 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.387 0.613 . . . . 0.0 109.632 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 69.4 mt -62.22 -47.52 84.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.304 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.13 -30.22 67.8 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.78 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 22.9 mmmt -85.82 -26.48 25.69 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.8 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtm 78.88 27.68 0.43 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.586 1.554 . . . . 0.0 108.718 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 44.7 m -105.07 154.21 20.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.969 -1.469 . . . . 0.0 110.812 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 55' ' ' MET . 38.4 mttp -115.47 -18.7 10.91 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.182 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.4 p-10 -55.75 121.13 8.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.479 0.657 . . . . 0.0 111.115 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.42 -25.43 59.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.307 1.443 . . . . 0.0 113.251 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.07 -20.56 62.35 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -98.02 -33.62 11.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.489 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -62.88 114.15 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 t -162.91 151.7 12.32 Favored Pre-proline 0 N--CA 1.432 -1.355 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 80.7 Cg_endo -77.12 20.71 0.63 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.559 2.84 . . . . 0.0 113.983 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.9 t -109.11 135.22 50.6 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 111.28 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 34' ' ' LYS . 4.2 mm? -109.69 -34.58 6.43 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.05 79.27 9.22 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.863 1.316 . . . . 0.0 113.616 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.78 16.23 0.1 OUTLIER Glycine 0 N--CA 1.408 -3.214 0 CA-C-N 112.61 -2.087 . . . . 0.0 108.642 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 1.8 pp -150.9 158.74 44.52 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.123 -1.038 . . . . 0.0 110.206 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 42.6 p -93.67 -172.88 3.01 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 45.7 mt-10 -62.75 -36.41 82.94 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 19.3 ptpt -59.31 -36.67 76.06 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 122.229 1.014 . . . . 0.0 109.019 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 83' ' ' THR . 6.5 mm-40 -76.96 -52.87 8.64 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 125.936 1.694 . . . . 0.0 109.568 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD23 ' A' ' 90' ' ' LEU . 7.2 mm -53.88 -44.82 62.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.837 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.02 -32.43 69.72 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.628 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.4 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 45.9 m -64.73 -45.22 87.43 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.899 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.08 -31.19 65.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.758 177.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 3.3 t-20 -58.01 -32.75 68.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.861 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 12.5 t70 -65.25 -50.72 64.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.363 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.452 ' CG ' HD22 ' A' ' 65' ' ' LEU . 91.3 m95 -58.65 -45.0 90.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.035 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 47.1 mt-10 -50.92 -49.69 59.13 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 121.317 0.58 . . . . 0.0 109.818 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.1 m -58.0 -34.65 70.24 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.211 1.405 . . . . 0.0 111.371 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.4 mmtp -76.29 -43.73 40.28 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.378 -174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -69.23 -37.57 78.06 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.52 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.52 -24.13 30.17 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 125.31 1.444 . . . . 0.0 114.064 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.75 -8.97 23.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.749 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 70.6 mmtt -114.38 -50.13 2.81 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.859 0.838 . . . . 0.0 109.869 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -104.44 143.9 27.63 Favored Pre-proline 0 N--CA 1.421 -1.888 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.559 -172.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 56.8 Cg_endo -85.47 142.34 8.22 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.909 2.406 . . . . 0.0 111.628 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -80.15 106.0 10.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 27.7 m -94.25 5.83 7.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.083 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.32 -165.05 34.75 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.306 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.684 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.3 ptp180 -112.78 161.82 16.48 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 122.967 0.507 . . . . 0.0 110.644 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 35' ' ' GLY . 10.2 p -119.08 136.34 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.654 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 167.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.684 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -125.52 147.98 30.14 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.682 -171.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 N--CA 1.39 -3.427 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 171.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 CA--C 1.517 -0.289 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.3 -86.96 0.12 Allowed Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 62.79 82.48 0.18 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.813 0.845 . . . . 0.0 110.797 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -106.04 94.86 5.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -79.68 110.65 15.21 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.538 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -81.46 155.52 25.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -139.6 90.76 2.43 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 111.41 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -173.56 -78.71 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER 165.48 155.72 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.225 0 C-N-CA 126.626 1.971 . . . . 0.0 106.541 169.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -136.98 141.43 42.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 33.7 tt0 -93.38 127.05 38.83 Favored 'General case' 0 N--CA 1.388 -3.571 0 CA-C-O 121.634 0.73 . . . . 0.0 110.505 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' VAL . 96.5 m-85 -122.0 144.67 48.75 Favored 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.189 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 16' ' ' GLN . 16.5 m -97.15 155.46 16.82 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.33 -46.02 87.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.52 -33.73 76.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' CD ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -74.66 -35.84 62.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.801 177.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.3 OUTLIER -64.24 -37.78 88.72 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 59.2 m -60.66 2.48 0.1 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ASP . 46.6 mt-30 -110.91 -13.48 14.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.399 0.618 . . . . 0.0 109.99 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 76.3 m-85 -87.13 15.73 5.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.963 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.416 ' HA ' ' C ' ' A' ' 57' ' ' ALA . 27.8 p30 -73.38 -1.64 19.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.397 0.618 . . . . 0.0 112.105 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.9 -4.39 56.11 Favored Glycine 0 CA--C 1.487 -1.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.894 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 39.2 m -93.89 -4.05 50.67 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.471 0.653 . . . . 0.0 110.382 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' GLN . 12.3 t70 -77.57 161.46 27.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 87.19 2.25 Favored 'General case' 0 N--CA 1.409 -2.48 0 CA-C-O 121.914 0.864 . . . . 0.0 111.667 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.8 t 81.53 15.71 0.52 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.246 -1.797 . . . . 0.0 113.467 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.273 27.0 mtmm -87.97 138.0 31.22 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 118.252 -1.379 . . . . 0.0 113.687 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' O ' ' HD1' ' A' ' 20' ' ' TYR . 9.3 Cg_endo -52.22 152.3 15.32 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 124.95 3.767 . . . . 0.0 114.021 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 20.0 mt -97.51 133.05 40.78 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 123.556 0.742 . . . . 0.0 109.782 -172.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA2' ' A' ' 58' ' ' GLY . 79.7 m-85 -148.21 132.06 17.06 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 56' ' ' PHE . 7.4 p -112.67 135.63 51.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -111.43 136.08 51.09 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-O 121.09 0.471 . . . . 0.0 110.337 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.35 112.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 7.9 tmtm? 71.25 18.97 5.55 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.812 1.291 . . . . 0.0 108.529 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 101.12 -8.65 57.53 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.605 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -92.28 113.64 25.97 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -90.7 121.47 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.933 0.396 . . . . 0.0 110.575 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 74.2 m-85 -110.24 149.04 30.72 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -86.79 123.29 31.77 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.067 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 29' ' ' ILE . 7.1 m -119.79 14.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.418 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.4 m -62.89 -27.91 69.68 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -66.26 -26.49 67.37 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.249 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.04 47.34 1.03 Allowed Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 79.8 tttt -54.04 -34.88 61.18 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.386 1.075 . . . . 0.0 112.719 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.8 m -59.04 -30.85 68.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -92.99 -39.35 11.16 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.28 0.562 . . . . 0.0 110.5 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -93.09 -69.29 0.76 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -90.14 52.99 3.54 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.212 -173.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -142.66 10.09 1.81 Allowed 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.69 47.22 57.44 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 -162.04 38.06 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.016 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -73.72 -24.98 59.99 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.118 0.961 . . . . 0.0 108.818 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.94 23.56 4.81 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.396 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 p -62.93 -27.31 69.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.652 1.215 . . . . 0.0 110.903 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.627 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 18.2 mmt -84.26 -15.43 46.79 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.037 -175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 31' ' ' VAL . 6.5 m-85 -97.52 -42.59 7.62 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.843 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.416 ' C ' ' HA ' ' A' ' 21' ' ' ASN . . . -41.67 -16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 -171.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -174.03 40.97 0.13 Allowed Glycine 0 CA--C 1.472 -2.636 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.636 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -147.18 157.63 43.67 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 11.2 t70 -85.2 124.85 32.32 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.41 20.49 17.7 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 31.9 p -55.05 -43.99 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 78' ' ' SER . 58.5 ttt180 -70.62 -34.28 71.94 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.979 0.419 . . . . 0.0 110.467 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -72.77 -33.54 66.39 Favored 'General case' 0 CA--C 1.473 -2.009 0 CA-C-O 121.478 0.656 . . . . 0.0 109.372 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 75.0 mt -66.38 -31.19 71.81 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.742 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.0 -28.73 36.49 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.21 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.7 mmmt -86.59 -30.92 21.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.934 0.397 . . . . 0.0 110.721 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.6 mtm 72.51 62.55 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 125.613 1.565 . . . . 0.0 106.954 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 50.9 m -144.39 159.41 42.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.496 -174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.627 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 75.6 mttt -122.45 -18.89 6.57 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.688 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.581 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.6 p-10 -53.99 139.98 32.66 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.272 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.99 -26.6 60.42 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.656 -1.157 . . . . 0.0 113.569 -174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HB3' HD22 ' A' ' 71' ' ' ASN . 12.7 tp10 -58.36 -54.68 44.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.072 0.463 . . . . 0.0 110.771 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 39.2 m-20 -80.19 -21.14 43.3 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 4.4 t -81.64 102.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -150.01 151.25 31.73 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 88.4 Cg_endo -80.0 20.25 0.93 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.534 2.823 . . . . 0.0 113.327 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 18.9 t -151.33 148.33 28.02 Favored 'General case' 0 CA--C 1.476 -1.892 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.556 HD11 ' CD2' ' A' ' 90' ' ' LEU . 3.3 mm? -70.0 -69.8 0.33 Allowed 'General case' 0 C--N 1.28 -2.428 0 O-C-N 124.732 1.27 . . . . 0.0 110.479 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 53.91 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.71 -24.64 27.94 Favored Glycine 0 N--CA 1.41 -3.044 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.23 169.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.606 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 10.5 mp -61.75 117.77 6.27 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -85.54 -177.24 6.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.556 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -53.69 -41.88 67.39 Favored 'General case' 0 C--O 1.204 -1.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -52.5 -53.14 49.79 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.362 0.665 . . . . 0.0 110.751 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 82' ' ' LEU . 48.9 mt-10 -70.89 -42.37 70.09 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.972 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 53.8 mt -62.8 -42.32 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.9 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -54.7 -35.43 63.62 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 121.326 0.584 . . . . 0.0 111.065 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 91.4 m -66.85 -49.01 67.05 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.07 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.556 ' CD2' HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -69.53 -34.07 73.72 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 123.267 0.627 . . . . 0.0 110.872 178.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 2.6 t-20 -58.61 -34.18 70.84 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.705 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 34.4 t70 -74.47 -37.11 63.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.916 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CG ' HD22 ' A' ' 65' ' ' LEU . 89.5 m95 -65.31 -42.59 92.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.488 0.715 . . . . 0.0 112.328 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 51.2 mt-10 -49.17 -52.83 24.13 Favored 'General case' 0 C--O 1.217 -0.609 0 O-C-N 123.582 0.551 . . . . 0.0 110.17 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.9 m -58.04 -29.68 65.55 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 74.7 mmtt -74.95 -35.49 62.12 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.366 1.079 . . . . 0.0 108.845 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -84.08 -51.38 7.14 Favored 'General case' 0 C--N 1.27 -2.874 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.587 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.509 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -57.12 -29.11 63.27 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.418 1.487 . . . . 0.0 112.252 -172.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.481 ' C ' ' HD3' ' A' ' 100' ' ' LYS . . . -93.88 -3.89 50.96 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.589 -0.695 . . . . 0.0 111.635 -174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -126.02 -55.58 1.47 Allowed 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.64 0.733 . . . . 0.0 111.46 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 42.4 m-85 -76.36 139.42 67.99 Favored Pre-proline 0 C--N 1.272 -2.78 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.661 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 78.3 Cg_endo -81.92 137.07 9.64 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.909 2.406 . . . . 0.0 112.679 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.09 103.76 2.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 30.1 m -89.1 -16.34 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 175.9 -153.88 15.89 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.122 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.643 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -121.33 161.93 21.21 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-O 121.275 0.559 . . . . 0.0 110.977 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.608 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.2 p -121.75 130.86 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 25.9 m -114.23 144.46 21.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.949 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.417 -2.115 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.597 -175.825 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.307 0.099 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.72 109.3 2.57 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -79.32 81.95 5.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.434 0.635 . . . . 0.0 110.453 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -89.85 -23.43 21.68 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -91.55 93.98 9.22 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -107.76 104.44 13.94 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.69 -176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -96.59 96.22 8.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.724 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 64.21 -74.45 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.62 1.168 . . . . 0.0 113.022 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -133.0 134.04 43.93 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 121.04 0.448 . . . . 0.0 110.001 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -108.62 131.21 55.1 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.868 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.1 tt0 -85.72 127.98 34.66 Favored 'General case' 1 N--CA 1.378 -4.038 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 169.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 108' ' ' VAL . 53.1 m-85 -122.06 148.52 44.76 Favored 'General case' 0 N--CA 1.394 -3.256 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.97 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.586 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 2.7 m -101.31 155.59 17.95 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.31 -47.45 69.26 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.02 -30.93 65.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.84 0.829 . . . . 0.0 110.481 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.586 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -71.68 -42.12 67.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.007 177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -62.71 -38.3 89.91 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.942 0.897 . . . . 0.0 108.658 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.8 m -62.98 -11.6 19.99 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -99.71 1.04 43.0 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.297 0.57 . . . . 0.0 110.523 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 82.8 m-85 -108.01 28.79 7.9 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.49 -17.58 59.21 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.578 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.21 13.39 54.44 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -85.41 -11.85 53.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 117.873 0.837 . . . . 0.0 110.274 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.41 173.88 11.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -86.04 85.31 7.37 Favored 'General case' 1 N--CA 1.37 -4.454 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.573 -175.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t 76.0 80.12 0.1 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.818 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -129.43 159.79 67.57 Favored Pre-proline 0 C--N 1.313 -0.986 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 168.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.35 143.5 99.7 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.901 1.734 . . . . 0.0 111.082 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.7 mp -107.95 131.18 58.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HG13 ' A' ' 37' ' ' VAL . 71.3 m-85 -131.13 149.65 52.5 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.347 0.594 . . . . 0.0 112.287 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.17 160.9 37.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.96 137.32 49.21 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.992 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.42 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 56.5 mt -132.22 116.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 68.16 20.73 8.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.093 0.557 . . . . 0.0 109.89 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 81.75 8.39 86.87 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.249 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 75.0 mtp180 -96.78 125.28 41.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 30' ' ' TYR . 89.6 t -93.47 122.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.083 0.468 . . . . 0.0 111.547 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -106.94 140.89 39.03 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.93 114.81 22.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.4 m -113.32 25.24 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.178 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.3 m -67.83 -22.83 65.13 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.9 p -70.09 -50.73 37.96 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.853 175.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.96 3.2 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -61.11 -36.22 79.12 Favored 'General case' 0 N--CA 1.423 -1.809 0 C-N-CA 124.287 1.035 . . . . 0.0 112.098 -176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -59.15 -21.61 59.62 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.721 0.408 . . . . 0.0 111.388 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -91.51 -42.04 10.48 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.26 -53.88 2.56 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . -50.7 -72.02 0.55 Allowed Glycine 0 N--CA 1.466 0.688 0 N-CA-C 119.017 2.367 . . . . 0.0 119.017 -167.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 m -90.8 8.86 32.64 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 117.609 0.705 . . . . 0.0 112.637 -168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.56 49.69 0.55 Allowed Glycine 0 N--CA 1.424 -2.119 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.917 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.6 -164.46 33.23 Favored Glycine 0 N--CA 1.426 -1.996 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.49 -27.48 63.26 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.778 0.799 . . . . 0.0 110.308 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.95 19.14 20.0 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.611 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -60.04 -23.07 63.43 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.211 0.604 . . . . 0.0 111.51 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 15.0 mmt -67.41 -33.14 74.56 Favored 'General case' 0 C--O 1.207 -1.17 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -76.16 -22.52 55.3 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.549 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 128.9 37.9 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.452 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 75.32 13.7 82.6 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 114.258 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HD2' HG11 ' A' ' 75' ' ' VAL . 9.0 ptpp? -146.56 165.49 29.32 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.903 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 9.7 t70 -84.22 124.55 31.31 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.65 22.16 13.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.715 -173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' LEU . 53.0 p -59.07 -40.64 85.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.4 ttt180 -67.29 -33.74 75.93 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.122 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.53 -33.79 73.31 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD22 ' CG ' ' A' ' 93' ' ' TRP . 72.1 mt -65.64 -44.34 86.71 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.06 176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.93 -39.26 28.56 Favored Glycine 0 CA--C 1.499 -0.966 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.851 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.8 mmmt -78.1 -30.67 49.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.7 mtp 67.64 60.94 0.45 Allowed 'General case' 0 CA--C 1.478 -1.819 0 C-N-CA 124.772 1.229 . . . . 0.0 107.733 -176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 51.1 m -138.56 130.06 27.54 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.18 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -97.43 -7.04 32.59 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.605 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.5 p-10 -66.26 134.91 53.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.619 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HA ' HG23 ' A' ' 75' ' ' VAL . 41.2 mt-10 -58.07 -28.03 64.18 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.993 0.917 . . . . 0.0 111.562 -173.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.551 ' HB2' HD22 ' A' ' 71' ' ' ASN . 38.6 mt-10 -57.97 -31.13 66.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.233 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -107.85 -0.09 21.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.575 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 2.2 t -88.11 101.87 12.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.9 t -155.03 152.94 26.43 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.34 -11.63 19.07 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.698 2.265 . . . . 0.0 111.156 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -83.7 127.63 33.92 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.0 mt -109.09 4.87 23.51 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.015 -175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.298 38.3 tt0 -86.27 78.6 9.29 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 123.148 1.452 . . . . 0.0 112.974 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.601 ' C ' HD12 ' A' ' 82' ' ' LEU . . . -173.68 21.76 0.06 OUTLIER Glycine 0 C--N 1.268 -3.239 0 N-CA-C 105.944 -2.862 . . . . 0.0 105.944 172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 81' ' ' GLY . 6.8 mp -141.52 142.93 33.55 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-N 112.717 -1.742 . . . . 0.0 107.58 -175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 87' ' ' ILE . 69.3 p -105.42 -169.6 1.62 Allowed 'General case' 0 C--N 1.27 -2.86 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.11 -41.52 75.38 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 118.242 0.473 . . . . 0.0 111.367 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 14.7 pttp -62.5 -44.86 95.34 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 15.8 mp0 -67.15 -39.56 86.54 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 83' ' ' THR . 72.8 mt -62.93 -41.59 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.746 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -52.15 -35.0 47.33 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.983 0.421 . . . . 0.0 111.774 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 72.7 m -65.51 -48.76 71.44 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.859 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.44 -37.4 68.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 177.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.656 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -53.37 -34.23 56.82 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.583 1.153 . . . . 0.0 108.978 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 36.4 t70 -75.64 -39.45 57.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.417 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.466 ' CG ' HD22 ' A' ' 65' ' ' LEU . 75.3 m95 -60.31 -34.85 74.36 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.656 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 42.5 mt-10 -53.73 -43.3 68.94 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 61.5 m -69.71 -29.27 66.63 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.68 1.192 . . . . 0.0 111.963 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.7 mmtt -75.11 -32.91 61.52 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 122.042 0.925 . . . . 0.0 108.752 -174.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 42.0 m-85 -81.6 -44.88 16.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.179 172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm-40 -54.81 -27.13 39.57 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -97.43 -3.63 39.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.684 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -124.94 -46.72 1.82 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -175.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.89 140.01 20.66 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 123.279 0.632 . . . . 0.0 110.485 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -84.35 138.04 7.35 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.455 2.103 . . . . 0.0 112.352 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.401 HG21 HH21 ' A' ' 36' ' ' ARG . 92.8 t -75.36 107.05 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 27.2 m -95.1 0.49 10.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.497 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 160.6 -147.77 15.04 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.905 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.537 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.6 ptp180 -132.44 161.89 32.55 Favored 'General case' 0 CA--C 1.471 -2.069 0 CA-C-O 121.296 0.569 . . . . 0.0 111.591 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.7 p -118.91 132.56 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.598 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.537 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -112.88 137.58 45.33 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.114 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.405 -2.677 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.379 -171.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.494 -1.205 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.34 109.05 2.31 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -91.43 143.54 26.51 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -88.91 24.94 1.92 Allowed 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.746 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -133.19 93.3 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.343 173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 3.6 p-80 -159.87 179.8 8.48 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -126.45 -86.09 0.61 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -105.12 -37.11 7.04 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -87.84 158.52 18.71 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -136.71 150.26 48.33 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 29.1 tt0 -81.97 123.84 29.24 Favored 'General case' 0 N--CA 1.397 -3.1 0 CA-C-O 121.868 0.842 . . . . 0.0 111.886 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 98.0 m-85 -116.72 134.71 54.47 Favored 'General case' 0 N--CA 1.387 -3.602 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.262 171.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.656 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.3 m -95.81 153.92 17.49 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.68 90.09 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.9 -37.46 76.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.623 0.725 . . . . 0.0 111.316 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.656 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 28.9 mt-30 -76.55 -31.62 57.71 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.687 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -67.64 -32.7 73.59 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -61.35 -3.98 1.1 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 45.0 mt-30 -95.85 -8.61 33.68 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.038 0.447 . . . . 0.0 110.399 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.85 31.18 3.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.573 0.701 . . . . 0.0 109.896 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -76.15 -18.06 59.28 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.488 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 82.56 3.9 90.33 Favored Glycine 0 CA--C 1.5 -0.844 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.2 m -99.56 -37.34 9.2 Favored 'General case' 0 N--CA 1.408 -2.526 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.83 114.15 26.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.057 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 35.0 mt-10 59.0 24.55 12.79 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.093 0.957 . . . . 0.0 112.533 170.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.7 p 54.89 25.69 7.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.549 1.14 . . . . 0.0 112.241 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' HB2' ' A' ' 25' ' ' GLU . 36.4 mtmm -61.48 151.44 77.45 Favored Pre-proline 0 C--N 1.349 0.544 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.747 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -45.07 132.09 11.13 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.9 3.067 . . . . 0.0 112.437 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.561 HD13 ' HA3' ' A' ' 48' ' ' GLY . 24.4 mt -93.22 121.76 44.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.412 -172.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -135.19 138.47 43.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.108 0.48 . . . . 0.0 110.588 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -114.0 162.05 12.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -129.85 141.43 50.82 Favored 'General case' 0 C--N 1.275 -2.634 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.647 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 65' ' ' LEU . 23.4 mt -129.2 112.76 26.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' H ' ' HB2' ' A' ' 62' ' ' SER . 4.9 tmtt? 62.14 28.81 17.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.37 1.068 . . . . 0.0 109.18 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 94.73 6.83 60.51 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.582 -0.736 . . . . 0.0 113.838 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.45 ' NH1' HG21 ' A' ' 103' ' ' VAL . 28.3 mtm180 -114.41 127.51 55.87 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 117.998 0.899 . . . . 0.0 109.196 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.56 125.24 43.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 120.931 0.396 . . . . 0.0 111.137 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 50.0 m-85 -111.0 142.94 42.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.75 124.99 32.16 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.65 24.19 4.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -71.4 -28.8 64.27 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.771 0.796 . . . . 0.0 109.942 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -68.45 -21.99 64.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.175 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.6 38.99 2.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 29' ' ' ILE . 82.1 tttt -58.28 -36.57 73.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.842 0.354 . . . . 0.0 110.78 -176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 m -57.83 -18.53 22.8 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.007 0.923 . . . . 0.0 112.316 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -102.75 -43.27 5.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -92.34 -74.56 0.51 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -88.53 37.62 3.28 Favored Glycine 0 N--CA 1.475 1.277 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.958 -174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -172.13 -29.23 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.344 0.657 . . . . 0.0 109.236 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.16 -20.01 79.72 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.531 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.39 -55.38 3.26 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.775 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.92 -42.6 99.85 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 124.146 0.978 . . . . 0.0 112.247 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.36 10.4 36.44 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.094 0.473 . . . . 0.0 111.591 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.4 t -75.41 -16.83 60.31 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.226 0.536 . . . . 0.0 109.789 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -71.58 -25.27 62.13 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.655 0.74 . . . . 0.0 109.098 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.61 -21.9 41.12 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.13 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 132.65 35.29 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.349 0.595 . . . . 0.0 110.906 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 80.7 12.0 83.33 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.237 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' CG ' HG12 ' A' ' 75' ' ' VAL . 4.1 tppp? -146.49 157.79 43.8 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 12.2 t70 -87.07 130.8 34.34 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 171.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.577 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -110.35 23.06 14.76 Favored 'General case' 0 C--N 1.269 -2.918 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' H ' ' A' ' 34' ' ' LYS . 17.7 t -54.09 -43.48 70.38 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 120.794 0.331 . . . . 0.0 111.113 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 78' ' ' SER . 35.5 ttt180 -75.08 -33.23 61.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 120.537 0.208 . . . . 0.0 111.268 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -74.3 -33.71 63.3 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-O 121.301 0.572 . . . . 0.0 109.747 -173.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 92.7 mt -63.72 -47.49 80.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.407 176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.04 -51.14 47.48 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.324 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.9 OUTLIER -65.68 -31.2 72.07 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.129 0.971 . . . . 0.0 111.998 176.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 73.25 22.64 2.78 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 125.138 1.375 . . . . 0.0 107.972 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.7 m -100.02 139.22 36.0 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.46 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -103.44 -16.88 15.45 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.257 -173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.8 p-10 -59.12 129.44 42.12 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.143 176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -22.31 41.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.31 -41.17 98.3 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 15.8 t70 -83.27 -34.09 25.87 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.123 -172.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 3.4 t -66.03 113.67 2.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.1 t -169.65 151.55 4.34 Favored Pre-proline 0 CA--C 1.56 1.331 0 C-N-CA 123.123 0.569 . . . . 0.0 109.896 -170.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.9 -7.41 14.39 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 123.497 2.798 . . . . 0.0 112.747 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 38.5 t -86.54 144.46 27.22 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.945 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD21 ' OG ' ' A' ' 62' ' ' SER . 26.6 mt -103.16 13.33 34.3 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.645 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 43.97 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.714 2.006 . . . . 0.0 114.556 168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.31 32.78 1.36 Allowed Glycine 0 N--CA 1.411 -3.023 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 86' ' ' GLU . 28.2 mt -69.44 144.46 53.29 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 124.317 1.047 . . . . 0.0 110.752 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.0 p -88.43 -179.58 6.12 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.512 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.31 -47.01 72.93 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -74.08 -26.65 60.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.149 -174.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB3' HD22 ' A' ' 82' ' ' LEU . 6.5 mm-40 -67.59 -51.68 47.51 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.098 0.952 . . . . 0.0 108.637 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 80.8 mt -63.92 -42.24 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.993 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -59.43 -32.85 70.59 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.4 m -61.13 -39.31 89.54 Favored 'General case' 0 N--CA 1.423 -1.787 0 O-C-N 123.431 0.457 . . . . 0.0 110.653 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.9 -34.33 64.36 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 93.3 m-20 -58.57 -39.84 81.45 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.473 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 95' ' ' THR . 51.8 m-20 -64.59 -43.18 94.63 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.488 ' HB3' HD22 ' A' ' 65' ' ' LEU . 46.2 m95 -54.27 -50.43 67.25 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.749 -1.114 . . . . 0.0 113.068 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.23 -39.29 89.76 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 89.8 m -58.99 -28.25 66.18 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.699 1.2 . . . . 0.0 111.248 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.5 -43.1 50.91 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 45.7 m-85 -62.8 -40.78 98.39 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.758 173.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 15.7 mm-40 -55.52 -19.27 9.33 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 125.257 1.423 . . . . 0.0 112.994 175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.49 -7.25 21.04 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.052 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 -66.6 0.46 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -74.77 128.01 86.1 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.964 -173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.5 Cg_endo -80.54 142.31 14.49 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 123.01 2.473 . . . . 0.0 113.323 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.45 HG21 ' NH1' ' A' ' 36' ' ' ARG . 84.2 t -81.64 106.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -98.29 -0.18 10.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.346 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . 169.7 -159.21 31.85 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.864 177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.521 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 12.1 ptp180 -126.96 160.29 31.51 Favored 'General case' 0 CA--C 1.457 -2.621 0 CA-C-O 120.583 0.23 . . . . 0.0 110.741 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.9 p -118.83 138.63 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.751 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 22.4 m -129.25 136.62 59.06 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.842 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.41 -2.443 0 C-N-CA 118.756 -1.177 . . . . 0.0 111.569 176.397 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.503 -0.846 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.0 57.88 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.611 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.606 ' O ' ' HB3' ' A' ' 11' ' ' GLU . 56.8 m-70 -116.22 85.74 2.35 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 31.8 t-80 -68.26 -50.76 51.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.87 112.31 24.23 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.624 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -108.63 -169.02 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -117.64 68.18 0.76 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.362 0.601 . . . . 0.0 109.818 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 176.66 -49.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.673 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.52 172.1 18.93 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.231 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.519 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 11.2 pt-20 -99.24 133.51 43.43 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.606 ' HB3' ' O ' ' A' ' 3' ' ' HIS . 23.5 tt0 -93.01 133.16 36.43 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.026 0.917 . . . . 0.0 112.124 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.54 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 83.1 m-85 -118.45 136.57 53.71 Favored 'General case' 0 N--CA 1.399 -3.008 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.071 170.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.708 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 14.4 m -98.87 149.99 22.36 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.05 71.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.26 -36.91 81.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.861 0.838 . . . . 0.0 110.144 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.708 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 33.9 mt-30 -77.31 -39.56 47.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.287 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 17' ' ' LEU . 1.9 tm? -62.03 -37.07 83.52 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.922 0.889 . . . . 0.0 109.221 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.8 t -61.82 -12.71 18.64 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.939 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 65.1 mt-30 -92.95 -9.07 41.3 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.211 0.529 . . . . 0.0 109.992 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 97.0 m-85 -107.87 80.0 1.34 Allowed 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.49 0.662 . . . . 0.0 110.911 178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 23' ' ' THR . 33.7 p30 -130.84 -3.09 4.1 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.33 8.96 62.3 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 115.305 0.882 . . . . 0.0 115.305 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.7 t -97.28 -30.55 12.9 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.819 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.4 t70 -87.22 93.89 9.51 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.013 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 60.19 17.82 7.27 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.873 0.869 . . . . 0.0 110.575 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.1 t 62.61 65.02 0.86 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.468 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 19' ' ' GLN . 64.6 mttm -67.11 159.36 77.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 79.8 Cg_exo -49.29 135.55 31.58 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.168 1.912 . . . . 0.0 110.286 175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' A' ' 44' ' ' LYS . 34.0 mt -103.4 128.71 56.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 37' ' ' VAL . 95.4 m-85 -130.08 155.64 45.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 23.0 m -128.92 160.9 39.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -130.38 133.18 46.19 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.721 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.0 mt -131.72 112.57 20.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 53.1 mmtt 57.21 31.26 19.75 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.428 0.632 . . . . 0.0 111.712 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 86.79 -10.95 65.81 Favored Glycine 0 C--O 1.213 -1.193 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.0 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.513 ' HB3' HG21 ' A' ' 103' ' ' VAL . 81.1 mtp180 -76.49 111.91 12.47 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 88.7 t -90.94 117.58 34.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.256 -178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 103' ' ' VAL . 92.5 m-85 -106.44 143.69 34.2 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.84 117.03 27.54 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.5 m -111.84 21.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.718 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.4 m -62.95 -30.09 71.3 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.124 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.6 t -69.59 -22.98 63.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.283 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.71 41.92 2.09 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.4 ttmt -54.72 -37.02 65.36 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 123.886 0.874 . . . . 0.0 111.853 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.7 m -62.86 -22.22 66.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.072 0.463 . . . . 0.0 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -97.7 -35.06 10.69 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.534 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' SER . 61.5 m-85 -102.69 -64.44 1.07 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -78.48 -32.11 43.46 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -170.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 m -88.54 22.39 2.59 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.442 0.621 . . . . 0.0 112.007 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.43 52.14 6.24 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.92 -163.67 38.26 Favored Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.602 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.04 -14.71 61.04 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.871 0.843 . . . . 0.0 110.81 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -117.22 26.02 10.06 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.993 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 22.8 t -64.04 -32.17 73.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.118 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.683 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 22.9 mmt -71.67 -17.79 62.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.869 0.366 . . . . 0.0 111.338 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' O ' HG12 ' A' ' 31' ' ' VAL . 53.2 m-85 -83.83 -19.88 34.17 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.803 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.26 116.09 5.14 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.69 35.68 92.35 Favored Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.688 -1.142 . . . . 0.0 114.725 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -145.91 151.57 38.06 Favored 'General case' 1 N--CA 1.378 -4.04 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.4 t70 -76.33 123.25 25.65 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -115.74 25.58 10.65 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -171.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 m -55.02 -42.3 72.39 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.025 0.441 . . . . 0.0 111.672 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 72.3 ttt180 -69.02 -35.29 76.49 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.144 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.39 -33.84 69.86 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD22 ' HB3' ' A' ' 93' ' ' TRP . 85.5 mt -62.72 -47.89 81.62 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.611 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.37 81.3 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.48 -0.866 . . . . 0.0 112.162 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 14.6 mmmm -77.96 -26.97 49.08 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.3 mtp 72.32 24.27 3.07 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.009 1.324 . . . . 0.0 108.216 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.509 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 42.2 m -110.06 147.84 32.82 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-N 113.665 -1.607 . . . . 0.0 111.318 -172.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' O ' ' HG3' ' A' ' 55' ' ' MET . 44.6 mttp -104.85 -19.44 13.89 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.31 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.539 HD22 ' HG2' ' A' ' 73' ' ' GLU . 2.3 p-10 -54.32 128.99 33.82 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 110.701 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.58 -24.11 54.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' A' ' 71' ' ' ASN . 10.7 pt-20 -66.59 -32.94 74.6 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.27 -3.89 56.45 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 5.4 t -87.25 102.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.6 t -161.89 152.74 14.92 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.15 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 40.9 Cg_endo -71.87 -21.37 24.78 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.603 2.202 . . . . 0.0 111.323 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 30.1 t -75.66 132.98 40.93 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.078 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.19 80.21 1.29 Allowed 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -123.49 133.27 54.04 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.39 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.58 18.12 57.33 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 86' ' ' GLU . 85.7 mt -122.55 117.6 26.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 113.386 -1.407 . . . . 0.0 111.463 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -81.6 170.61 15.64 Favored 'General case' 0 N--CA 1.388 -3.55 0 CA-C-N 112.229 -2.259 . . . . 0.0 107.14 176.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.21 -40.54 94.35 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -67.22 -28.22 67.89 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.279 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' HB3' HD22 ' A' ' 82' ' ' LEU . 31.4 mm-40 -71.07 -40.87 71.36 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.334 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 83' ' ' THR . 79.2 mt -68.31 -43.26 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.3 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -53.54 -32.33 50.21 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.677 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.517 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 85.8 m -60.34 -45.9 91.82 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.912 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -73.66 -31.39 63.45 Favored 'General case' 0 C--O 1.205 -1.262 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -176.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.487 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -54.83 -40.28 69.41 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.218 175.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.4 t70 -68.06 -34.06 75.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.426 0.632 . . . . 0.0 109.704 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.555 ' HB3' HD22 ' A' ' 65' ' ' LEU . 65.8 m95 -64.3 -32.73 74.44 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.739 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 33' ' ' ILE . 44.8 mt-10 -56.0 -53.9 51.29 Favored 'General case' 0 C--O 1.199 -1.577 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 22.7 m -53.67 -26.36 22.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 126.793 2.037 . . . . 0.0 112.859 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 74.1 mmtt -76.06 -36.38 59.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.949 0.88 . . . . 0.0 108.686 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -83.08 -40.35 19.97 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.221 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 49.4 mt-10 -55.32 -26.81 42.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.583 1.153 . . . . 0.0 113.433 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.94 -9.79 20.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.3 mptm? -112.45 -30.6 7.09 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -130.07 146.24 60.63 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 95.7 Cg_endo -78.7 133.61 11.62 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.253 1.969 . . . . 0.0 111.324 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 38' ' ' PHE . 11.5 p -85.77 94.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.66 -28.09 24.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.636 -171.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -179.64 -138.96 3.5 Favored Glycine 0 N--CA 1.415 -2.718 0 C-N-CA 118.365 -1.874 . . . . 0.0 114.15 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.8 ptp180 -132.95 159.92 38.56 Favored 'General case' 0 CA--C 1.467 -2.214 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -115.36 135.65 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.487 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.655 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 17.5 m -129.85 138.14 54.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.785 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.604 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 N--CA 1.404 -2.73 0 C-N-CA 117.098 -1.841 . . . . 0.0 111.204 163.832 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.22 -170.75 33.32 Favored Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.418 ' HB3' ' H ' ' A' ' 4' ' ' HIS . 27.3 m170 60.8 -156.81 0.34 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 117.334 0.567 . . . . 0.0 110.813 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.418 ' H ' ' HB3' ' A' ' 3' ' ' HIS . 55.7 t-80 76.84 -67.05 0.23 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.47 1.108 . . . . 0.0 112.348 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -141.18 104.76 4.69 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.945 0.403 . . . . 0.0 111.259 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -138.98 92.23 2.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -71.13 -46.93 60.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.533 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -89.11 160.44 17.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 105' ' ' GLY . 1.3 pt? -79.59 157.86 27.23 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.52 121.52 33.29 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -86.15 124.45 32.57 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.3 m-85 -121.11 151.89 39.35 Favored 'General case' 0 C--N 1.249 -3.782 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.949 174.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.613 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.5 m -102.53 159.44 15.44 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 172.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -47.2 76.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 114.239 1.199 . . . . 0.0 114.239 -170.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -69.84 -30.84 68.43 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.8 0.81 . . . . 0.0 110.3 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.613 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 34.5 mt-30 -75.86 -31.15 59.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.674 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -68.54 -38.8 81.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.6 m -69.15 9.13 0.46 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.367 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -97.24 -10.51 25.63 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 88.6 m-85 -124.82 85.67 2.45 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.495 ' OD1' ' HA3' ' A' ' 58' ' ' GLY . 13.4 m-80 -114.05 -11.95 12.65 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.435 0.636 . . . . 0.0 109.302 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' CA ' HG13 ' A' ' 29' ' ' ILE . . . 99.56 -30.67 9.51 Favored Glycine 0 CA--C 1.492 -1.388 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.926 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -83.07 -3.49 57.34 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.976 0.893 . . . . 0.0 108.767 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.69 82.93 2.89 Favored 'General case' 0 N--CA 1.41 -2.474 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.126 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 60.66 17.94 8.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.251 1.02 . . . . 0.0 112.643 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.2 t 67.43 38.96 3.04 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.847 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -75.68 160.18 79.7 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 77.7 Cg_exo -50.08 131.04 29.64 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.619 2.213 . . . . 0.0 112.487 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' HA3' ' A' ' 48' ' ' GLY . 2.5 mp -93.38 132.49 37.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -174.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -130.61 142.24 50.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.242 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 56' ' ' PHE . 31.1 m -118.59 161.19 17.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -140.52 140.77 35.31 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.633 177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 47.3 mt -137.52 119.79 19.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt 64.76 25.83 12.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.75 0.656 . . . . 0.0 112.666 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' CG1' ' A' ' 107' ' ' VAL . . . 85.07 12.09 74.7 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.473 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 39.9 mtm180 -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -90.95 127.49 43.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 123.6 0.563 . . . . 0.0 110.674 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -113.75 139.42 49.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -86.81 123.63 32.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.67 27.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.3 p -68.37 -26.9 65.8 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.361 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -64.45 -22.2 66.89 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.091 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.48 38.56 2.17 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.58 -33.09 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.749 0.419 . . . . 0.0 110.888 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -57.37 -23.45 49.16 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.434 0.694 . . . . 0.0 111.685 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -93.09 -48.07 6.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.157 0.503 . . . . 0.0 110.13 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.75 -63.58 1.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -85.47 22.92 9.32 Favored Glycine 0 C--O 1.221 -0.714 0 C-N-CA 121.03 -0.605 . . . . 0.0 114.297 -172.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 m -117.73 9.89 13.15 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.457 0.646 . . . . 0.0 109.356 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.54 45.2 37.8 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 -170.25 38.52 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.362 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 70' ' ' LYS . 10.6 t70 -60.4 -36.0 77.09 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.064 0.935 . . . . 0.0 110.014 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.79 17.1 6.97 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.633 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.5 t -74.01 -9.72 58.92 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.4 mmt -73.71 -25.74 60.36 Favored 'General case' 0 C--O 1.208 -1.089 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 29.0 m-85 -88.78 -17.21 30.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.61 -177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.78 113.55 13.37 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.495 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 86.96 22.52 45.26 Favored Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -143.62 141.21 30.51 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 14.4 t70 -84.06 98.49 9.89 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 166.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.78 2.56 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.04 -168.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.408 ' HB3' HD21 ' A' ' 79' ' ' LEU . 27.7 m -55.17 -44.25 75.06 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.85 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -70.33 -30.53 67.51 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.731 -0.605 . . . . 0.0 111.446 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.93 66.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.9 mt -61.08 -46.56 90.15 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.146 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.33 -23.51 77.83 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.26 -0.971 . . . . 0.0 114.237 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -103.45 -6.95 21.33 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.018 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 70.99 -52.25 0.68 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.209 1.404 . . . . 0.0 109.068 -171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t 43.03 -86.73 0.01 OUTLIER 'General case' 0 C--O 1.242 0.694 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER 71.19 15.37 6.47 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.497 1.919 . . . . 0.0 112.088 -172.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 10.9 p30 -103.81 144.09 31.95 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 167.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -58.4 -21.04 49.16 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 13.2 mm-40 -64.6 -40.72 96.01 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 123.098 0.559 . . . . 0.0 111.025 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -92.96 -3.56 54.26 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 71' ' ' ASN . 13.5 t -81.02 114.3 21.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -174.69 148.31 1.19 Allowed Pre-proline 0 C--O 1.25 1.085 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -169.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 Cg_endo -72.98 -24.37 17.49 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.547 2.165 . . . . 0.0 112.655 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.7 m -76.63 137.78 39.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.448 0.642 . . . . 0.0 112.7 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' SER . 24.2 mt -110.13 5.65 22.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.93 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.61 130.78 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.281 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.38 -27.51 9.96 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.8 mt -73.65 139.38 45.4 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.326 -0.937 . . . . 0.0 111.629 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 p -95.59 -179.17 4.65 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.109 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.57 -39.87 95.04 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HG3' ' HG3' ' A' ' 86' ' ' GLU . 19.3 ptpt -60.5 -35.67 76.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.13 0.967 . . . . 0.0 109.096 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.8 mt-10 -77.23 -52.38 9.32 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.873 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 55.9 mt -62.26 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.582 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -58.22 -36.65 73.47 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.7 m -60.82 -48.04 83.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.396 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -72.0 -39.19 69.39 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 122.886 0.474 . . . . 0.0 111.042 177.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.575 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 4.6 t-20 -55.99 -35.11 66.42 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 124.609 1.164 . . . . 0.0 108.59 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 26.5 t70 -76.04 -45.84 32.26 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.386 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CG ' HD22 ' A' ' 65' ' ' LEU . 42.1 m95 -53.8 -37.8 63.88 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 48.5 mt-10 -48.48 -57.73 5.7 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.473 0.654 . . . . 0.0 109.346 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.463 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 23.9 m -58.21 -31.75 67.64 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.457 1.903 . . . . 0.0 112.186 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.4 mmtt -74.73 -34.06 62.48 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.183 0.992 . . . . 0.0 108.86 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.77 -46.4 15.49 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.638 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 39.3 mt-10 -55.84 -20.42 15.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.86 -8.16 19.94 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.426 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -118.7 -40.81 2.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -105.95 133.45 20.2 Favored Pre-proline 0 N--CA 1.427 -1.6 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.97 138.63 18.61 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.401 2.067 . . . . 0.0 112.462 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.5 t -72.96 105.01 2.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.46 -0.23 10.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.569 -177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 9' ' ' LEU . . . -178.6 -162.77 28.77 Favored Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 118.542 -1.789 . . . . 0.0 115.334 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 22.2 tpp180 -130.5 139.84 50.52 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 125.739 1.616 . . . . 0.0 108.634 -174.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.544 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 11.0 p -117.35 123.36 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' THR . 12.4 m -108.03 143.05 19.16 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 C--N 1.295 -1.794 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.12 -176.583 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--O 1.244 0.768 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.59 114.26 0.9 Allowed Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.73 154.28 22.15 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 3.7 p80 -70.52 139.3 51.56 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 117.867 -1.533 . . . . 0.0 107.958 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -71.45 -41.71 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -170.59 -168.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 8' ' ' HIS . 91.6 m-70 -75.22 71.76 2.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 119.593 1.088 . . . . 0.0 111.754 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 7' ' ' HIS . 44.7 t-80 164.6 108.26 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 126.815 2.046 . . . . 0.0 107.38 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD22 ' H ' ' A' ' 105' ' ' GLY . 68.7 mt 68.45 113.25 0.04 OUTLIER 'General case' 0 C--O 1.25 1.091 0 C-N-CA 124.744 1.217 . . . . 0.0 113.485 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 4' ' ' HIS . 1.5 pm0 -76.19 120.02 20.9 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' ARG . 26.8 tt0 -80.05 129.73 34.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.436 1.113 . . . . 0.0 113.438 -175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -119.8 155.12 33.18 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 113.483 -1.69 . . . . 0.0 108.152 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.618 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 20.7 m -108.69 151.35 26.3 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.44 91.03 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -169.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.62 -30.62 70.25 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 121.384 0.612 . . . . 0.0 109.67 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -77.19 -37.09 54.33 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.879 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.05 -31.42 72.55 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.099 0.559 . . . . 0.0 112.275 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.694 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 30.7 p -68.05 8.19 0.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 44.4 mt-30 -105.97 -15.22 14.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 97.1 m-85 -92.4 39.13 1.02 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.043 -178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -78.85 -14.85 59.02 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.823 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG12 ' A' ' 29' ' ' ILE . . . 90.43 -10.09 75.53 Favored Glycine 0 CA--C 1.495 -1.194 0 C-N-CA 120.525 -0.845 . . . . 0.0 115.086 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.2 t -96.73 -7.15 34.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 C-N-CA 118.454 -1.298 . . . . 0.0 110.914 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 84.05 6.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.156 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.27 -69.32 0.15 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.097 1.759 . . . . 0.0 111.329 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.7 t -169.51 20.24 0.02 OUTLIER 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.048 -170.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 19' ' ' GLN . 21.6 mtmm -66.45 148.22 98.67 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.73 150.68 28.1 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.439 2.759 . . . . 0.0 111.836 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 7.9 mt -118.63 136.49 55.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 81.9 m-85 -146.19 146.94 30.99 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -174.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.57 137.63 56.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -112.03 123.98 51.42 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 48.7 mt -127.7 116.75 44.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.36 9.5 6.99 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 124.229 1.012 . . . . 0.0 110.555 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 100.66 -13.22 59.55 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.751 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -79.92 130.5 35.34 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 97.6 t -94.94 129.95 44.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 O-C-N 123.234 0.334 . . . . 0.0 110.357 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -107.14 141.22 38.75 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -83.91 125.08 31.66 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.325 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 29' ' ' ILE . 15.6 m -126.19 18.29 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.157 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -66.24 -38.77 88.66 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.2 p -62.15 -22.72 66.09 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 113.458 -1.701 . . . . 0.0 111.812 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.59 42.43 1.93 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.26 -30.18 68.1 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 123.698 0.799 . . . . 0.0 113.117 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -75.58 -7.32 53.92 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 92.7 m-85 -113.44 -33.88 5.77 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.994 0.425 . . . . 0.0 111.289 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 62.4 m-85 -107.16 -34.93 6.99 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.32 -81.84 1.51 Allowed Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.278 -0.963 . . . . 0.0 114.013 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 t -89.05 2.25 54.33 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.786 0.803 . . . . 0.0 110.959 -173.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.14 31.59 1.95 Allowed Glycine 0 CA--C 1.476 -2.369 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 46' ' ' PHE . . . -64.08 92.54 0.12 Allowed Glycine 0 N--CA 1.425 -2.042 0 CA-C-N 112.99 -1.605 . . . . 0.0 116.428 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -79.27 -24.95 42.6 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 170.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -111.54 34.93 3.85 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 113.22 -1.809 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -63.73 -16.17 60.43 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.629 0.372 . . . . 0.0 111.956 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.3 mmt -85.11 -9.08 58.3 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 121.481 0.658 . . . . 0.0 110.894 175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -93.51 -38.52 11.36 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -60.94 107.29 0.69 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.775 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.45 14.77 77.78 Favored Glycine 0 N--CA 1.425 -2.041 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 12.2 tppt? -145.21 134.27 22.66 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-O 122.437 1.113 . . . . 0.0 113.951 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 77' ' ' PRO . 1.2 p-10 -57.18 99.51 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.514 172.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -105.78 23.8 13.33 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.968 -172.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.9 m -59.25 -50.97 71.97 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.702 0.287 . . . . 0.0 111.311 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -68.52 -30.32 69.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.864 0.364 . . . . 0.0 110.972 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -67.17 -33.32 75.14 Favored 'General case' 0 CA--C 1.477 -1.86 0 CA-C-O 121.453 0.644 . . . . 0.0 109.632 -171.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 93' ' ' TRP . 74.5 mt -60.99 -32.6 72.17 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.244 178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.39 -1.05 62.62 Favored Glycine 0 C--N 1.311 -0.82 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.864 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.2 mmpt? -106.72 -46.46 3.97 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.2 mtp 77.44 14.07 1.85 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.437 1.895 . . . . 0.0 109.146 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 49.4 m -93.1 142.44 27.29 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.674 -2.057 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 55' ' ' MET . 42.2 mttp -103.8 -7.54 20.48 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.773 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 3.8 p-10 -68.86 133.46 48.3 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.47 -30.52 65.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.31 -18.95 62.37 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 67' ' ' LYS . 8.7 m-20 -95.8 -0.66 50.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.258 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.9 t -101.84 117.61 47.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -160.92 156.99 22.25 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.515 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 89.4 Cg_endo -87.27 -7.23 6.96 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -93.54 155.34 17.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.44 79.85 1.27 Allowed 'General case' 0 N--CA 1.394 -3.243 0 CA-C-O 122.33 1.062 . . . . 0.0 109.196 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.19 154.85 42.22 Favored 'General case' 0 N--CA 1.39 -3.463 0 CA-C-N 112.836 -1.983 . . . . 0.0 105.709 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.04 16.87 60.29 Favored Glycine 0 C--N 1.266 -3.307 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' HB3' ' A' ' 86' ' ' GLU . 98.4 mt -139.91 132.17 28.24 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.319 -1.441 . . . . 0.0 108.95 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.1 t -91.07 175.85 6.8 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -52.58 -45.28 66.42 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.802 0.728 . . . . 0.0 111.773 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -39.42 88.17 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.235 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.2 mt-10 -69.8 -32.18 70.5 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-O 121.371 0.605 . . . . 0.0 110.899 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.54 -36.62 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.74 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.75 -35.9 61.74 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.272 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.4 m -62.78 -47.51 83.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.704 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.58 -38.85 70.88 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.5 0.72 . . . . 0.0 110.905 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 2.7 t-20 -56.09 -39.53 72.26 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.44 1.096 . . . . 0.0 108.407 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.615 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 18.8 t70 -66.57 -45.87 77.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.67 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CG ' HD22 ' A' ' 65' ' ' LEU . 36.7 m95 -56.68 -42.84 79.73 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.0 mt-10 -49.41 -60.22 3.03 Favored 'General case' 0 C--O 1.2 -1.546 0 CA-C-O 121.616 0.722 . . . . 0.0 109.153 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -35.84 53.39 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 127.527 2.331 . . . . 0.0 111.922 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.4 mmtt -77.24 -45.87 25.06 Favored 'General case' 0 CA--C 1.48 -1.736 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -73.52 -36.46 65.72 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.241 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -60.66 -20.71 61.57 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 124.147 0.979 . . . . 0.0 112.912 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.91 -13.26 25.58 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.664 0.269 . . . . 0.0 110.922 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 28.0 mtpp -103.3 -51.4 3.24 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-O 121.543 0.687 . . . . 0.0 110.402 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -106.84 135.55 19.54 Favored Pre-proline 0 N--CA 1.423 -1.787 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.799 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.86 136.58 23.18 Favored 'Trans proline' 0 C--O 1.251 1.138 0 C-N-CA 122.176 1.918 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.276 14.9 m -85.78 109.55 18.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.442 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.27 69.31 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.267 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.476 ' H ' HD22 ' A' ' 9' ' ' LEU . . . 147.99 -179.1 25.14 Favored Glycine 0 N--CA 1.414 -2.771 0 C-N-CA 118.376 -1.869 . . . . 0.0 115.153 171.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 16.8 tpp180 -140.51 128.12 21.56 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 125.839 1.656 . . . . 0.0 108.492 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.3 p -99.86 137.29 27.81 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.73 145.77 32.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 N--CA 1.41 -2.471 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.468 178.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.687 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.24 126.05 7.93 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -152.84 24.54 0.57 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 117.142 0.471 . . . . 0.0 111.826 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 67.96 117.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.865 1.266 . . . . 0.0 113.552 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.58 79.83 2.51 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.035 0.445 . . . . 0.0 111.1 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -144.32 90.6 2.11 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.5 m80 68.54 -0.76 2.15 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -88.9 154.83 19.93 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.314 1.3 pp -66.56 157.65 31.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.08 114.62 27.22 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.048 -1.433 . . . . 0.0 113.72 -170.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.12 114.05 25.27 Favored 'General case' 0 N--CA 1.395 -3.209 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' O ' HG22 ' A' ' 108' ' ' VAL . 74.0 m-85 -104.96 150.64 24.75 Favored 'General case' 0 N--CA 1.381 -3.89 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.279 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.682 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.7 m -113.54 146.71 39.23 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.93 -46.93 84.27 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -67.11 -32.11 73.02 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.202 0.525 . . . . 0.0 111.415 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.682 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 38.9 mt-30 -73.71 -33.95 64.61 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.447 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.8 tp -65.66 -26.0 67.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.846 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 24.9 m -60.1 -7.46 1.85 Allowed 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -106.93 -6.1 17.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.401 0.619 . . . . 0.0 111.809 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 84.3 m-85 -89.79 37.39 0.88 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 23' ' ' THR . 31.9 p30 -90.69 -9.07 48.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.684 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 75.15 14.93 81.41 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -86.74 -19.0 29.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.751 1.276 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 29.3 t70 -100.66 103.96 15.25 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.802 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.0 13.29 2.77 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 123.374 0.669 . . . . 0.0 111.013 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 32.7 t 55.46 65.93 1.35 Allowed 'General case' 0 N--CA 1.412 -2.328 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.976 -171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 32.9 mtmm -70.11 155.36 93.58 Favored Pre-proline 0 C--O 1.235 0.306 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -43.29 136.26 5.76 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.99 2.46 . . . . 0.0 111.785 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 29.2 mt -108.16 119.73 58.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.206 -170.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 37' ' ' VAL . 84.0 m-85 -131.35 136.63 48.24 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.115 0.483 . . . . 0.0 111.875 -177.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 56' ' ' PHE . 27.4 m -115.49 159.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.4 138.2 43.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.571 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 94' ' ' GLU . 40.5 mt -132.81 113.66 20.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 34.7 mmtt 62.31 30.66 17.51 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.285 0.634 . . . . 0.0 112.396 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 84.83 0.43 89.12 Favored Glycine 0 N--CA 1.427 -1.947 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.956 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -95.77 120.59 36.31 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 30' ' ' TYR . 99.3 t -90.94 123.51 43.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 121.144 0.497 . . . . 0.0 111.144 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -107.53 138.95 42.82 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.39 113.0 19.18 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.801 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 m -110.13 14.18 8.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.114 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.6 m -64.44 -30.29 71.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -69.94 -24.73 63.41 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.925 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.13 41.72 2.15 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HG3' HD11 ' A' ' 29' ' ' ILE . 40.7 ttmt -57.1 -31.48 65.32 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 125.069 1.347 . . . . 0.0 113.466 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.8 p -64.01 -21.87 66.69 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.006 0.431 . . . . 0.0 111.907 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -96.1 -46.16 6.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -90.66 -76.53 0.43 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -89.93 63.65 3.15 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.868 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 t -144.81 17.32 1.62 Allowed 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.96 30.95 72.2 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.54 -173.89 48.29 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.61 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.86 -21.58 62.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.496 0.665 . . . . 0.0 110.715 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -96.82 14.68 24.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.697 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.8 t -71.03 -9.86 58.76 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 20.7 mmt -84.48 -21.76 30.51 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.136 0.494 . . . . 0.0 110.688 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 31' ' ' VAL . 78.2 m-85 -84.24 -30.42 25.7 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.54 121.49 15.48 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.235 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 79.65 16.31 77.82 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.355 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -147.57 143.35 27.69 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.453 -0.439 . . . . 0.0 110.905 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.689 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.3 t70 -73.74 129.98 39.04 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -114.96 24.7 11.5 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -170.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB3' ' CD2' ' A' ' 79' ' ' LEU . 48.9 m -54.43 -46.0 73.14 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 69.2 ttt180 -75.01 -35.79 61.96 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.013 -0.429 . . . . 0.0 110.792 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -63.11 -41.19 99.3 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-O 121.801 0.81 . . . . 0.0 109.832 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 93' ' ' TRP . 48.5 mt -60.48 -39.7 88.6 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.24 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.16 -25.67 51.06 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.301 -1.428 . . . . 0.0 112.222 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.4 mmmt -84.4 -32.24 24.26 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.289 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.8 mtp 75.05 21.03 2.03 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 125.801 1.641 . . . . 0.0 107.732 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 47.5 m -102.18 137.54 40.31 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.666 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -103.6 -13.54 16.5 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.1 p-10 -61.95 140.8 58.29 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.481 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.52 -27.88 58.51 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.773 1.229 . . . . 0.0 112.779 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.5 tp10 -64.6 -38.54 91.35 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.93 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -101.29 -3.5 28.78 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.4 t -90.11 116.18 30.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 21.5 m -164.32 155.78 13.83 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.18 -168.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.689 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 85.7 Cg_endo -80.78 -10.62 12.9 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.829 3.019 . . . . 0.0 115.231 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 55.7 m -106.41 164.74 11.79 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.831 -0.543 . . . . 0.0 111.352 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 15.3 mt -91.69 3.94 53.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 61.48 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.3 1.44 . . . . 0.0 112.702 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.94 40.16 0.25 Allowed Glycine 0 N--CA 1.41 -3.055 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 86' ' ' GLU . 94.5 mt -72.91 135.27 45.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.112 -1.044 . . . . 0.0 112.441 -174.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.1 p -81.76 178.9 8.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -65.56 -31.25 72.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.4 -53.66 54.74 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.622 1.201 . . . . 0.0 109.202 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.8 mm-40 -62.9 -52.28 63.7 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.16 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.405 ' CD1' HD13 ' A' ' 79' ' ' LEU . 7.1 mm -59.63 -46.3 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.118 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -57.33 -33.15 67.43 Favored 'General case' 0 CA--C 1.484 -1.572 0 CA-C-O 120.721 0.296 . . . . 0.0 111.789 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 98.2 m -62.37 -48.52 79.41 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.14 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -72.22 -41.71 66.55 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.052 0.541 . . . . 0.0 111.158 177.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 7.1 t-20 -54.45 -35.07 62.59 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.629 0.728 . . . . 0.0 109.83 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 22.8 t70 -70.76 -44.53 66.56 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.849 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD22 ' A' ' 65' ' ' LEU . 71.8 m95 -56.68 -39.05 73.13 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.549 ' HG2' HG21 ' A' ' 33' ' ' ILE . 45.0 mt-10 -51.24 -56.6 12.05 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.6 m -53.8 -29.38 40.29 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 126.743 2.017 . . . . 0.0 112.091 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -75.91 -34.78 59.95 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.993 0.901 . . . . 0.0 109.594 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 60.0 m-85 -83.67 -42.88 16.15 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.09 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 45.1 mt-10 -56.0 -28.31 56.68 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.756 1.222 . . . . 0.0 113.807 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.96 6.66 41.36 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 120.673 0.273 . . . . 0.0 110.563 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -131.02 -43.74 1.06 Allowed 'General case' 0 N--CA 1.414 -2.261 0 C-N-CA 118.433 -1.307 . . . . 0.0 110.826 -170.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -116.69 145.09 34.59 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.013 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.32 142.23 16.6 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.812 2.341 . . . . 0.0 112.522 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.99 96.58 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.34 -3.41 8.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.284 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 166.06 -149.9 16.57 Favored Glycine 0 N--CA 1.413 -2.887 0 C-N-CA 119.531 -1.319 . . . . 0.0 113.067 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 13.3 ptp180 -137.3 162.77 32.63 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.207 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.7 p -118.47 132.41 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 167.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.621 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 6.2 m -130.02 144.0 39.35 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.412 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 N--CA 1.409 -2.52 0 C-N-CA 117.639 -1.624 . . . . 0.0 111.449 160.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HB3' ' OH ' ' A' ' 20' ' ' TYR . 1.4 mpt? . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.66 105.64 0.27 Allowed Glycine 0 C--O 1.213 -1.187 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 -78.99 0.48 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 122.428 -0.454 . . . . 0.0 109.924 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -159.62 113.55 2.28 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 124.308 1.043 . . . . 0.0 109.421 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -128.81 95.21 4.03 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.701 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -71.91 76.76 0.9 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -144.21 100.28 3.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 105.385 -2.079 . . . . 0.0 105.385 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 64.38 -159.25 0.3 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 86.7 mt -75.96 166.37 23.59 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.833 174.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -74.33 104.59 5.14 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -77.46 122.7 25.56 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 121.651 0.739 . . . . 0.0 111.321 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -122.51 141.15 51.96 Favored 'General case' 0 C--N 1.277 -2.585 0 CA-C-N 113.859 -1.518 . . . . 0.0 110.003 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.527 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 6.6 m -98.02 147.66 24.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 172.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.39 84.97 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -59.24 -48.28 82.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.55 0.69 . . . . 0.0 110.188 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.527 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -64.89 -38.49 91.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.289 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 19' ' ' GLN . 54.7 tp -67.74 -29.68 68.97 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 112.511 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -62.78 17.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LEU . 39.7 mt-30 -121.63 -16.17 7.8 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 1' ' ' MET . 97.2 m-85 -95.36 40.37 1.11 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.24 -172.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' OD1' HG22 ' A' ' 23' ' ' THR . 30.6 p30 -86.99 -6.62 58.7 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.271 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.44 72.11 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.322 -0.854 . . . . 0.0 115.188 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.526 HG22 ' OD1' ' A' ' 21' ' ' ASN . 7.6 t -93.76 -3.23 52.53 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 118.515 1.158 . . . . 0.0 111.501 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 9.4 t70 -82.69 -178.98 7.28 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.05 84.2 5.07 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-O 121.679 0.752 . . . . 0.0 112.065 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 36.6 t 77.54 68.98 0.05 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.034 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 24' ' ' ASP . 12.6 mptt -122.97 129.22 25.06 Favored Pre-proline 0 C--N 1.307 -1.249 0 CA-C-N 114.195 -1.366 . . . . 0.0 111.163 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.06 150.83 54.04 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.869 2.38 . . . . 0.0 109.438 171.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 44' ' ' LYS . 17.6 mt -109.16 120.88 61.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.453 ' HB3' HG13 ' A' ' 37' ' ' VAL . 67.5 m-85 -136.72 128.41 28.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG23 HG21 ' A' ' 40' ' ' VAL . 83.7 t -112.8 135.92 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.752 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -114.6 133.87 55.49 Favored 'General case' 0 N--CA 1.415 -2.179 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.722 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG21 ' HG2' ' A' ' 94' ' ' GLU . 38.2 mt -129.8 113.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? 64.26 14.32 8.6 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.459 1.104 . . . . 0.0 108.639 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.679 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 111.65 -18.46 24.73 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.454 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HB3' HG11 ' A' ' 103' ' ' VAL . 51.7 mtm-85 -85.41 124.4 31.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.757 0.778 . . . . 0.0 108.974 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 32' ' ' ALA . 50.5 t -96.84 119.37 44.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.349 0.595 . . . . 0.0 112.257 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.27 144.64 26.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.985 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -85.25 109.85 18.63 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.546 HG21 HG23 ' A' ' 31' ' ' VAL . 15.9 m -110.85 16.2 8.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 121.093 0.473 . . . . 0.0 110.427 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 m -65.55 -32.52 74.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -71.54 -23.02 61.69 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.391 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.52 39.31 2.92 Favored Glycine 0 CA--C 1.507 -0.463 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.543 ' HG3' HD11 ' A' ' 29' ' ' ILE . 83.8 tttt -54.23 -34.24 60.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.393 1.077 . . . . 0.0 111.923 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.4 m -56.88 -37.59 71.57 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 122.895 0.478 . . . . 0.0 111.834 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -89.06 -39.54 13.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.214 0.53 . . . . 0.0 110.915 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -92.33 -58.16 2.46 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.78 27.86 18.4 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 119.468 -1.348 . . . . 0.0 114.636 -171.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -126.28 17.35 7.72 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 117.23 0.515 . . . . 0.0 111.054 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.89 52.47 6.99 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -106.25 -170.01 23.05 Favored Glycine 0 N--CA 1.428 -1.857 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.75 -17.01 62.81 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.847 0.459 . . . . 0.0 112.09 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -118.46 19.34 13.38 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.993 0.425 . . . . 0.0 111.576 -174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 m -59.01 -28.11 66.09 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.593 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 25.6 mmt -82.25 -23.75 35.14 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.572 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' HG22 ' A' ' 31' ' ' VAL . 67.9 m-85 -82.61 -28.16 31.0 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.02 -29.42 4.9 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.8 25.54 2.1 Favored Glycine 0 CA--C 1.487 -1.697 0 C-N-CA 117.609 -2.234 . . . . 0.0 114.528 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 59' ' ' LYS . 39.7 ttmt -146.42 161.04 41.26 Favored 'General case' 1 N--CA 1.376 -4.158 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 10.8 t70 -68.25 126.84 30.84 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.08 33.38 5.65 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.966 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.8 m -54.4 -52.98 60.0 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 6.1 ttp180 -72.31 -30.93 65.25 Favored 'General case' 0 N--CA 1.435 -1.177 0 O-C-N 121.535 -0.728 . . . . 0.0 112.339 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -69.74 -33.76 72.89 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD22 ' CG ' ' A' ' 93' ' ' TRP . 34.5 mt -62.81 -47.22 84.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.92 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.69 -24.42 74.06 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.443 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.7 mmmt -97.57 -17.35 19.6 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 72.6 mtp 61.7 34.25 17.57 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 t -92.69 144.55 25.2 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.927 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' O ' ' HG3' ' A' ' 55' ' ' MET . 70.2 mttt -116.81 -5.48 11.54 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.147 -1.842 . . . . 0.0 110.061 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.5 127.52 32.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -57.99 -19.1 28.29 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 124.14 0.976 . . . . 0.0 112.724 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.26 -36.61 80.48 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 50.7 m-20 -91.59 -17.54 25.43 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-O 120.86 0.362 . . . . 0.0 111.468 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 9.7 t -77.11 102.01 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.1 t -154.88 147.54 17.83 Favored Pre-proline 0 N--CA 1.424 -1.729 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.624 -169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 58.5 Cg_endo -70.38 44.77 0.49 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 124.387 3.392 . . . . 0.0 113.558 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.4 t -170.76 163.01 7.86 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -103.07 13.16 34.84 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.847 0.832 . . . . 0.0 110.561 176.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 59.2 -92.71 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.21 -1.359 . . . . 0.0 114.023 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.02 35.5 0.66 Allowed Glycine 0 N--CA 1.408 -3.231 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 86' ' ' GLU . 78.6 mt -63.51 139.6 58.79 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.501 -0.849 . . . . 0.0 110.985 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.4 t -84.13 174.01 10.6 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.56 -43.06 65.0 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.65 0.38 . . . . 0.0 111.813 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -52.88 -52.97 55.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.733 0.778 . . . . 0.0 110.436 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' HB3' HD22 ' A' ' 82' ' ' LEU . 54.9 mm-40 -66.5 -49.78 65.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.188 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.03 -35.83 53.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.883 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.16 -38.72 40.88 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.214 0.606 . . . . 0.0 111.323 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -64.27 -44.85 90.46 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.789 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.05 -37.27 66.9 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -58.76 -39.83 82.11 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.721 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 10.5 t70 -62.32 -49.54 75.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.351 172.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CG ' HD22 ' A' ' 65' ' ' LEU . 65.9 m95 -55.23 -39.6 69.9 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.506 ' HG2' HG21 ' A' ' 33' ' ' ILE . 46.3 mt-10 -51.89 -51.28 57.92 Favored 'General case' 0 C--O 1.2 -1.53 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 50.8 m -62.77 -31.01 71.89 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.639 1.576 . . . . 0.0 111.955 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.2 mmtp -74.38 -42.57 59.08 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.0 m-85 -72.01 -44.45 63.41 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.501 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -55.51 -26.83 45.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.144 0.978 . . . . 0.0 113.528 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.34 4.9 46.56 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 122.369 -0.207 . . . . 0.0 110.825 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.565 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -130.71 -42.86 1.13 Allowed 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 118.671 -1.211 . . . . 0.0 110.643 -171.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -124.43 137.97 30.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.099 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.98 139.58 9.68 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.301 2.001 . . . . 0.0 111.842 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 36' ' ' ARG . 28.7 m -76.56 108.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 121.76 0.791 . . . . 0.0 110.316 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.64 1.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.247 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 9' ' ' LEU . . . -159.64 -171.62 25.73 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.729 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 10.2 ptp180 -136.44 157.07 47.66 Favored 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.679 HG12 ' HA2' ' A' ' 35' ' ' GLY . 9.1 p -112.08 135.14 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.797 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 168.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' PHE . 35.7 m -118.14 134.49 61.6 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.323 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.395 -3.205 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.432 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.581 0.229 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.01 137.29 13.68 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.914 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -163.74 133.53 4.14 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -89.08 158.66 17.89 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.236 0.541 . . . . 0.0 111.854 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -138.38 -1.24 1.92 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -155.77 179.89 8.77 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 126.551 1.94 . . . . 0.0 107.15 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -160.63 82.98 0.67 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -140.85 -63.92 0.46 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.324 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 ' HA2' ' A' ' 105' ' ' GLY . 1.3 tm? -141.43 90.14 2.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.09 124.75 36.41 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.605 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.49 120.9 26.85 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.752 0.787 . . . . 0.0 110.4 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 58.8 m-85 -119.1 128.57 54.43 Favored 'General case' 0 N--CA 1.395 -3.208 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.294 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 4.1 m -85.77 152.84 22.72 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.32 -45.78 65.76 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.27 -36.38 83.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.553 0.692 . . . . 0.0 110.322 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.58 -35.37 58.21 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.741 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -60.85 -39.92 90.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 29.9 m -63.29 -11.04 18.9 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.415 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.5 -11.76 41.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.292 0.567 . . . . 0.0 110.189 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -102.72 32.21 3.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.988 0.899 . . . . 0.0 109.94 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -76.8 -12.8 60.03 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.28 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.42 31.27 22.54 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.244 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -91.29 -8.82 47.18 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 122.111 0.958 . . . . 0.0 108.424 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.52 -178.32 5.29 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.37 87.58 4.4 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.002 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.0 t 74.61 -87.84 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.039 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CD ' ' A' ' 28' ' ' PRO . 38.4 mtmt 57.43 -173.92 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 27' ' ' LYS . 2.9 Cg_exo -79.96 137.68 12.56 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.374 1.169 . . . . 0.0 109.924 168.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.6 mp -106.62 138.98 29.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -133.26 147.96 51.95 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.325 0.583 . . . . 0.0 111.364 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 m -126.51 157.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -127.63 132.88 49.69 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.952 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 57.2 mt -134.63 118.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.1 tptm 71.74 18.81 5.1 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.232 1.013 . . . . 0.0 108.432 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 89.95 -1.51 80.68 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.115 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -95.79 128.22 42.49 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.98 123.56 46.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.1 0.476 . . . . 0.0 111.186 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.47 138.81 41.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.76 112.09 20.75 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.11 23.57 3.81 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.597 -177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 m -68.68 -24.87 64.56 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -64.36 -30.08 71.14 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.28 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.34 44.52 1.38 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HG2' ' OG ' ' A' ' 49' ' ' SER . 28.7 ttpp -55.9 -39.78 72.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 123.336 0.654 . . . . 0.0 111.36 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -49.49 -28.84 5.84 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.603 0.761 . . . . 0.0 112.142 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -91.24 -46.05 8.28 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.031 0.443 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.97 -46.58 6.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.56 10.06 Favored Glycine 0 C--N 1.323 -0.18 0 C-N-CA 119.489 -1.339 . . . . 0.0 114.503 -172.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.416 ' OG ' ' HG2' ' A' ' 44' ' ' LYS . 45.0 m -142.32 77.65 1.59 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 117.442 0.621 . . . . 0.0 111.916 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.24 61.32 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.571 -0.74 . . . . 0.0 113.745 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.06 167.67 15.22 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.05 -1.072 . . . . 0.0 113.549 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -68.94 -28.43 66.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.967 0.889 . . . . 0.0 109.699 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -86.4 15.72 5.15 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.651 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -65.45 -20.21 66.26 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.213 0.53 . . . . 0.0 110.584 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.489 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 19.6 mmt -74.09 -17.25 60.98 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 120.777 0.322 . . . . 0.0 110.572 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.46 -19.93 20.13 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.584 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.95 106.54 2.77 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' C ' HD12 ' A' ' 17' ' ' LEU . . . 84.35 28.02 34.59 Favored Glycine 0 CA--C 1.48 -2.145 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -142.03 145.65 34.62 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.817 -177.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.3 t70 -90.54 127.04 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 164.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.11 33.85 5.35 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.047 -171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.481 ' HB3' HD22 ' A' ' 79' ' ' LEU . 38.0 m -54.96 -43.97 73.93 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 60.1 ttt180 -68.76 -37.28 79.26 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.187 -0.32 . . . . 0.0 111.843 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.38 -34.04 72.11 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -173.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.54 HD22 ' CG ' ' A' ' 93' ' ' TRP . 52.4 mt -65.85 -28.07 68.7 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.31 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.23 -26.55 25.59 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 119.512 -1.327 . . . . 0.0 112.163 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 30.5 mmmt -90.04 -24.55 21.16 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.619 0.247 . . . . 0.0 110.651 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.0 mtp 75.99 20.48 1.7 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.253 1.421 . . . . 0.0 108.607 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.573 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 50.1 m -106.44 149.54 26.95 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 113.431 -1.713 . . . . 0.0 110.085 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 55' ' ' MET . 86.2 mttt -113.09 -16.03 12.69 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.058 -173.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.599 HD22 ' HB3' ' A' ' 73' ' ' GLU . 2.2 p-10 -55.75 141.88 36.65 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.991 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.6 -26.95 62.26 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.398 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HB3' HD22 ' A' ' 71' ' ' ASN . 10.2 tp10 -55.83 -44.46 77.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.261 0.553 . . . . 0.0 110.549 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 22.8 m-20 -94.78 -15.79 23.52 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.328 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 71' ' ' ASN . 22.3 t -79.88 101.96 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.1 t -152.06 146.64 18.76 Favored Pre-proline 0 N--CA 1.422 -1.835 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.159 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 95.2 Cg_endo -77.2 33.72 0.44 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 123.924 3.083 . . . . 0.0 113.417 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 t -153.22 173.37 15.63 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 62' ' ' SER . 0.4 OUTLIER -134.48 25.47 3.77 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -61.41 120.96 11.49 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.695 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.66 -13.97 20.23 Favored Glycine 0 N--CA 1.4 -3.704 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.524 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 9.0 mp -87.7 114.71 24.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.0 -0.6 . . . . 0.0 111.087 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 85' ' ' LYS . 10.0 t -82.63 -174.47 5.23 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.12 -46.22 65.23 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 52.5 pttt -60.66 -41.75 95.64 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 10.3 mm-40 -70.79 -42.57 70.18 Favored 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.9 mt -64.3 -37.86 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.476 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.354 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -52.13 -40.29 61.14 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 65' ' ' LEU . 94.3 m -61.14 -44.5 97.22 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.495 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -72.99 -36.91 67.16 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -55.84 -38.99 70.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.485 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.6 t70 -68.23 -40.89 81.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.443 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.54 ' CG ' HD22 ' A' ' 65' ' ' LEU . 85.6 m95 -62.13 -41.44 98.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.712 176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 53.9 mt-10 -52.03 -42.87 63.42 Favored 'General case' 0 C--O 1.212 -0.895 0 CA-C-O 121.615 0.721 . . . . 0.0 109.389 175.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 32.0 m -67.25 -29.48 69.12 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.954 -1.476 . . . . 0.0 112.072 -175.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -75.47 -42.95 51.88 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.12 0.962 . . . . 0.0 109.213 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -72.59 -40.68 66.37 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.578 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -56.37 -21.06 22.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.948 1.299 . . . . 0.0 113.102 -176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.91 -5.6 22.13 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.87 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 12.9 mptt -122.09 -39.66 2.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.31 0.576 . . . . 0.0 111.508 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -112.33 130.33 23.45 Favored Pre-proline 0 C--N 1.295 -1.761 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.057 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.53 140.27 16.8 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.424 2.083 . . . . 0.0 111.955 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.46 108.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -103.86 7.9 9.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.372 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.407 ' HA2' HD22 ' A' ' 9' ' ' LEU . . . 164.28 -156.13 27.87 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 119.806 -1.188 . . . . 0.0 112.902 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.39 160.83 37.21 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.247 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 11.7 p -106.28 136.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.775 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.11 144.01 28.68 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.896 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.169 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.402 -2.851 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -175.806 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.217 -0.606 0 CA-C-O 120.76 0.314 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.41 -149.2 51.61 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.979 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -89.1 -62.61 1.44 Allowed 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -141.79 -26.5 0.67 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.12 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.7 p80 49.03 -169.71 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.812 1.645 . . . . 0.0 112.984 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 10' ' ' GLU . 26.5 t60 68.88 17.63 8.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.567 1.147 . . . . 0.0 111.144 173.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -89.97 154.42 19.85 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.022 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 76.42 -64.29 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.949 1.299 . . . . 0.0 108.608 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -174.14 179.47 1.88 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 6' ' ' HIS 0.251 32.2 tt0 -136.71 123.32 21.0 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 115.69 -2.404 . . . . 0.0 114.931 174.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 30.2 tt0 -85.94 116.07 23.94 Favored 'General case' 1 N--CA 1.375 -4.198 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.024 171.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.503 ' O ' HG22 ' A' ' 108' ' ' VAL . 57.5 m-85 -102.24 144.93 30.14 Favored 'General case' 0 C--N 1.244 -3.989 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.546 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.655 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 16.6 m -103.75 146.2 28.96 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 170.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.63 91.67 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -166.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.58 -36.06 81.5 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.655 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 39.3 mt-30 -76.32 -31.55 58.21 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.318 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 19' ' ' GLN . 60.3 tp -65.9 -26.83 67.8 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.056 0.543 . . . . 0.0 110.207 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t -71.16 20.1 0.05 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 110.864 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 17' ' ' LEU . 34.2 mt-30 -121.33 2.29 10.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -114.36 34.14 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.329 1.052 . . . . 0.0 110.293 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 23' ' ' THR . 19.1 m-80 -79.42 -16.28 56.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.5 28.21 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 21' ' ' ASN . 36.6 m -96.86 -39.62 9.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -100.45 106.88 18.49 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.715 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 58.13 19.67 6.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.629 1.172 . . . . 0.0 112.796 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.3 t 62.13 38.53 13.72 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.459 0.704 . . . . 0.0 111.077 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -62.88 155.73 70.1 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.603 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 75.8 Cg_exo -42.22 137.35 3.51 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.696 2.931 . . . . 0.0 113.068 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.48 HG12 ' HA2' ' A' ' 48' ' ' GLY . 2.3 mp -102.51 137.27 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 81.4 m-85 -139.23 147.68 42.07 Favored 'General case' 0 N--CA 1.407 -2.608 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 4.3 p -131.91 128.39 59.65 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.983 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -107.84 140.38 41.02 Favored 'General case' 0 N--CA 1.405 -2.678 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.342 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 62.2 mt -134.14 116.15 22.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.581 177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 61.9 26.45 16.0 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 122.482 1.134 . . . . 0.0 109.789 176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 98.35 -1.79 59.0 Favored Glycine 0 N--CA 1.427 -1.934 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.438 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 78.9 mtm-85 -103.11 121.42 42.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 117.749 0.775 . . . . 0.0 109.016 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 32' ' ' ALA . 82.5 t -89.92 121.96 40.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 120.983 0.42 . . . . 0.0 111.246 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.2 m-85 -106.49 147.54 29.25 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -92.12 124.15 35.99 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.0 23.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.2 m -70.52 -23.52 62.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -67.91 -22.8 65.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.733 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.42 37.04 3.28 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -58.72 -28.02 65.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.981 0.912 . . . . 0.0 111.844 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -69.58 -21.76 63.58 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.047 0.451 . . . . 0.0 110.789 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -106.86 -34.04 7.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -105.48 -24.01 12.7 Favored 'General case' 0 C--O 1.204 -1.341 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 29' ' ' ILE . . . -64.84 -102.87 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 -166.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 m -85.25 -33.11 22.26 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -165.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.04 47.98 0.4 Allowed Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.58 171.8 32.3 Favored Glycine 0 N--CA 1.41 -3.074 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -78.61 -13.85 59.62 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.488 0.661 . . . . 0.0 110.476 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -114.72 17.87 16.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.258 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 m -63.16 -8.54 8.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.417 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.8 mpt? -64.91 -33.48 76.13 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.329 0.585 . . . . 0.0 109.84 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 50.0 m-85 -82.39 -30.02 30.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.435 -176.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.73 113.53 1.68 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.986 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.23 10.83 65.53 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD2' ' CG1' ' A' ' 75' ' ' VAL . 23.9 mtmt -141.75 165.33 27.77 Favored 'General case' 0 N--CA 1.395 -3.196 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 8.0 t70 -95.94 137.81 34.47 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.63 29.82 7.0 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 119.941 -0.703 . . . . 0.0 112.72 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.526 ' HA ' HD13 ' A' ' 90' ' ' LEU . 49.3 m -54.43 -48.06 72.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 78' ' ' SER . 62.8 ttt180 -71.34 -30.59 66.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -75.66 -34.98 60.5 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.7 mt -69.57 -36.7 76.54 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.851 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.8 58.97 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 119.413 -1.375 . . . . 0.0 112.921 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -92.88 -27.27 17.21 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 122.614 -0.345 . . . . 0.0 110.946 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.8 mtp 82.38 14.19 0.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.031 1.733 . . . . 0.0 110.013 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.7 m -80.99 133.66 35.54 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 113.318 -1.764 . . . . 0.0 110.206 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB3' ' HG2' ' A' ' 55' ' ' MET . 29.1 mttp -100.64 -14.95 17.93 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.041 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 p-10 -64.4 141.32 58.82 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.254 177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.2 -29.5 65.73 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.474 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.46 ' HB2' HD22 ' A' ' 71' ' ' ASN . 41.5 mt-10 -56.52 -33.06 65.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.579 0.352 . . . . 0.0 111.909 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.86 6.52 31.63 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.507 ' CG1' ' HD2' ' A' ' 59' ' ' LYS . 15.3 t -94.08 129.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t 178.1 148.87 0.38 Allowed Pre-proline 0 C--O 1.252 1.236 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.682 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 37.3 Cg_endo -65.89 -20.66 58.08 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.638 2.892 . . . . 0.0 113.017 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 68.2 m -96.82 127.98 43.32 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.893 -177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 79' ' ' LEU 0.301 0.2 OUTLIER -80.48 1.27 30.05 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.753 0.787 . . . . 0.0 112.658 178.034 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 59.18 -98.46 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 167.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.94 19.14 5.26 Favored Glycine 0 N--CA 1.414 -2.778 0 C-N-CA 119.842 -1.171 . . . . 0.0 112.201 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.744 HD22 ' HB3' ' A' ' 86' ' ' GLU . 70.8 mt -59.77 133.22 55.89 Favored 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 123.288 0.635 . . . . 0.0 111.323 178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -83.31 177.16 8.63 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.252 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.61 -46.28 77.38 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.646 0.779 . . . . 0.0 111.431 -170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 45.1 pttt -63.09 -36.64 84.25 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.332 0.587 . . . . 0.0 111.788 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.744 ' HB3' HD22 ' A' ' 82' ' ' LEU . 11.0 mm-40 -70.32 -45.92 65.27 Favored 'General case' 0 CA--C 1.468 -2.186 0 CA-C-O 122.034 0.921 . . . . 0.0 108.706 -175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.6 mt -61.86 -37.45 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.779 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -56.15 -35.03 66.69 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 55.2 m -60.93 -42.9 99.07 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.866 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.66 -39.35 67.18 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.9 OUTLIER -53.15 -40.87 64.59 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.724 176.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.8 t70 -68.29 -37.25 80.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.261 175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CG ' HD22 ' A' ' 65' ' ' LEU . 74.8 m95 -66.04 -34.9 79.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.813 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 44.3 mt-10 -54.12 -52.84 59.78 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.6 m -50.82 -30.9 15.53 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.942 1.697 . . . . 0.0 112.141 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' O ' ' HD3' ' A' ' 100' ' ' LYS . 75.1 mmtt -75.71 -38.28 58.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.131 0.967 . . . . 0.0 108.711 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.58 -37.21 23.24 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.974 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.66 -29.81 53.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.464 1.506 . . . . 0.0 112.755 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -104.15 -0.74 28.18 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.864 -175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -121.69 -38.84 2.7 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.126 -175.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.33 144.06 31.57 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.295 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 96.0 Cg_endo -80.16 138.73 12.92 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.254 1.969 . . . . 0.0 112.178 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.14 107.46 11.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.9 m -96.59 3.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.386 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 159.6 -149.48 19.24 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.726 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 8.2 ptp180 -130.35 164.01 25.6 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 120.781 0.325 . . . . 0.0 110.743 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.566 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.5 p -122.53 130.04 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.599 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.1 m -116.76 143.95 25.7 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.914 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.527 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.407 -2.595 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.957 -176.204 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.05 -146.66 49.12 Favored Glycine 0 N--CA 1.445 -0.747 0 O-C-N 123.639 0.587 . . . . 0.0 112.653 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 70.26 -66.46 0.28 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.442 1.097 . . . . 0.0 112.722 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -56.18 113.0 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -157.52 142.85 17.09 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.5 m-70 -123.11 124.72 43.72 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.824 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -148.7 95.25 2.4 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 160.83 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.61 1.564 . . . . 0.0 107.449 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.461 1.2 pp 73.95 140.71 0.06 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 127.296 2.238 . . . . 0.0 114.141 -175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -137.21 164.66 27.97 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.295 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -94.51 138.53 32.31 Favored 'General case' 0 N--CA 1.403 -2.804 0 CA-C-O 121.939 0.876 . . . . 0.0 111.176 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 108' ' ' VAL . 82.5 m-85 -121.76 154.43 36.95 Favored 'General case' 0 N--CA 1.407 -2.618 0 C-N-CA 125.618 1.567 . . . . 0.0 107.712 173.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.554 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 11.8 m -106.78 153.08 22.98 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 172.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.42 65.72 Favored 'General case' 0 C--O 1.21 -0.994 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -68.11 -30.81 70.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.354 0.597 . . . . 0.0 112.09 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -76.22 -33.91 59.25 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.601 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.46 HD13 ' HA2' ' A' ' 58' ' ' GLY . 2.8 tm? -77.27 -41.92 39.08 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 124.08 0.952 . . . . 0.0 109.945 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 70.9 m -64.03 -3.43 2.61 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.57 -30.55 23.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -87.4 76.03 9.13 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.664 0.745 . . . . 0.0 110.669 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.476 ' OD1' HG22 ' A' ' 23' ' ' THR . 37.1 p30 -113.82 -12.35 12.74 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.582 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 89.66 -10.43 73.63 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 173.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.476 HG22 ' OD1' ' A' ' 21' ' ' ASN . 10.5 t -85.71 -10.76 55.15 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.496 1.148 . . . . 0.0 111.112 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.613 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 24.8 t70 -104.89 104.9 14.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 119.321 -0.371 . . . . 0.0 110.509 -178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.08 19.77 5.0 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.482 0.713 . . . . 0.0 111.934 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.6 t 64.57 56.22 1.23 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 123.837 0.71 . . . . 0.0 111.218 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 67.5 mttm -66.1 154.81 89.02 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.49 144.64 40.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.941 1.761 . . . . 0.0 109.993 173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.582 HG13 ' HA3' ' A' ' 22' ' ' GLY . 1.9 mp -115.41 135.46 55.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.436 ' HB3' HG13 ' A' ' 37' ' ' VAL . 76.4 m-85 -143.66 158.06 43.95 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 56' ' ' PHE . 7.9 p -134.07 146.7 31.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -116.27 131.13 57.03 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.273 0.559 . . . . 0.0 111.53 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.5 mt -132.72 113.01 19.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm 55.4 34.82 23.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 84.08 3.35 89.07 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.134 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 17.4 mmm180 -90.54 123.13 33.96 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 30' ' ' TYR . 92.2 t -99.5 112.75 32.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 120.904 0.383 . . . . 0.0 110.329 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -100.74 143.85 30.4 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.946 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 102' ' ' PRO . 10.2 t70 -79.98 109.54 14.52 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.219 0.533 . . . . 0.0 109.861 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.6 21.56 5.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.799 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 m -77.44 -25.74 50.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.6 m -67.22 -22.64 65.7 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.191 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.27 48.61 0.96 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -57.14 -38.99 74.33 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.261 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 m -66.46 -6.82 16.07 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -108.18 -27.08 10.27 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 120.487 0.184 . . . . 0.0 111.006 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 54' ' ' SER . 57.9 m-85 -119.93 -21.43 7.14 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.57 -96.57 0.02 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.35 1.3 . . . . 0.0 116.35 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -109.91 -49.77 3.05 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.104 -0.644 . . . . 0.0 111.03 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.39 8.86 64.65 Favored Glycine 0 C--N 1.31 -0.895 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.676 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.82 151.12 40.54 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.12 -30.23 55.13 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.768 0.794 . . . . 0.0 109.955 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -94.32 24.45 4.44 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.825 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 36.6 t -62.66 -18.28 62.04 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.787 0.835 . . . . 0.0 111.249 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.461 ' SD ' ' HG3' ' A' ' 72' ' ' GLU . 17.6 mmt -77.43 -27.72 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.5 m-85 -74.16 -37.97 63.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.172 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.31 117.1 2.18 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.402 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 64.3 29.02 73.87 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.119 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HB2' ' NZ ' ' A' ' 59' ' ' LYS . 4.6 ttmp? -145.32 156.9 44.08 Favored 'General case' 1 N--CA 1.375 -4.175 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.3 t70 -83.45 124.42 30.68 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 173.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -111.43 22.46 15.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' HD12 ' A' ' 65' ' ' LEU . 32.1 m -54.68 -39.97 68.62 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.643 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 26.9 ttm180 -67.4 -39.66 85.58 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.962 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.8 -34.43 71.74 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.81 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 80.4 mt -59.26 -48.22 82.43 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.067 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.49 -31.81 65.28 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.953 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.1 mmmt -75.71 -33.81 60.35 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.7 mtp 72.19 68.86 0.14 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.2 m -156.77 -173.01 4.27 Favored 'General case' 0 N--CA 1.386 -3.659 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -159.95 -18.15 0.06 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.562 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -62.94 146.53 52.82 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.348 0.522 . . . . 0.0 110.532 175.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG3' ' SD ' ' A' ' 55' ' ' MET . 50.9 mt-10 -57.16 -14.84 4.49 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.039 0.936 . . . . 0.0 113.33 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.18 -33.03 74.84 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 125.062 1.345 . . . . 0.0 107.651 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -116.82 6.7 13.2 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 71' ' ' ASN . 33.8 t -85.93 102.21 11.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.6 t -152.04 145.46 17.66 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.052 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.82 -20.1 4.68 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.464 2.776 . . . . 0.0 114.774 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 23.1 t -62.92 -44.14 96.9 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' HA ' HD12 ' A' ' 82' ' ' LEU . 15.4 mt 69.74 33.62 2.89 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 123.226 1.489 . . . . 0.0 107.927 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 1.1 pm0 -54.02 -66.38 0.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 110.918 -2.856 . . . . 0.0 115.075 -174.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 80' ' ' GLU . . . -115.77 66.18 0.3 Allowed Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 86' ' ' GLU . 95.7 mt -137.33 125.67 23.31 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 122.417 0.287 . . . . 0.0 110.769 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.3 p -77.86 177.03 8.54 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.57 -30.1 71.26 Favored 'General case' 0 C--O 1.188 -2.175 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.763 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -54.4 -53.39 54.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.179 0.99 . . . . 0.0 109.342 174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.673 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.4 mm-40 -63.84 -52.04 61.91 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.77 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.405 HD12 HD13 ' A' ' 79' ' ' LEU . 26.3 mm -59.94 -47.65 90.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.668 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -57.68 -32.66 67.56 Favored 'General case' 0 CA--C 1.48 -1.746 0 C-N-CA 123.248 0.619 . . . . 0.0 112.132 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' HD1' ' A' ' 93' ' ' TRP . 72.0 m -63.22 -41.87 99.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.625 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -73.49 -34.36 65.26 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -176.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 92.6 m-20 -55.26 -34.67 64.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.71 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.3 t70 -69.66 -48.6 59.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.545 ' HB3' HD22 ' A' ' 65' ' ' LEU . 30.8 m95 -54.02 -45.62 71.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.495 1.518 . . . . 0.0 113.112 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -56.06 -52.75 63.15 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.438 0.695 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.484 ' HA ' ' HB2' ' A' ' 98' ' ' GLU . 27.6 m -57.72 -28.48 63.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.451 1.5 . . . . 0.0 111.647 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.4 mmtp -76.2 -40.56 51.94 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.21 -40.92 77.71 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.67 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' THR . 45.0 mm-40 -55.24 -28.45 53.33 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 125.209 1.404 . . . . 0.0 113.946 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.4 -13.2 14.91 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.298 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -105.48 -37.27 6.86 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.15 0.5 . . . . 0.0 110.57 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -109.66 143.79 28.58 Favored Pre-proline 0 N--CA 1.421 -1.921 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.487 ' HG2' ' HB3' ' A' ' 39' ' ' ASP . 53.6 Cg_endo -76.49 123.5 7.08 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 C-N-CA 121.39 1.393 . . . . 0.0 110.805 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.437 HG11 ' NH2' ' A' ' 36' ' ' ARG . 10.0 p -78.16 95.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.825 1.298 . . . . 0.0 108.658 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 6' ' ' HIS . 34.1 m -94.66 1.21 10.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.734 -171.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.92 -177.37 39.17 Favored Glycine 0 N--CA 1.411 -2.969 0 C-N-CA 117.888 -2.101 . . . . 0.0 115.312 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 15.2 tpp180 -131.42 128.03 38.69 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 127.228 2.211 . . . . 0.0 107.333 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' HA2' ' A' ' 35' ' ' GLY . 13.3 p -106.56 130.97 57.51 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 12' ' ' PHE . 14.6 m -111.38 144.37 19.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.262 -3.199 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.992 -171.125 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 152.25 27.06 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.432 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.5 -18.21 49.26 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.252 12.4 m-70 72.0 94.54 0.08 Allowed 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -94.86 92.34 6.88 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 173.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.584 ' CB ' ' HB2' ' A' ' 10' ' ' GLU 0.302 7.7 p80 -87.2 115.69 24.78 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 -170.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -73.53 126.19 29.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.326 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 72.96 -70.01 0.17 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.763 1.225 . . . . 0.0 110.107 -175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.32 -177.66 3.74 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 6' ' ' HIS . 29.0 tt0 -137.24 137.38 39.0 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.078 -1.849 . . . . 0.0 110.767 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.02 126.24 34.0 Favored 'General case' 1 N--CA 1.377 -4.1 0 CA-C-O 121.802 0.811 . . . . 0.0 108.94 172.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 87.6 m-85 -116.12 139.34 50.41 Favored 'General case' 0 N--CA 1.388 -3.548 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.858 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 12.4 m -95.41 151.22 19.48 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.86 -44.92 63.87 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -68.79 -33.95 74.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.151 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.615 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.55 -34.35 58.51 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.396 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -61.24 -32.19 71.98 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.408 1.083 . . . . 0.0 108.767 -178.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.8 m -60.62 -20.03 59.57 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.427 ' NE2' ' HA ' ' A' ' 16' ' ' GLN . 2.5 mp0 -81.06 -5.23 57.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.296 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 91.5 m-85 -106.79 22.81 15.33 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.613 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 10.4 p30 -70.43 -19.16 63.0 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.977 0.418 . . . . 0.0 111.535 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.44 -4.11 28.05 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.801 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.4 m -91.08 2.54 56.25 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.226 1.012 . . . . 0.0 110.167 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 15.2 t70 -70.95 -177.77 1.73 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' SER . 42.6 mt-10 -106.53 69.35 0.78 Allowed 'General case' 0 N--CA 1.386 -3.668 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 73.6 m 84.64 83.51 0.02 OUTLIER 'General case' 0 N--CA 1.404 -2.765 0 CA-C-N 112.049 -2.342 . . . . 0.0 115.753 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' OD1' ' A' ' 24' ' ' ASP . 22.1 mtmm -140.38 150.54 61.42 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.81 148.1 93.84 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.385 2.057 . . . . 0.0 110.792 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.5 mp -99.9 133.67 42.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' HB3' HG13 ' A' ' 37' ' ' VAL . 41.8 m-85 -128.72 130.97 47.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -175.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 40' ' ' VAL . 85.1 t -118.13 137.77 50.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . . . -121.37 129.64 53.16 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 121.115 0.483 . . . . 0.0 111.177 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 94' ' ' GLU . 55.9 mt -129.7 120.2 49.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt 64.3 24.12 13.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.371 0.605 . . . . 0.0 110.689 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 86.75 -7.42 79.83 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.144 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -82.99 111.12 18.56 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG13 ' HB3' ' A' ' 30' ' ' TYR . 25.6 t -84.76 118.95 32.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.191 0.52 . . . . 0.0 111.206 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 28.4 m-85 -105.61 147.13 28.79 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.33 106.47 17.41 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 31' ' ' VAL . 18.6 m -101.68 17.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.16 -28.64 70.19 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.1 t -64.6 -26.36 68.37 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.429 0.633 . . . . 0.0 110.398 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.98 43.94 1.55 Allowed Glycine 0 N--CA 1.427 -1.911 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -54.05 -35.38 61.92 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.804 0.842 . . . . 0.0 111.728 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 49' ' ' SER . 23.5 m -60.18 -27.72 67.35 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -83.02 -46.89 12.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 110.209 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -96.91 -68.88 0.78 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -81.7 22.83 5.34 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 115.078 0.791 . . . . 0.0 115.078 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 45' ' ' SER . 36.5 m -121.58 14.6 11.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 122.362 -0.493 . . . . 0.0 110.96 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.45 25.43 54.24 Favored Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.747 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.6 -174.66 39.44 Favored Glycine 0 CA--C 1.479 -2.201 0 CA-C-O 121.407 0.448 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.45 -34.63 69.18 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.819 0.818 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -101.5 21.36 14.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.408 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -67.14 -18.77 65.44 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.925 0.393 . . . . 0.0 111.502 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mmt -80.66 -24.04 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.6 m-85 -91.22 -8.73 47.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.028 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -77.34 -1.94 32.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -171.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' C ' HD12 ' A' ' 17' ' ' LEU . . . -153.73 27.7 0.75 Allowed Glycine 0 CA--C 1.492 -1.387 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.019 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -146.16 169.54 18.53 Favored 'General case' 0 CA--C 1.458 -2.583 0 CA-C-O 121.944 0.878 . . . . 0.0 113.229 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.6 t70 -86.77 103.61 15.37 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 168.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.15 24.12 10.61 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.052 -169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.665 ' HB3' HD21 ' A' ' 79' ' ' LEU . 16.2 m -59.06 -41.72 88.63 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 82' ' ' LEU . 49.5 ttt180 -72.88 -30.6 64.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 118.955 -1.098 . . . . 0.0 110.253 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -70.67 -33.03 70.49 Favored 'General case' 0 C--O 1.202 -1.403 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 93' ' ' TRP . 61.5 mt -62.5 -33.57 75.16 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.992 175.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.62 17.14 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.428 -1.367 . . . . 0.0 112.431 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -88.14 -23.94 23.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 122.408 0.283 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.1 mmm 65.21 42.09 4.17 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.379 1.072 . . . . 0.0 109.996 -175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 42.3 t -94.98 162.45 13.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.34 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -129.22 -9.48 4.74 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.416 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -76.36 141.52 41.48 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.833 176.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -57.93 -24.98 60.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.28 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.46 -54.38 40.89 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.976 0.798 . . . . 0.0 110.608 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.02 -8.36 59.32 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 12.2 t -74.79 100.96 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -152.49 151.57 27.37 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.088 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 57.7 Cg_endo -72.55 -3.19 13.01 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.583 2.855 . . . . 0.0 114.557 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.3 t -65.13 122.61 17.46 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.665 HD21 ' HB3' ' A' ' 62' ' ' SER . 11.3 mt -114.3 6.18 16.03 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.144 169.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -13.17 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.298 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.63 41.28 2.22 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 79' ' ' LEU . 76.1 mt -145.16 128.5 16.84 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.601 0.76 . . . . 0.0 109.356 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 86' ' ' GLU . 15.4 t -92.61 -172.71 3.14 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.84 -46.15 81.89 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HG2' HG23 ' A' ' 83' ' ' THR . 17.9 ptpt -59.48 -35.82 74.83 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.0 0.905 . . . . 0.0 109.611 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.622 ' HB3' HD22 ' A' ' 82' ' ' LEU . 48.4 mt-10 -77.0 -51.4 11.17 Favored 'General case' 0 N--CA 1.407 -2.602 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.284 -175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.6 -48.34 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.97 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -54.97 -35.07 63.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.7 m -62.12 -47.78 83.09 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.37 0.605 . . . . 0.0 109.915 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -73.0 -40.73 64.96 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.665 177.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -51.85 -38.09 54.58 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.236 1.015 . . . . 0.0 109.454 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 17.4 t70 -66.06 -49.59 67.1 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.492 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CG ' HD22 ' A' ' 65' ' ' LEU . 41.1 m95 -56.22 -41.34 75.49 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 90' ' ' LEU . 84.3 mt-10 -48.01 -57.09 6.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.91 0.862 . . . . 0.0 109.474 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 m -56.0 -29.45 60.34 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 126.601 1.96 . . . . 0.0 112.925 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.8 mmtt -74.94 -35.71 62.15 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.121 0.963 . . . . 0.0 108.702 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -82.99 -48.47 10.62 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.713 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 94' ' ' GLU . 38.6 mt-10 -55.6 -20.84 14.96 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.69 19.65 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.72 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -112.83 -34.36 5.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -111.13 140.24 22.63 Favored Pre-proline 0 C--N 1.297 -1.706 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.008 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 80.7 Cg_endo -81.11 142.13 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.207 2.604 . . . . 0.0 112.658 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.4 t -81.55 113.46 20.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.4 m -109.71 8.01 8.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.46 -155.23 26.46 Favored Glycine 0 CA--C 1.493 -1.305 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.667 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -135.5 164.26 28.21 Favored 'General case' 0 CA--C 1.462 -2.422 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 9.2 p -114.18 135.01 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.446 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 168.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 12' ' ' PHE . 27.3 m -115.64 144.16 23.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.089 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.275 -2.642 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.698 -170.325 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.08 76.76 0.83 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.545 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -80.98 94.2 6.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 t60 62.03 101.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -93.02 173.52 7.7 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -162.3 95.55 0.94 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.76 0.79 . . . . 0.0 113.087 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -133.67 75.88 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 m80 73.61 -52.45 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.217 1.407 . . . . 0.0 109.53 -169.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.3 mt -138.92 -178.59 5.4 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 15.8 pt-20 -123.25 152.87 40.89 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.437 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 30.5 tt0 -99.31 142.39 30.85 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-O 121.358 0.599 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 97.1 m-85 -121.93 136.16 54.91 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.384 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.617 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 8.8 m -89.06 153.07 21.29 Favored 'General case' 0 C--N 1.273 -2.727 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -46.02 66.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.13 -37.9 84.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.781 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.617 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.4 mp0 -76.31 -45.01 34.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.644 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.69 -46.92 77.54 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 110.278 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 50.2 m -64.09 -13.77 49.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' A' ' 16' ' ' GLN . 49.7 mt-30 -83.34 -18.06 40.23 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.182 0.515 . . . . 0.0 109.786 177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 89.9 m-85 -86.94 22.88 1.88 Allowed 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 123.255 0.622 . . . . 0.0 112.089 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.47 -16.9 61.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.34 0.591 . . . . 0.0 110.758 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 114.55 -39.9 2.65 Favored Glycine 0 CA--C 1.492 -1.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.423 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.2 m -64.13 -27.24 68.95 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 123.387 0.675 . . . . 0.0 111.703 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.712 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 14.1 t70 -87.4 95.45 10.01 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 122.141 -0.349 . . . . 0.0 110.428 -174.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 39.7 mt-10 59.28 23.24 11.62 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.753 0.821 . . . . 0.0 112.28 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 p 56.92 70.17 0.68 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.079 0.943 . . . . 0.0 112.368 -176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 24' ' ' ASP . 46.2 mmtm -83.88 158.1 62.52 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.254 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.84 149.92 89.59 Favored 'Trans proline' 0 C--N 1.355 0.872 0 N-CA-C 107.634 -1.718 . . . . 0.0 107.634 166.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 3.0 mp -101.49 129.92 51.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.378 -170.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.38 134.08 39.38 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.109 0.48 . . . . 0.0 110.645 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 30.0 m -113.38 160.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.06 134.65 46.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.951 0.405 . . . . 0.0 110.204 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 94' ' ' GLU . 60.9 mt -128.31 110.43 21.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 58.5 mmtt 58.36 29.86 18.77 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.457 0.646 . . . . 0.0 112.613 -175.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.16 -12.88 68.48 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.797 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -78.04 109.72 12.36 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 90.0 t -91.61 120.27 40.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.473 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 84.8 m-85 -107.7 138.8 43.28 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.748 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -82.12 116.97 21.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -112.26 19.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.232 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -67.38 -30.42 70.2 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -70.68 -22.51 62.46 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.373 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.32 37.43 3.24 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.84 -31.54 66.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.261 0.624 . . . . 0.0 110.543 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 m -52.47 -22.44 4.8 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 124.431 1.092 . . . . 0.0 112.494 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 91.0 m-85 -98.77 -44.6 6.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.62 0.248 . . . . 0.0 110.845 174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -86.83 -79.8 0.26 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.4 -5.53 82.27 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.227 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 9.35 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 109.89 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 -15.02 15.36 Favored Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.97 -60.07 1.37 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.26 -24.58 67.93 Favored 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.217 1.007 . . . . 0.0 113.208 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 94.0 m-85 -107.75 6.65 27.8 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -77.63 -8.2 57.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 1.9 mpt? -63.32 -33.34 75.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 3.3 p90 -110.76 68.17 0.66 Allowed 'General case' 0 N--CA 1.407 -2.599 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.955 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.34 -14.29 12.81 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.145 172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -163.44 51.72 0.3 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 55' ' ' MET . 7.4 mmpt? -144.7 153.99 42.29 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.172 0.589 . . . . 0.0 109.493 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 10.7 t70 -89.81 110.01 20.97 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 168.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -103.74 27.86 7.12 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.156 -174.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.448 ' OG ' HD21 ' A' ' 79' ' ' LEU . 23.2 t -55.03 -41.37 71.3 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 78' ' ' SER . 48.6 ttt180 -71.81 -36.74 70.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.793 0.33 . . . . 0.0 111.843 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.4 -33.41 69.44 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 121.72 0.771 . . . . 0.0 108.95 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 93' ' ' TRP . 57.4 mt -61.16 -32.21 71.94 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.047 -1.433 . . . . 0.0 112.153 176.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.37 -30.96 9.33 Favored Glycine 0 N--CA 1.438 -1.218 0 C-N-CA 119.248 -1.453 . . . . 0.0 112.457 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 5.1 mmpt? -73.18 -30.71 63.74 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.1 mmm 67.33 56.45 0.62 Allowed 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -173.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 m -145.05 172.88 12.45 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.591 -176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.76 2.13 0.17 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 p30 -67.06 140.43 57.63 Favored 'General case' 0 CA--C 1.478 -1.816 0 C-N-CA 119.521 -0.871 . . . . 0.0 108.787 174.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.43 -20.23 28.87 Favored 'General case' 0 C--N 1.28 -2.429 0 C-N-CA 126.832 2.053 . . . . 0.0 111.399 -175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.456 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 26.9 mt-10 -75.76 -38.31 58.47 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.38 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.41 -30.44 22.1 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.755 0.312 . . . . 0.0 110.77 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 71' ' ' ASN . 47.8 t -61.24 124.14 15.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 t -175.77 152.26 1.29 Allowed Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.333 -170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.6 -10.62 14.45 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.021 2.481 . . . . 0.0 112.378 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 32.9 t -77.86 145.35 36.32 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.852 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' OG ' ' A' ' 62' ' ' SER . 37.8 mt -117.04 84.2 2.11 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.54 136.49 41.21 Favored 'General case' 0 N--CA 1.402 -2.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.117 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.28 23.59 43.58 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -126.32 127.72 45.98 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.074 -1.063 . . . . 0.0 110.209 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 p -88.56 -178.3 5.8 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.03 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.07 -45.21 87.48 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -54.08 -49.05 69.93 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.844 0.831 . . . . 0.0 110.569 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 82' ' ' LEU . 52.1 mt-10 -66.76 -41.01 88.45 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.42 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.1 mt -68.46 -41.57 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.444 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.628 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -51.94 -37.12 51.58 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.117 0.484 . . . . 0.0 111.508 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 95.6 m -61.23 -44.06 97.87 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.5 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -74.27 -38.83 63.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 12.2 m120 -54.95 -39.87 69.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.355 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 13.2 t70 -63.2 -47.89 80.65 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.012 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.539 ' CG ' HD22 ' A' ' 65' ' ' LEU . 77.1 m95 -54.38 -46.78 73.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 46.9 mt-10 -50.16 -49.23 52.86 Favored 'General case' 0 C--O 1.21 -0.981 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 70.7 m -59.9 -33.03 71.32 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 126.355 1.862 . . . . 0.0 112.159 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 74.9 mmtt -76.32 -43.56 40.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 121.73 0.776 . . . . 0.0 109.046 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 59.4 m-85 -66.4 -38.43 87.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.943 175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.41 -28.0 40.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 124.766 1.227 . . . . 0.0 112.882 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' C ' ' HE3' ' A' ' 100' ' ' LYS . . . -107.32 -20.32 13.31 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.498 ' HE3' ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -100.54 -29.24 12.46 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.886 -0.509 . . . . 0.0 111.687 -174.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -132.45 148.0 67.89 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 116.308 -0.405 . . . . 0.0 112.011 -172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 52.8 Cg_endo -86.56 134.94 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.777 2.318 . . . . 0.0 112.874 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.5 t -74.97 105.4 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.77 2.04 8.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 153.42 -153.42 24.83 Favored Glycine 0 CA--C 1.486 -1.773 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.451 177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.501 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -132.41 164.36 26.7 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.57 HG12 ' HA2' ' A' ' 35' ' ' GLY . 12.4 p -99.38 140.04 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.209 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 168.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' THR . 4.8 p -123.31 145.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.74 173.0 55.08 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -129.21 -46.92 1.21 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -141.48 105.01 4.68 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -70.3 135.51 48.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 66.49 60.63 0.59 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 125.14 1.376 . . . . 0.0 112.42 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -145.24 147.79 32.78 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -81.12 -53.29 6.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.6 109.21 13.77 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.408 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.35 136.48 46.87 Favored 'General case' 0 N--CA 1.396 -3.172 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.7 tt0 -82.98 114.68 21.42 Favored 'General case' 1 N--CA 1.37 -4.44 0 CA-C-O 122.13 0.967 . . . . 0.0 111.279 176.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 60.2 m-85 -99.35 135.41 40.8 Favored 'General case' 0 N--CA 1.387 -3.62 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.374 174.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.7 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 23.3 m -95.79 146.32 24.64 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -172.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.98 -35.37 76.62 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.386 0.612 . . . . 0.0 110.604 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.7 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.1 mp0 -75.98 -36.39 59.25 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.967 178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.67 -27.65 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.556 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -64.45 8.5 0.11 Allowed 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -105.49 -21.67 13.17 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.711 0.767 . . . . 0.0 108.996 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 29' ' ' ILE . 95.5 m-85 -87.4 22.36 2.19 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.957 -175.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.577 ' O ' ' HA2' ' A' ' 48' ' ' GLY . 10.0 p30 -79.95 -14.53 58.53 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.252 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 26' ' ' SER . . . 103.59 -6.14 48.7 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.322 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.3 m -89.14 -41.79 12.06 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.308 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 t70 -67.96 97.26 0.66 Allowed 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 62.09 12.05 4.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.12 0.568 . . . . 0.0 110.963 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 27.4 t 58.35 63.03 1.82 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.044 0.938 . . . . 0.0 110.524 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 47.0 mttm -77.67 168.54 26.93 Favored Pre-proline 0 N--CA 1.479 1.006 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.882 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -54.97 150.45 38.07 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.552 2.168 . . . . 0.0 110.177 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' TYR . 2.4 mp -106.68 124.8 62.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.288 -170.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.55 ' HB3' HG13 ' A' ' 37' ' ' VAL . 86.0 m-85 -134.53 127.78 32.02 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' PHE . 95.8 t -112.6 141.1 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' ARG . . . -121.18 136.62 54.94 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.293 0.568 . . . . 0.0 112.291 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 54.2 mt -134.28 113.87 18.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt 60.98 24.42 14.51 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.243 0.545 . . . . 0.0 111.809 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 92.67 -3.03 74.13 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.432 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 53.1 mtp85 -87.45 108.87 19.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 30' ' ' TYR . 54.8 t -89.01 115.58 29.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.176 0.512 . . . . 0.0 111.381 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 66.4 m-85 -103.77 144.61 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.52 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.06 122.07 29.57 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.49 24.38 4.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -62.97 -26.15 68.7 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.822 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -75.96 -22.99 55.33 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.211 0.529 . . . . 0.0 111.037 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.28 40.65 2.44 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -54.86 -38.21 67.2 Favored 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.772 0.829 . . . . 0.0 111.834 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.8 m -65.91 -15.17 62.71 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.552 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 97.5 m-85 -98.85 -40.02 8.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.221 0.534 . . . . 0.0 110.04 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 54' ' ' SER . 74.3 m-85 -101.34 -70.05 0.76 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 113.385 0.884 . . . . 0.0 113.385 -176.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 21' ' ' ASN . . . -73.87 -18.32 79.56 Favored Glycine 0 C--N 1.314 -0.649 0 N-CA-C 116.639 1.415 . . . . 0.0 116.639 -170.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 m -131.08 91.23 3.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 118.405 1.103 . . . . 0.0 112.414 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.89 42.78 60.46 Favored Glycine 0 C--O 1.24 0.491 0 CA-C-N 114.69 -1.141 . . . . 0.0 114.667 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 46' ' ' PHE . . . -100.29 176.76 28.14 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 119.911 -1.138 . . . . 0.0 110.437 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -75.61 -25.81 57.28 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.149 0.976 . . . . 0.0 109.014 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -91.94 14.55 15.38 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.917 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 23.2 t -65.96 -19.23 65.79 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.4 mmt -85.94 -17.99 33.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.678 0.751 . . . . 0.0 109.895 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.461 ' O ' HG22 ' A' ' 31' ' ' VAL . 40.4 m-85 -95.92 -18.17 20.51 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.549 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.76 -38.42 15.51 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -145.67 44.4 0.87 Allowed Glycine 0 CA--C 1.473 -2.582 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 3.1 tppp? -146.62 140.46 26.06 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 114.447 -0.877 . . . . 0.0 109.01 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 t70 -72.76 107.81 5.4 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 168.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 64' ' ' ALA . . . -107.41 29.24 7.34 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.871 -171.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.0 m -55.11 -40.2 70.21 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 34.3 ttm180 -73.43 -39.15 65.22 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.8 -0.563 . . . . 0.0 109.741 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -64.34 -36.02 82.77 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.388 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.2 mt -60.54 -31.62 70.7 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.19 -1.368 . . . . 0.0 112.865 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.06 -18.37 43.57 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.143 -1.504 . . . . 0.0 112.085 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 31.1 mmmt -97.39 -15.61 20.61 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 122.818 -0.225 . . . . 0.0 111.07 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 96.7 mmm 59.49 29.36 18.91 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.061 0.934 . . . . 0.0 109.745 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 t -97.78 152.02 19.58 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.022 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -126.68 2.91 6.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.596 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.1 p-10 -102.47 137.61 40.48 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.315 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.21 -22.79 43.35 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 71' ' ' ASN . 37.3 mt-10 -55.84 -35.62 66.61 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.39 0.431 . . . . 0.0 110.162 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -109.73 -7.8 15.02 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 18.5 t -84.41 115.77 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 m -168.29 160.62 9.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.851 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.422 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 93.8 Cg_endo -87.52 -22.62 1.57 Allowed 'Trans proline' 0 CA--C 1.551 1.33 0 C-N-CA 122.603 2.202 . . . . 0.0 114.692 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.471 ' C ' HD23 ' A' ' 79' ' ' LEU . 27.3 p -92.22 147.97 22.51 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 78' ' ' SER . 13.4 mt -115.58 19.66 15.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.893 -171.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.22 -16.06 58.98 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.827 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.48 2.94 42.81 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' A' ' 86' ' ' GLU . 8.9 mp -112.29 116.39 30.31 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 123.027 0.531 . . . . 0.0 112.011 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.523 HG23 ' HG2' ' A' ' 85' ' ' LYS . 9.0 t -88.25 -178.25 5.87 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 170.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -52.56 -40.24 62.35 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -174.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.3 ptpt -56.75 -40.58 76.04 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.321 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.605 ' HB3' ' HG ' ' A' ' 82' ' ' LEU . 27.1 mm-40 -77.61 -44.86 26.93 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 123.617 0.767 . . . . 0.0 108.975 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.0 -38.91 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.828 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -50.0 -36.69 29.5 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -65.96 -47.29 75.09 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 121.155 0.502 . . . . 0.0 110.8 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -70.98 -36.78 72.64 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 123.433 0.693 . . . . 0.0 110.689 177.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 12.3 t-20 -56.32 -34.6 66.71 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 124.779 1.231 . . . . 0.0 108.893 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 14.5 t70 -69.72 -50.75 40.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.938 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.586 ' CG ' HD22 ' A' ' 65' ' ' LEU . 60.0 m95 -54.61 -43.11 71.94 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 46.3 mt-10 -50.61 -44.33 57.05 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-O 121.898 0.856 . . . . 0.0 109.55 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 m -70.78 -33.55 70.88 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.293 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 34.6 mmtp -75.25 -34.11 61.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-O 121.807 0.813 . . . . 0.0 109.868 -173.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.4 -47.97 11.66 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.7 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -62.41 -28.2 69.63 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.169 0.588 . . . . 0.0 111.302 -173.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.98 -6.83 27.9 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 122.091 -0.381 . . . . 0.0 111.655 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 -24.75 7.28 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.28 148.8 59.06 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 90.4 Cg_endo -81.21 127.69 6.06 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.393 2.062 . . . . 0.0 112.323 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 38' ' ' PHE . 7.8 p -78.12 103.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.3 m -85.34 -56.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.715 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -135.78 -152.21 6.34 Favored Glycine 0 N--CA 1.425 -2.085 0 C-N-CA 119.138 -1.506 . . . . 0.0 113.479 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 3.5 ptp180 -128.24 163.7 24.16 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-O 120.753 0.311 . . . . 0.0 110.712 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG12 ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -124.01 136.06 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 167.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.9 m -122.26 144.95 29.84 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.406 -2.671 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.259 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.63 -127.56 9.26 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 69.82 -177.24 0.21 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.742 0.817 . . . . 0.0 112.534 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 73.51 -1.08 3.16 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -86.53 131.0 34.29 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.828 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -123.14 173.34 7.94 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -82.99 -26.6 31.12 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -70.5 -64.42 0.9 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.06 146.21 26.83 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 1.3 pm0 -93.47 127.99 39.36 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -94.98 136.12 35.67 Favored 'General case' 0 N--CA 1.392 -3.362 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.446 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 108' ' ' VAL . 88.2 m-85 -123.1 141.63 51.75 Favored 'General case' 0 C--N 1.255 -3.539 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.958 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.703 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 18.6 m -100.55 145.16 28.68 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 171.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.19 76.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -167.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.2 -32.61 74.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.736 0.779 . . . . 0.0 110.234 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.703 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 30.0 mt-30 -76.24 -34.05 59.2 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.263 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -65.43 -27.55 68.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 123.223 0.609 . . . . 0.0 110.776 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 8.4 t -65.96 2.52 1.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.589 0.755 . . . . 0.0 111.992 -174.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -111.55 -2.79 15.35 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 122.665 0.386 . . . . 0.0 110.029 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -95.68 38.83 1.15 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.998 0.904 . . . . 0.0 110.568 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -87.15 0.15 55.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.43 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . 59.13 35.92 86.28 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.78 173.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -106.72 -27.63 10.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.486 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 11.4 m-20 -102.09 133.84 46.29 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 63.13 5.78 2.06 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.185 0.994 . . . . 0.0 113.099 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t 61.94 41.44 11.32 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.355 1.062 . . . . 0.0 109.591 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.0 mttt -58.83 160.38 10.91 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.78 150.04 86.33 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' HA3' ' A' ' 48' ' ' GLY . 38.0 mt -112.43 128.24 69.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' HB3' ' CG1' ' A' ' 37' ' ' VAL . 93.7 m-85 -130.56 142.52 50.47 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 56' ' ' PHE . 28.3 m -121.71 161.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 37' ' ' VAL . . . -137.73 150.93 47.68 Favored 'General case' 0 C--N 1.279 -2.461 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.525 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.674 HG21 ' HG2' ' A' ' 94' ' ' GLU . 69.2 mt -138.48 112.05 7.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.6 mttp 66.36 15.6 10.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.808 0.443 . . . . 0.0 112.098 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.45 -23.17 30.78 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.777 -1.202 . . . . 0.0 113.366 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -78.98 120.23 23.26 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 117.879 0.839 . . . . 0.0 110.639 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 30' ' ' TYR . 91.0 t -88.82 126.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.317 -176.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 72.2 m-85 -111.78 139.93 46.84 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.13 130.12 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.46 23.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.444 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -67.54 -23.8 65.48 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.4 p -69.66 -36.37 76.0 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.899 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' O ' ' HD1' ' A' ' 47' ' ' TYR . . . -103.19 41.28 2.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG3' HD11 ' A' ' 29' ' ' ILE . 65.5 tttm -56.76 -34.17 67.32 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.578 0.751 . . . . 0.0 112.444 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -56.19 -27.64 55.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.466 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -97.25 -48.45 5.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.874 0.369 . . . . 0.0 111.484 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 43' ' ' GLY . 64.8 m-85 -84.61 -60.93 1.92 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -97.41 47.7 1.57 Allowed Glycine 0 CA--C 1.498 -1.027 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.11 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.8 t -129.83 6.06 5.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.39 68.39 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.039 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.97 -149.88 22.56 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.487 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.13 -41.29 74.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.779 0.799 . . . . 0.0 110.497 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.75 19.03 5.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.265 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -73.84 -21.44 60.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.305 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 18.8 mmt -72.6 -22.82 60.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.015 0.436 . . . . 0.0 110.003 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 31' ' ' VAL . 58.1 m-85 -80.5 -28.03 37.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.673 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.34 115.64 5.27 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.104 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 81.54 19.68 65.68 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.133 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' CG ' HG12 ' A' ' 75' ' ' VAL . 13.5 tppt? -146.83 146.17 30.13 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.714 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 77' ' ' PRO . 9.8 t70 -76.44 137.27 39.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 168.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -120.47 19.53 12.0 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 27.8 p -55.11 -41.7 72.0 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 76' ' ' SER . 14.5 ttt180 -70.06 -33.51 72.02 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.203 0.525 . . . . 0.0 111.812 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -71.13 -42.72 68.85 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 93' ' ' TRP . 53.2 mt -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.901 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.62 -12.92 83.73 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 119.778 -1.201 . . . . 0.0 113.333 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' CG ' HD21 ' A' ' 82' ' ' LEU . 42.6 mtmt -116.19 4.63 13.6 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 122.009 -0.701 . . . . 0.0 111.131 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 83.5 mtp 65.72 22.44 11.57 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.84 0.828 . . . . 0.0 109.625 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 74' ' ' ASP . 26.1 t -83.93 153.17 24.09 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.327 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 55' ' ' MET . 13.7 ptpt -151.54 20.92 0.72 Allowed 'General case' 1 C--N 1.237 -4.305 0 CA-C-N 112.088 -2.324 . . . . 0.0 106.161 -176.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.621 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.9 p-10 -102.59 148.58 25.37 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.904 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.91 -34.95 68.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.57 -21.04 60.47 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.443 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 41.7 m-20 -104.03 -14.03 16.08 Favored 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.838 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 71' ' ' ASN . 21.2 t -73.25 117.59 17.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 50.9 m -166.66 152.11 7.55 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.558 -163.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' OD1' ' A' ' 60' ' ' ASP . 67.8 Cg_endo -85.35 32.46 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 124.157 3.238 . . . . 0.0 115.063 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.4 p -153.35 163.7 39.46 Favored 'General case' 0 CA--C 1.476 -1.88 0 O-C-N 122.146 -0.346 . . . . 0.0 111.283 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 62' ' ' SER . 6.9 mt -102.34 30.53 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.65 128.53 36.96 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.94 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.05 23.06 Favored Glycine 0 N--CA 1.401 -3.66 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.708 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 86' ' ' GLU . 75.8 mt -136.84 132.12 34.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 C-N-CA 123.422 0.689 . . . . 0.0 111.606 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.6 p -91.26 174.32 7.45 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -55.5 -36.42 66.67 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.163 0.438 . . . . 0.0 111.188 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -53.71 -45.95 70.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 122.156 0.979 . . . . 0.0 109.915 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' HB3' HD22 ' A' ' 82' ' ' LEU . 50.2 mt-10 -77.4 -45.56 25.49 Favored 'General case' 0 N--CA 1.41 -2.464 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.514 -175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.4 -39.39 74.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.011 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -50.42 -35.22 27.58 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 65' ' ' LEU . 27.0 m -64.53 -39.23 93.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.118 0.485 . . . . 0.0 111.194 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -73.82 -37.26 64.93 Favored 'General case' 0 C--O 1.203 -1.375 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.62 -34.52 58.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.966 173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.3 t70 -66.26 -42.01 89.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.584 0.707 . . . . 0.0 109.411 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.602 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.5 m95 -65.99 -31.34 72.19 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.911 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.674 ' HG2' HG21 ' A' ' 33' ' ' ILE . 43.2 mt-10 -75.74 14.57 0.63 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.447 0.642 . . . . 0.0 110.328 174.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 93' ' ' TRP . 48.9 m -122.53 -36.95 2.85 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.8 mmtp -75.75 -44.06 43.63 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.438 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -75.59 -39.44 58.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.767 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.58 -25.74 67.54 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.889 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.81 4.25 42.73 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.979 -0.451 . . . . 0.0 110.28 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -126.97 -35.61 2.25 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.796 -171.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -121.65 145.17 42.33 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 66.1 Cg_endo -82.65 142.5 11.54 Favored 'Trans proline' 0 C--O 1.248 0.998 0 C-N-CA 122.879 2.386 . . . . 0.0 112.468 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.3 t -76.32 99.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.3 m -78.19 -46.87 25.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.758 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . -157.22 -140.71 3.0 Favored Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 119.792 -1.194 . . . . 0.0 112.621 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.9 ptp180 -136.12 160.28 39.15 Favored 'General case' 0 CA--C 1.474 -1.966 0 CA-C-O 121.347 0.594 . . . . 0.0 111.944 -176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.53 HG12 ' HA2' ' A' ' 35' ' ' GLY . 11.3 p -116.95 133.4 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.659 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.611 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 26.4 m -118.41 145.8 23.87 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.502 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.271 -2.831 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.41 157.68 9.73 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.811 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -126.18 164.28 21.3 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -144.98 81.07 1.63 Allowed 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 123.909 0.884 . . . . 0.0 109.367 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -112.61 96.91 6.24 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -78.89 168.31 19.89 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.392 -172.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.1 m80 69.91 10.24 7.4 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.601 1.161 . . . . 0.0 111.625 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -143.59 170.81 15.13 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -81.35 135.52 35.68 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.472 177.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.08 137.44 32.36 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 32.6 tt0 -99.06 116.34 31.06 Favored 'General case' 0 N--CA 1.381 -3.912 0 CA-C-O 121.727 0.775 . . . . 0.0 109.216 171.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 108' ' ' VAL . 52.5 m-85 -108.44 137.49 46.32 Favored 'General case' 0 N--CA 1.388 -3.57 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.035 175.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 25.5 m -95.13 142.7 27.27 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 170.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.32 66.44 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.71 -35.19 72.26 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.008 0.432 . . . . 0.0 110.988 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.789 HE21 ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -76.49 -36.33 57.87 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.245 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.4 tp -64.67 -32.92 74.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.702 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 27.7 m -63.94 -7.74 9.24 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.356 0.598 . . . . 0.0 111.983 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.05 -19.63 31.66 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -96.86 23.77 6.8 Favored 'General case' 0 C--O 1.21 -1.001 0 C-N-CA 124.345 1.058 . . . . 0.0 109.685 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.643 ' HA ' ' HA3' ' A' ' 58' ' ' GLY . 10.6 p30 -59.54 -0.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.11 -24.71 10.43 Favored Glycine 0 C--N 1.306 -1.122 0 N-CA-C 115.603 1.001 . . . . 0.0 115.603 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 21' ' ' ASN . 11.0 t -96.99 14.57 25.09 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.294 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' CG ' ' HE2' ' A' ' 27' ' ' LYS . 18.5 t70 -79.02 -179.71 6.83 Favored 'General case' 0 N--CA 1.4 -2.975 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 169.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' SER . 38.9 mt-10 -118.97 79.24 1.37 Allowed 'General case' 1 N--CA 1.37 -4.453 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -173.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 50.0 m 91.39 79.89 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.211 -2.268 . . . . 0.0 115.919 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' CG ' ' A' ' 24' ' ' ASP . 66.0 mttm -140.68 151.8 64.24 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 166.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 32.4 Cg_exo -61.89 150.01 87.87 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 121.524 1.482 . . . . 0.0 109.594 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.589 HG22 HG23 ' A' ' 40' ' ' VAL . 2.6 mp -110.6 134.47 52.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -171.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 90.0 m-85 -148.47 128.45 13.55 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 122.059 -0.401 . . . . 0.0 109.987 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.05 135.18 54.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.89 126.54 52.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 51.3 mt -120.61 122.27 67.55 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.827 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 11.5 tmtt? 74.31 -57.77 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.492 1.117 . . . . 0.0 109.608 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 173.91 22.9 0.02 OUTLIER Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 177.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -119.67 123.86 44.87 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.91 118.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-O 121.059 0.457 . . . . 0.0 110.86 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -101.94 140.55 36.08 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.127 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -84.53 127.85 34.27 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.893 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 29' ' ' ILE . 13.4 m -125.04 23.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.899 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.5 m -71.74 -24.86 61.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 p -67.15 -36.04 80.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.953 176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.63 43.89 1.58 Allowed Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.91 -37.18 73.56 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.231 0.612 . . . . 0.0 111.008 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 m -61.26 -16.39 44.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.065 0.46 . . . . 0.0 111.943 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.509 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 98.9 m-85 -105.06 -48.99 3.58 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 120.984 0.421 . . . . 0.0 110.298 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -89.59 -42.32 11.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 29' ' ' ILE . . . -116.01 34.56 4.67 Favored Glycine 0 CA--C 1.5 -0.88 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.267 -174.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -173.72 -28.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.897 0.379 . . . . 0.0 111.331 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' ASP . . . -84.99 -18.84 60.38 Favored Glycine 0 CA--C 1.492 -1.383 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.386 -175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 -37.41 1.29 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-O 121.326 0.403 . . . . 0.0 113.385 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' GLY . 25.7 t70 -57.72 -27.15 62.7 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 125.892 1.677 . . . . 0.0 112.72 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 84.9 m-85 -119.59 17.97 12.79 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -64.14 -25.41 68.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.215 0.531 . . . . 0.0 112.357 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.401 ' SD ' ' N ' ' A' ' 55' ' ' MET . 1.3 pmm? -78.88 -15.05 58.85 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.229 0.538 . . . . 0.0 110.931 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -100.2 -38.97 8.28 Favored 'General case' 0 C--O 1.209 -1.062 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.051 174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.93 -24.39 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 127.033 2.133 . . . . 0.0 116.037 -172.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 21' ' ' ASN . . . -161.56 40.17 0.4 Allowed Glycine 0 CA--C 1.466 -2.985 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 27.7 tptt -145.3 135.57 24.0 Favored 'General case' 1 N--CA 1.371 -4.415 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -62.75 108.56 1.2 Allowed 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -99.73 23.96 8.95 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -54.59 -58.83 5.96 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.395 0.678 . . . . 0.0 111.88 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 22.9 ttm180 -68.37 -32.63 72.85 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.584 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -68.62 -33.95 74.92 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.451 0.643 . . . . 0.0 109.95 -168.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 43.3 mt -65.43 -44.6 86.85 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.072 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.59 -24.5 76.07 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.216 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 29.2 mmmt -88.77 -35.23 16.77 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 78.1 mtp 82.24 20.99 0.28 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.06 1.744 . . . . 0.0 109.308 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 m -90.66 153.84 20.01 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.284 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 8.3 mptt -124.64 5.85 8.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.506 0.669 . . . . 0.0 110.606 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.5 p-10 -80.11 134.11 36.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.023 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -57.36 -35.6 70.15 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 125.803 1.641 . . . . 0.0 111.7 -167.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.71 -23.05 66.06 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -103.3 -2.35 27.27 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.771 0.796 . . . . 0.0 109.392 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 71' ' ' ASN . 8.7 t -89.43 141.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -177.06 146.41 0.66 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -166.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.09 -22.85 18.87 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.0 t -91.83 163.35 14.08 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-O 121.807 0.813 . . . . 0.0 109.975 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.95 8.2 43.6 Favored 'General case' 0 N--CA 1.392 -3.347 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.506 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 57.23 -90.69 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 125.9 1.68 . . . . 0.0 112.801 170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.41 24.38 1.09 Allowed Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 ' HB3' ' A' ' 86' ' ' GLU . 87.6 mt -58.99 141.05 54.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.271 1.028 . . . . 0.0 111.998 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -90.87 179.75 5.69 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.61 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.01 -40.67 85.65 Favored 'General case' 0 C--O 1.212 -0.883 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -53.75 -52.9 58.69 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.352 1.073 . . . . 0.0 109.906 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.646 ' HB3' HD22 ' A' ' 82' ' ' LEU . 18.9 mm-40 -63.03 -52.18 63.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.872 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -66.45 -39.43 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.121 -176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -55.71 -32.68 63.53 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.183 0.516 . . . . 0.0 111.146 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 84.9 m -64.62 -42.16 95.69 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.898 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.557 HD23 HD22 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -73.59 -34.86 65.29 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.653 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.557 HD22 HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -51.87 -33.51 36.85 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.011 174.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.676 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 26.6 t70 -74.86 -48.39 25.23 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CG ' HD22 ' A' ' 65' ' ' LEU . 97.3 m95 -58.66 -41.62 86.52 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.095 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.614 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 42.8 mt-10 -49.34 -65.11 0.62 Allowed 'General case' 0 C--O 1.196 -1.761 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 174.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -45.04 -40.82 6.97 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.57 1.948 . . . . 0.0 112.948 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 53.5 mtmt -76.49 -43.04 41.34 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.409 0.623 . . . . 0.0 109.407 -172.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -72.34 -34.56 68.12 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.131 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 37.4 mt-10 -55.36 -19.87 10.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.383 1.473 . . . . 0.0 113.163 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.12 -6.55 56.94 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.299 0.571 . . . . 0.0 109.703 -175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -47.98 1.53 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.82 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -94.13 133.72 26.98 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.495 -175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -85.39 140.06 7.23 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.91 2.407 . . . . 0.0 111.802 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.17 112.61 17.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.88 -0.75 10.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.373 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.92 -159.32 32.53 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.823 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.677 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 5.9 ptp180 -111.04 161.74 15.58 Favored 'General case' 0 CA--C 1.485 -1.544 0 C-N-CA 123.802 0.841 . . . . 0.0 110.486 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG12 ' HA2' ' A' ' 35' ' ' GLY . 8.0 p -119.15 138.16 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.781 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 166.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.677 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 32.7 m -122.68 144.14 33.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.501 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 36.62 11.93 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.553 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -75.32 142.03 43.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -80.02 135.27 36.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -73.82 99.52 3.21 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.524 0.678 . . . . 0.0 111.452 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -138.75 104.42 5.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -94.19 97.49 10.3 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -166.11 -65.52 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.45 131.95 36.82 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -137.67 146.26 43.62 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -84.12 127.15 33.73 Favored 'General case' 0 N--CA 1.393 -3.276 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 79.9 m-85 -115.75 135.75 53.72 Favored 'General case' 0 N--CA 1.399 -2.985 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.411 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 m -94.25 158.7 15.46 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.28 -48.82 73.48 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -165.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.26 -30.26 63.33 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.627 0.727 . . . . 0.0 110.569 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.729 ' OE1' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -69.77 -31.27 69.12 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.86 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' CD1' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER -66.2 -34.52 78.22 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.42 1.088 . . . . 0.0 108.438 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.6 m -67.91 6.61 0.66 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -102.3 8.97 40.23 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -126.36 34.71 4.78 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.156 1.455 . . . . 0.0 108.029 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 23' ' ' THR . 27.9 p-10 -91.33 7.54 40.46 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 112.527 -2.124 . . . . 0.0 110.605 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.32 2.73 79.57 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 21' ' ' ASN . 12.3 t -102.03 -4.2 26.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 118.244 -1.382 . . . . 0.0 109.895 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.95 175.1 8.43 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.822 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 26' ' ' SER . 43.9 mt-10 -105.18 90.08 3.32 Favored 'General case' 1 N--CA 1.358 -5.038 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -168.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 37.2 m 79.63 16.89 0.82 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.075 -1.875 . . . . 0.0 114.48 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -89.92 151.35 45.17 Favored Pre-proline 0 C--N 1.314 -0.948 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.365 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 65.1 Cg_exo -53.54 149.8 29.8 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 123.067 2.511 . . . . 0.0 112.901 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.9 mm -98.51 138.03 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 28' ' ' PRO . 70.3 m-85 -138.06 148.46 45.07 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 56' ' ' PHE . 12.4 p -134.18 149.0 29.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.92 119.36 34.1 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.29 0.567 . . . . 0.0 111.554 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' CD1' HD11 ' A' ' 65' ' ' LEU . 71.4 mt -119.13 127.7 75.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 71.7 -73.78 0.09 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.9 16.53 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 62.8 mtp180 -103.44 137.5 41.45 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 30' ' ' TYR . 90.8 t -102.39 126.67 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.518 0.199 . . . . 0.0 111.087 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.5 m-85 -117.54 151.05 37.93 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -85.25 121.46 28.02 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -116.53 23.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.453 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 m -71.47 -25.25 62.2 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -63.31 -22.77 67.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.548 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.95 42.84 1.34 Allowed Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -54.06 -35.81 62.44 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 123.154 0.582 . . . . 0.0 111.674 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 m -54.46 -28.44 44.46 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.447 0.467 . . . . 0.0 111.843 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.513 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 95.0 m-85 -87.01 -44.51 11.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.261 0.553 . . . . 0.0 110.261 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 84.1 m-85 -94.2 -71.17 0.67 Allowed 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.06 44.51 2.83 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.428 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.7 t -138.15 14.55 2.83 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.24 38.2 81.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.319 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.75 -169.54 45.49 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -78.6 -14.58 59.25 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 121.434 0.635 . . . . 0.0 110.376 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.513 ' CD2' ' HB3' ' A' ' 46' ' ' PHE . 90.5 m-85 -97.69 14.61 26.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.426 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -69.57 -16.64 63.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.0 mmm -79.77 -16.52 55.41 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.5 m-85 -87.71 -40.9 13.74 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.916 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 47' ' ' TYR . . . -52.0 113.72 1.1 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.635 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' HA2' ' CD1' ' A' ' 17' ' ' LEU . . . 65.26 28.06 73.13 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.922 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HG3' HG12 ' A' ' 75' ' ' VAL . 3.2 tppp? -146.16 131.95 19.02 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.587 0.708 . . . . 0.0 111.861 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' OD1' ' HD3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -59.01 107.1 0.49 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.512 171.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -109.49 19.85 18.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.887 -173.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HB3' HD22 ' A' ' 79' ' ' LEU . 10.2 m -54.28 -49.61 69.18 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.277 0.631 . . . . 0.0 111.67 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.667 ' O ' ' HG2' ' A' ' 67' ' ' LYS . 32.3 ttt180 -71.85 -34.01 68.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.383 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 75' ' ' VAL . . . -66.04 -32.99 74.78 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 121.746 0.784 . . . . 0.0 108.908 -172.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 61' ' ' ALA . 65.0 mt -63.27 -43.34 98.22 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.251 -1.34 . . . . 0.0 112.667 178.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.5 -24.23 54.38 Favored Glycine 0 CA--C 1.499 -0.913 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.412 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 63' ' ' ARG . 27.6 mmmt -92.26 -27.79 17.39 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.1 mtp 76.66 18.53 1.67 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.41 1.884 . . . . 0.0 109.209 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.585 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . 22.3 m -91.45 146.53 23.73 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.705 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -112.26 -18.64 12.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.479 -171.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 10.0 p-10 -57.46 122.56 12.94 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.59 174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.05 -20.23 37.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.133 0.573 . . . . 0.0 112.129 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.34 -29.5 68.25 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.203 0.525 . . . . 0.0 110.334 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.41 -25.97 15.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 71' ' ' ASN . 12.7 t -65.55 115.3 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 t -160.39 159.08 26.24 Favored Pre-proline 0 N--CA 1.436 -1.133 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -167.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HD3' ' OD1' ' A' ' 60' ' ' ASP . 91.4 Cg_endo -84.63 11.36 3.39 Favored 'Trans proline' 0 C--N 1.364 1.361 0 C-N-CA 122.785 2.324 . . . . 0.0 112.355 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 t -87.72 141.72 28.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.085 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -152.12 81.11 1.26 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -141.18 -61.17 0.48 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.176 -169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.6 55.48 4.99 Favored Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 86' ' ' GLU . 45.9 mt -139.32 136.53 34.94 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.638 -171.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -85.74 -174.65 5.25 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 25.9 tt0 -59.97 -41.99 93.18 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.095 -173.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -53.22 -53.06 56.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.877 0.846 . . . . 0.0 110.781 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.68 ' HB3' HD22 ' A' ' 82' ' ' LEU . 12.1 mm-40 -58.39 -48.67 79.89 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.966 -175.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 52.1 mt -72.4 -41.37 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.387 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 91' ' ' ASN . 94.9 m-20 -52.47 -35.37 52.45 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.24 0.543 . . . . 0.0 111.146 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.0 m -61.0 -44.27 97.66 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.911 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.2 -36.14 61.43 Favored 'General case' 0 C--O 1.209 -1.031 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 88' ' ' ASN . 12.3 m120 -52.75 -35.9 56.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.385 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.562 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 20.7 t70 -62.25 -47.04 86.13 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.594 ' CG ' HD22 ' A' ' 65' ' ' LEU . 95.9 m95 -61.09 -36.86 80.77 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.396 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 44.1 mt-10 -61.34 -44.26 97.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.53 0.681 . . . . 0.0 110.045 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.0 m -58.91 -31.62 68.8 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.113 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 33.9 mmtp -73.25 -35.73 66.27 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.719 -178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 11.2 p90 -76.01 -38.08 57.72 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 118.223 -1.391 . . . . 0.0 108.024 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -55.3 -21.01 13.02 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.562 1.545 . . . . 0.0 113.687 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 100' ' ' LYS . . . -117.24 -1.81 11.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -132.72 -44.42 0.89 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 97' ' ' PHE . 16.6 m-85 -103.06 131.39 22.19 Favored Pre-proline 0 C--N 1.296 -1.728 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.089 -172.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 91.6 Cg_endo -75.89 124.33 7.99 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 122.194 1.929 . . . . 0.0 112.072 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 38' ' ' PHE . 70.2 t -71.37 108.33 2.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.07 -58.65 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.711 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -140.63 -147.14 4.91 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 119.334 -1.413 . . . . 0.0 112.558 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.572 ' HD3' ' CG1' ' A' ' 108' ' ' VAL . 11.5 ptp180 -129.36 160.74 32.12 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 120.935 0.397 . . . . 0.0 111.946 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 8.4 p -115.03 138.47 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 168.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.572 ' CG1' ' HD3' ' A' ' 106' ' ' ARG . 33.2 m -129.49 144.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.383 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 57.8 p . . . . . 0 N--CA 1.408 -2.557 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.78 173.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.01 39.56 2.71 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.074 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -84.65 88.53 7.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 117.718 0.759 . . . . 0.0 109.104 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . 0.251 0.5 OUTLIER -152.65 63.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -150.97 81.76 1.33 Allowed 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 124.931 1.292 . . . . 0.0 110.93 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -128.45 -31.92 2.23 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 52.6 t-80 -173.91 148.43 1.41 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 7' ' ' HIS . 58.9 t-80 75.29 152.79 0.14 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 123.844 0.715 . . . . 0.0 111.103 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.73 153.56 23.87 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.41 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.523 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 16.1 pt-20 -81.83 116.86 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.597 0.713 . . . . 0.0 110.548 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.03 140.99 28.9 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-O 121.489 0.662 . . . . 0.0 110.005 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' O ' HG12 ' A' ' 108' ' ' VAL . 90.3 m-85 -119.8 162.37 19.21 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.563 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 41.1 m -121.73 149.28 43.5 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 168.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.69 -46.38 67.27 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.33 -40.89 92.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.441 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.563 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 2.2 mp0 -71.23 -31.96 68.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.928 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.5 tp -66.07 -30.23 70.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.035 0.445 . . . . 0.0 110.974 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.6 m -65.89 -6.88 13.65 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.82 -18.95 49.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.657 0.741 . . . . 0.0 109.234 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.5 37.08 1.29 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.523 -174.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -83.53 -12.01 56.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.379 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 58.57 6.01 Favored Glycine 0 CA--C 1.476 -2.353 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.6 p -119.89 -19.29 7.97 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-O 121.427 0.632 . . . . 0.0 109.706 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 13.0 m-20 -97.84 99.94 11.28 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.605 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 58.24 14.9 3.04 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t 64.03 32.7 12.74 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 123.996 0.81 . . . . 0.0 110.632 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 24' ' ' ASP . 52.3 mtmt -60.1 151.53 65.83 Favored Pre-proline 0 C--N 1.346 0.429 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -26.83 118.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.939 1 C-N-CA 125.439 4.092 . . . . 0.0 115.197 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' HA3' ' A' ' 48' ' ' GLY . 37.3 mt -107.57 132.3 55.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.224 -176.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CE1' HG21 ' A' ' 104' ' ' VAL . 67.4 m-85 -133.77 153.27 51.84 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.44 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.46 160.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.62 130.67 42.45 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.837 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 60.8 mt -134.63 122.11 37.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 62.67 18.5 10.64 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.303 0.573 . . . . 0.0 110.494 -176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.48 -7.41 76.41 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.303 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -80.73 119.76 23.75 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 30' ' ' TYR . 93.8 t -93.49 121.73 44.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.244 0.545 . . . . 0.0 110.362 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 98' ' ' GLU . 65.3 m-85 -113.7 147.47 38.13 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.585 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.28 125.16 32.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.56 19.18 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.718 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.7 m -64.49 -26.13 68.3 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.2 t -71.81 -22.64 61.53 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.037 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.72 39.21 2.93 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.17 -25.94 68.58 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 122.831 0.452 . . . . 0.0 111.072 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 m -61.86 -26.62 68.25 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.97 -49.1 4.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.914 0.388 . . . . 0.0 111.747 -177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -90.41 -63.81 1.22 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.174 -174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.544 ' HA3' HD13 ' A' ' 29' ' ' ILE . . . -71.53 -9.1 68.38 Favored Glycine 0 C--O 1.22 -0.742 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -89.95 10.33 24.37 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 122.18 -0.6 . . . . 0.0 109.983 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.59 41.13 76.78 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.51 -158.25 28.09 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.95 -0.625 . . . . 0.0 113.387 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.1 -27.01 63.29 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.161 0.585 . . . . 0.0 111.286 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -110.22 25.53 11.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.998 0.427 . . . . 0.0 111.289 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.2 t -69.52 -10.19 57.06 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.832 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -48.72 70.47 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.901 0.88 . . . . 0.0 112.06 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -94.5 12.34 27.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -175.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.42 107.03 4.15 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . 80.53 22.3 62.57 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 56' ' ' PHE . 4.4 tppp? -146.06 137.86 25.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.839 0.352 . . . . 0.0 111.711 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' CG ' ' HA ' ' A' ' 77' ' ' PRO . 8.4 t70 -79.2 126.01 30.2 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . . . -127.57 32.79 4.94 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 120.789 0.328 . . . . 0.0 110.142 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.8 t -56.63 -42.7 79.29 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.48 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . 33.4 ptt180 -75.23 -30.44 60.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.463 -1.295 . . . . 0.0 112.009 176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 93' ' ' TRP . 39.4 mt -61.68 -30.32 70.66 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.2 -1.363 . . . . 0.0 112.032 174.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' HB ' ' A' ' 89' ' ' THR . . . -87.02 -20.04 54.28 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.768 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.58 ' HD3' HD21 ' A' ' 82' ' ' LEU . 29.5 mmmt -96.54 -29.35 13.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.881 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.407 ' HG2' HG21 ' A' ' 89' ' ' THR . 93.1 mmm 80.83 18.78 0.5 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.095 1.358 . . . . 0.0 108.97 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.7 m -87.58 139.76 30.21 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.032 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -110.45 -10.19 14.57 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.16 0.505 . . . . 0.0 110.534 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.3 p-10 -72.88 139.19 46.71 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.696 0.76 . . . . 0.0 112.587 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -57.38 -33.22 67.6 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.433 -177.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.61 -17.37 54.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.269 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -117.09 4.93 12.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.501 0.667 . . . . 0.0 110.621 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' ASN . 39.2 t -94.6 124.35 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t -150.7 151.22 30.03 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -171.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HA ' ' CG ' ' A' ' 60' ' ' ASP . 67.0 Cg_endo -71.84 15.27 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.461 2.774 . . . . 0.0 113.939 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 66.2 m -158.34 176.25 12.7 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 123.445 0.698 . . . . 0.0 110.079 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 63' ' ' ARG . 6.4 mp -88.87 -41.79 12.24 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.633 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . 0.315 13.8 pt-20 57.83 -51.68 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 128.233 2.613 . . . . 0.0 117.133 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.07 62.41 0.6 Allowed Glycine 0 C--N 1.293 -1.833 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 86' ' ' GLU . 92.1 mt -134.24 129.68 36.03 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 122.858 0.463 . . . . 0.0 110.208 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -86.51 174.09 9.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -52.99 -40.43 63.79 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 118.65 0.659 . . . . 0.0 111.828 -177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HA ' HD22 ' A' ' 88' ' ' ASN . 32.7 ttmt -52.07 -53.22 44.92 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.285 0.634 . . . . 0.0 109.788 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.717 ' HB3' HD22 ' A' ' 82' ' ' LEU . 16.4 mm-40 -64.66 -45.0 88.61 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.423 -178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 72.0 mt -63.56 -33.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.133 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 85' ' ' LYS . 50.8 m-80 -49.45 -35.77 20.45 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.526 ' HB ' ' HA2' ' A' ' 66' ' ' GLY . 54.2 m -64.51 -48.49 74.94 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.723 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -72.42 -43.77 63.38 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.063 0.545 . . . . 0.0 110.576 178.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 33.9 t-20 -51.19 -34.53 32.07 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.196 0.998 . . . . 0.0 109.595 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 23.1 t70 -71.3 -46.32 61.0 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CG ' HD22 ' A' ' 65' ' ' LEU . 66.6 m95 -59.62 -38.43 81.29 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 91' ' ' ASN . 54.7 mt-10 -49.64 -51.62 36.59 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.5 m -61.96 -28.77 69.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.833 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.3 mmtt -75.44 -41.88 54.76 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-O 121.519 0.676 . . . . 0.0 109.271 -173.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 69.6 m-85 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.609 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -65.02 -31.52 72.8 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 123.456 0.702 . . . . 0.0 110.011 -175.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -95.1 9.48 39.43 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.66 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.5 OUTLIER -129.76 -36.31 1.62 Allowed 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.018 -171.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.04 148.91 44.52 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.9 Cg_endo -82.79 142.13 11.17 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.83 2.353 . . . . 0.0 112.999 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.29 108.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 172.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 30' ' ' TYR . 21.3 m -90.46 -20.45 6.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.524 0.678 . . . . 0.0 110.658 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 175.36 -148.34 9.43 Favored Glycine 0 N--CA 1.42 -2.423 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.87 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.84 162.03 37.8 Favored 'General case' 0 CA--C 1.47 -2.103 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.88 131.45 49.81 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.074 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 13' ' ' THR . 2.8 p -117.65 136.65 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.196 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--N 1.276 -2.591 0 CA-C-O 118.303 -0.856 . . . . 0.0 108.955 177.48 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 66.5 mtt . . . . . 0 CA--C 1.512 -0.509 0 CA-C-O 120.927 0.394 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.86 11.17 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -89.46 66.57 7.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.956 0.884 . . . . 0.0 111.898 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -155.76 126.89 7.08 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.307 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -110.81 153.96 24.65 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.931 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 10' ' ' GLU . 57.0 m80 -84.48 92.24 8.03 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -76.53 89.66 3.29 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.194 0.521 . . . . 0.0 111.543 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 172.25 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -177.74 147.52 0.49 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 172.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 19.3 mt-10 -104.63 113.53 27.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -175.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG3' ' HD3' ' A' ' 106' ' ' ARG . 37.2 tt0 -88.18 122.8 32.15 Favored 'General case' 1 N--CA 1.378 -4.053 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 46.0 m-85 -118.31 134.92 54.63 Favored 'General case' 0 N--CA 1.385 -3.707 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.389 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.645 ' HB ' ' NE2' ' A' ' 16' ' ' GLN . 7.3 m -93.42 155.61 17.26 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.03 -46.95 68.69 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.03 -34.17 68.59 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.633 -0.667 . . . . 0.0 110.039 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.645 ' NE2' ' HB ' ' A' ' 13' ' ' THR . 37.5 mt-30 -67.36 -40.14 85.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.833 176.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -59.14 -38.89 80.75 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.169 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 40.9 m -61.02 -21.41 63.57 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.737 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -86.12 1.49 50.31 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.505 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.44 30.77 7.03 Favored 'General case' 0 C--O 1.214 -0.778 0 C-N-CA 122.777 0.431 . . . . 0.0 111.051 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 9.9 p30 -81.61 1.78 32.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.254 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 29' ' ' ILE . . . 92.15 -9.06 77.13 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -75.21 -20.1 59.44 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.1 t70 -76.82 91.01 3.49 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 69.76 -64.78 0.33 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.528 1.531 . . . . 0.0 112.321 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -179.15 22.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.39 0.676 . . . . 0.0 110.347 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 21.6 ptmt -71.41 160.09 83.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.106 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 41' ' ' THR . 11.2 Cg_endo -52.32 151.3 17.97 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.279 3.319 . . . . 0.0 113.458 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 HG13 ' HA3' ' A' ' 22' ' ' GLY . 2.7 mp -111.88 134.35 54.6 Favored 'Isoleucine or valine' 0 C--O 1.249 1.073 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.174 -175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CE1' HG21 ' A' ' 104' ' ' VAL . 93.7 m-85 -135.31 130.84 35.68 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 56' ' ' PHE . 30.4 m -111.66 155.88 12.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' ASP . . . -131.73 136.77 47.87 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CG2' ' HG2' ' A' ' 94' ' ' GLU . 61.6 mt -132.18 112.19 19.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.629 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 1.1 tmtp? 69.06 16.98 8.62 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.048 1.404 . . . . 0.0 108.267 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.641 ' HA2' HG12 ' A' ' 107' ' ' VAL . . . 105.9 -12.66 45.66 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.025 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -88.93 117.05 27.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 117.602 0.701 . . . . 0.0 109.625 -177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.09 126.59 44.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.69 0.281 . . . . 0.0 110.817 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HA ' ' O ' ' A' ' 102' ' ' PRO . 79.8 m-85 -113.76 143.6 44.36 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 -179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.48 115.84 23.44 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 101' ' ' TYR . 23.3 m -119.81 26.56 3.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.118 0.485 . . . . 0.0 110.235 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 28' ' ' PRO . 28.5 m -63.41 -31.42 72.57 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.401 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.2 p -74.22 -27.3 60.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.19 41.97 2.01 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.25 -33.55 72.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.664 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -64.28 -4.34 3.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.103 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 96.5 m-85 -111.95 -47.6 3.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -95.36 -65.38 0.98 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.04 -5.72 88.97 Favored Glycine 0 N--CA 1.466 0.682 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.223 -170.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.9 t -159.74 21.44 0.17 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.77 -16.63 38.45 Favored Glycine 0 CA--C 1.471 -2.663 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.11 -48.19 2.38 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.575 -0.813 . . . . 0.0 114.683 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.83 -41.35 75.08 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 120.973 0.416 . . . . 0.0 111.296 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 99.3 m-85 -101.62 23.82 10.67 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.925 0.393 . . . . 0.0 110.315 178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -62.44 -29.61 70.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.043 0.925 . . . . 0.0 111.377 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 20.7 mmt -86.21 -8.16 58.0 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.245 -174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.2 m-85 -99.71 -30.78 11.9 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.253 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 21' ' ' ASN . . . -45.53 -26.68 0.62 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.794 1.637 . . . . 0.0 115.161 -173.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' SER . . . -155.81 44.99 0.53 Allowed Glycine 0 CA--C 1.473 -2.548 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.8 tppt? -147.23 148.95 32.0 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 9.1 t70 -78.33 121.36 24.34 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 171.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.84 25.66 11.4 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.184 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 34' ' ' LYS . 22.0 p -55.03 -51.75 65.32 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 82' ' ' LEU . 57.9 ttt180 -61.89 -39.13 90.91 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.527 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.83 -33.25 73.51 Favored 'General case' 0 C--O 1.204 -1.319 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.59 -171.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.623 HD22 ' CG ' ' A' ' 93' ' ' TRP . 60.8 mt -63.69 -39.84 95.33 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.085 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.11 -26.35 41.02 Favored Glycine 0 C--N 1.312 -0.782 0 C-N-CA 119.222 -1.466 . . . . 0.0 111.793 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.527 ' HG3' ' OD1' ' A' ' 74' ' ' ASP . 6.1 mmpt? -80.85 -33.19 34.7 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.8 mtp 70.79 33.57 2.2 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 125.821 1.648 . . . . 0.0 107.807 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.4 m -113.88 134.32 54.88 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 113.305 -1.771 . . . . 0.0 110.212 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 55' ' ' MET . 22.8 mttt -106.33 -8.53 17.2 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.139 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -59.07 117.61 4.9 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 171.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.86 -26.58 58.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.842 1.257 . . . . 0.0 111.41 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.98 -33.79 71.08 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.48 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.527 ' OD1' ' HG3' ' A' ' 67' ' ' LYS . 16.3 t70 -88.29 -36.7 16.53 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.777 -177.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.37 131.52 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.38 -172.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.5 t -162.13 147.65 10.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -166.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' ASP . 91.3 Cg_endo -80.01 31.68 0.49 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 123.94 3.093 . . . . 0.0 114.202 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 23.1 t -153.51 166.13 33.68 Favored 'General case' 0 CA--C 1.466 -2.264 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 90' ' ' LEU . 6.1 mt -76.18 -45.49 33.04 Favored 'General case' 0 N--CA 1.413 -2.277 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 63.95 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 168.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.58 57.09 0.44 Allowed Glycine 0 CA--C 1.477 -2.307 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 86' ' ' GLU . 69.2 mt -136.58 125.74 24.61 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.643 -0.778 . . . . 0.0 110.366 -177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 85' ' ' LYS . 6.5 t -91.95 -179.29 5.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 170.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -52.65 -46.97 67.38 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 83' ' ' THR . 18.6 ptpt -57.99 -36.71 73.02 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.406 0.622 . . . . 0.0 109.937 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.523 ' HB3' HD22 ' A' ' 82' ' ' LEU . 55.6 mt-10 -78.9 -44.72 22.12 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 124.547 1.139 . . . . 0.0 110.518 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.57 -41.47 88.01 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.104 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.864 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -50.47 -35.76 30.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.509 0.724 . . . . 0.0 112.573 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.0 m -67.31 -48.25 68.17 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.483 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -69.95 -39.55 75.99 Favored 'General case' 0 C--O 1.207 -1.148 0 C-N-CA 123.095 0.558 . . . . 0.0 110.696 177.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.26 -39.05 69.33 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 124.97 1.308 . . . . 0.0 108.314 178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 96' ' ' LYS . 32.5 t70 -68.67 -43.8 75.4 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.802 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.623 ' CG ' HD22 ' A' ' 65' ' ' LEU . 78.9 m95 -56.13 -47.77 77.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.474 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 49.1 mt-10 -50.6 -52.6 37.75 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 92' ' ' ASP . 52.7 m -51.79 -31.59 27.71 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 126.224 1.809 . . . . 0.0 112.353 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 75.9 mmtt -75.85 -43.45 45.73 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 93' ' ' TRP . 44.4 m-85 -71.45 -43.6 66.36 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.325 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -54.37 -20.21 6.93 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.129 1.772 . . . . 0.0 113.793 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -113.65 -9.24 13.22 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.444 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 96' ' ' LYS . 13.5 mptt -120.73 -50.77 2.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 112.404 -176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' CD1' HG12 ' A' ' 40' ' ' VAL . 98.2 m-85 -92.48 140.48 24.09 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.179 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 77.6 Cg_endo -78.31 132.31 11.24 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.523 2.149 . . . . 0.0 113.514 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.3 t -79.74 104.73 8.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 30' ' ' TYR . 29.7 m -90.43 -9.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.556 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 10' ' ' GLU . . . 167.71 -149.95 15.66 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.601 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HD3' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -133.16 164.63 26.63 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.641 HG12 ' HA2' ' A' ' 35' ' ' GLY . 14.2 p -106.59 137.84 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.567 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 168.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' OE2' ' A' ' 11' ' ' GLU . 27.3 m -116.63 144.81 23.43 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.414 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.408 -2.529 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.856 . . . . . . . . 0 0 . 1 stop_ save_